• 2025.04.27
  ASHP供給不足情報（2025年4月21日～4月27日）

  Generic Name	Shortage Status	Revision Date
  Meperidine Hydrochloride Injection	Current Shortages	25-Apr-25
  Amifostine Injection	Discontinued Drugs	24-Apr-25
  Rho(D) Immune Globulin (Human)	Current Shortages	24-Apr-25
  Amphetamine Mixed Salts, Immediate-Release Tablets	Current Shortages	23-Apr-25
  Bivalirudin Injection	Current Shortages	23-Apr-25
  Erythromycin Lactobionate Injection	Current Shortages	23-Apr-25
  Liraglutide Injection	Current Shortages	23-Apr-25
  Potassium Chloride Injection	Current Shortages	23-Apr-25
  Alteplase Injection	Current Shortages	22-Apr-25
  Clindamycin Phosphate Injection	Current Shortages	22-Apr-25
  Dicyclomine Oral Presentations	Current Shortages	22-Apr-25
  Ephedrine Injection	Current Shortages	22-Apr-25
  Heparin Sodium Premixed Bags	Current Shortages	22-Apr-25
  Hydroxocobalamin Injection	Current Shortages	22-Apr-25
  Lidocaine 5% Transdermal Patch	Current Shortages	22-Apr-25
  Orphenadrine Citrate Injection	Current Shortages	22-Apr-25
  Aminocaproic Acid Injection	Current Shortages	21-Apr-25
  Amiodarone Injection	Current Shortages	21-Apr-25
  Clonazepam Oral Tablets	Current Shortages	21-Apr-25
  Droperidol Injection	Current Shortages	21-Apr-25
  Hydrocortisone Sodium Succinate Injection	Current Shortages	21-Apr-25
  Leucovorin Calcium Injection	Current Shortages	21-Apr-25
  Lidocaine Hydrochloride Oral Topical Solution (Viscous) 2%	Current Shortages	21-Apr-25
  Methadone Hydrochloride Oral Solution	Current Shortages	21-Apr-25
  Methylprednisolone Sodium Succinate Injection	Current Shortages	21-Apr-25
  Mitomycin Injection	Current Shortages	21-Apr-25
  Propranolol Hydrochloride Oral Solution	Current Shortages	21-Apr-25

• 2025.04.27
  FDA供給不足情報：新規（2025年4月21日～4月27日）

  April 25, 2025
  Liraglutide Injection (Currently In Shortage)

  April 24, 2025
  Topiramate Capsule, Extended Release (Discontinuation)

  April 23, 2025
  Baclofen Tablet (Discontinuation)

  April 22, 2025
  Oxaliplatin Injection (Discontinuation)

• 2025.04.21
  ASHP供給不足情報（2025年4月14日～4月20日）

  Generic Name	Shortage Status	Revision Date
  Amino Acid Products	Current Shortages	20-Apr-25
  Azithromycin Powder for Oral Suspension Packets	Current Shortages	20-Apr-25
  Hydroxyzine Pamoate Oral Capsules	Current Shortages	20-Apr-25
  Lorazepam Tablets	Current Shortages	20-Apr-25
  Oseltamivir Oral Suspension and Capsules	Current Shortages	20-Apr-25
  Penicillin V Potassium Oral Presentations	Current Shortages	20-Apr-25
  Amifostine Injection	Current Shortages	18-Apr-25
  Aminocaproic Acid Injection	Current Shortages	18-Apr-25
  Becaplermin Topical Gel	Current Shortages	18-Apr-25
  Mefloquine Hydrochloride Tablets	Current Shortages	18-Apr-25
  Morphine Sulfate Immediate-Release Tablets	Current Shortages	18-Apr-25
  Oxymorphone Immediate-Release Tablets	Current Shortages	18-Apr-25
  Methylphenidate Extended Release Oral Presentations	Current Shortages	17-Apr-25
  Dexamethasone Oral Solution/Elixir	Current Shortages	16-Apr-25
  Hydromorphone Immediate-Release Oral Presentations	Current Shortages	16-Apr-25
  Naltrexone Tablets	Current Shortages	16-Apr-25
  Dofetilide Capsules	Current Shortages	15-Apr-25
  Morphine Sulfate Extended-Release Tablets	Current Shortages	15-Apr-25
  Pyridostigmine Bromide Extended-Release Tablets	Current Shortages	15-Apr-25
  Sufentanil Injection	Current Shortages	15-Apr-25
  Acamprosate Calcium Tablets	Current Shortages	14-Apr-25
  Epinephrine Auto-Injectors	Current Shortages	14-Apr-25
  Fluvoxamine Maleate Extended-Release Capsules	Resolved Shortages	14-Apr-25
  Methadone Hydrochloride Oral Solution	Current Shortages	14-Apr-25
  Propranolol Hydrochloride Oral Solution	Current Shortages	14-Apr-25
  Ribavirin Inhalation	Current Shortages	14-Apr-25

• 2025.04.21
  FDA供給不足情報：新規（2025年4月14日～4月20日）

  April 14, 2025

  • Adalimumab-adaz Injection (Discontinuation)
• 2025.04.14
  ASHP供給不足情報（2025年4月7日～4月13日）

  Generic Name	Shortage Status	Revision Date
  Bupivacaine Injection	Current Shortages	13-Apr-25
  Disulfiram Tablets	Current Shortages	13-Apr-25
  Lisdexamfetamine Dimesylate Capsules	Current Shortages	13-Apr-25
  Losartan and Hydrochlorothiazide Tablets	Current Shortages	13-Apr-25
  Mefloquine Hydrochloride Tablets	Current Shortages	13-Apr-25
  Moxifloxacin Tablets	Current Shortages	13-Apr-25
  Theophylline 24-Hour Extended Release Capsules and Tablets	Current Shortages	13-Apr-25
  Acetaminophen Injection	Current Shortages	11-Apr-25
  Aprepitant Oral Suspension	Resolved Shortages	11-Apr-25
  Bupivacaine Hydrochloride Implant	Discontinued Drugs	11-Apr-25
  Nalbuphine Injection	Current Shortages	11-Apr-25
  Diazepam Oral Solution	Current Shortages	10-Apr-25
  Fluorescein Sodium Ophthalmic Strips	Current Shortages	10-Apr-25
  Iloprost Inhalation Solution (Ventavis)	Current Shortages	10-Apr-25
  Insulin Glargine Injection (Recombinant)	Current Shortages	10-Apr-25
  Sodium Acetate Injection	Current Shortages	10-Apr-25
  23.4% Sodium Chloride Injection	Current Shortages	9-Apr-25
  Amoxapine Tablets	Resolved Shortages	9-Apr-25
  Amphetamine Extended-Release Oral Presentations	Current Shortages	9-Apr-25
  Bacteriostatic 0.9% Sodium Chloride Vials	Current Shortages	9-Apr-25
  Cromolyn Oral Solution	Current Shortages	9-Apr-25
  Dexmethylphenidate Extended Release Capsules	Current Shortages	9-Apr-25
  Heparin Sodium Premixed Bags	Current Shortages	9-Apr-25
  Hydroxyethyl Starch (Hetastarch)	Current Shortages	9-Apr-25
  Methotrexate Injection	Current Shortages	9-Apr-25
  Midazolam Injection	Current Shortages	9-Apr-25
  Phentolamine Mesylate for Injection	Current Shortages	9-Apr-25
  Terbutaline Sulfate Injection	Current Shortages	9-Apr-25
  Albuterol sulfate and Ipratropium Bromide Inhalation Solution	Current Shortages	8-Apr-25
  Azathioprine Sodium Injection	Current Shortages	8-Apr-25
  Chlorothiazide Sodium Injection	Current Shortages	8-Apr-25
  Doxorubicin Injection	Current Shortages	8-Apr-25
  Etomidate Injection	Current Shortages	8-Apr-25
  Fentanyl Citrate Injection	Current Shortages	8-Apr-25
  Fluconazole Injection	Current Shortages	8-Apr-25
  Heparin Injection	Current Shortages	8-Apr-25
  Hydromorphone Hydrochloride Injection	Current Shortages	8-Apr-25
  Insulin Aspart Injection	Current Shortages	8-Apr-25
  Levofloxacin Injection in 5% Dextrose	Current Shortages	8-Apr-25
  Mesna Injection	Current Shortages	8-Apr-25
  Mitomycin Injection	Current Shortages	8-Apr-25
  Morphine Injection	Current Shortages	8-Apr-25
  Phenylephrine Ophthalmic Solution	Current Shortages	8-Apr-25
  Carboplatin Solution for Injection	Current Shortages	7-Apr-25
  Epinephrine Injection	Current Shortages	7-Apr-25
  Meperidine Hydrochloride Injection	Current Shortages	7-Apr-25
  Vancomycin Hydrochloride Injection	Current Shortages	7-Apr-25

• 2025.04.14
  FDA供給不足情報：新規（2025年4月7日～4月13日）

  April 10, 2025

  • Tamsulosin Hydrochloride Capsule (Discontinuation)

   

  April 7, 2025

  • Haloperidol Decanoate Injection (Discontinuation)
• 2025.04.07
  ASHP供給不足情報（2025年3月31日～4月6日）

  Generic Name	Shortage Status	Revision Date
  Acetaminophen Injection	Current Shortages	6-Apr-25
  Amiodarone Injection	Current Shortages	6-Apr-25
  Epinephrine Injection	Current Shortages	6-Apr-25
  Morphine Sulfate Immediate-Release Tablets	Current Shortages	6-Apr-25
  Quinapril Tablets	Current Shortages	6-Apr-25
  Remifentanil Injection	Current Shortages	6-Apr-25
  Triamcinolone Hexacetonide Injection	Current Shortages	6-Apr-25
  Atropine Sulfate Injection	Current Shortages	4-Apr-25
  Epoetin Alfa Injection	Current Shortages	4-Apr-25
  Nitrofurantoin Oral Suspension	Current Shortages	4-Apr-25
  Nelarabine Injection	Current Shortages	3-Apr-25
  Lanthanum Carbonate Oral Presentations	Current Shortages	2-Apr-25
  Amoxicillin Oral Presentations	Current Shortages	1-Apr-25
  Hypromellose Ophthalmic Solution	Current Shortages	1-Apr-25
  Magnesium Citrate Oral Solution	Current Shortages	1-Apr-25
  Methylphenidate Transdermal System	Current Shortages	1-Apr-25
  50% Dextrose Injection	Current Shortages	31-Mar-25
  Aminocaproic Acid Injection	Current Shortages	31-Mar-25
  Budesonide Suspension for Inhalation	Current Shortages	31-Mar-25
  Cefdinir Oral Presentations	Current Shortages	31-Mar-25
  Dexamethasone Sodium Phosphate Injection	Current Shortages	31-Mar-25
  Diazepam Injection	Current Shortages	31-Mar-25
  Diltiazem Hydrochloride Injection	Current Shortages	31-Mar-25
  Dobutamine Injection	Current Shortages	31-Mar-25
  Dopamine Hydrochloride Injection	Current Shortages	31-Mar-25
  Hydrocortisone Sodium Succinate Injection	Current Shortages	31-Mar-25
  Meperidine Hydrochloride Injection	Current Shortages	31-Mar-25
  Penicillin G Benzathine / Penicillin G Procaine	Current Shortages	31-Mar-25
  Progesterone Capsules	Current Shortages	31-Mar-25
  Sodium Bicarbonate Injection	Current Shortages	31-Mar-25
  Testosterone Cypionate Injection	Current Shortages	31-Mar-25
  Vasopressin Injection	Current Shortages	31-Mar-25
  Vecuronium Bromide Injection	Current Shortages	31-Mar-25

• 2025.04.07
  FDA供給不足情報：新規（2025年3月31日～4月6日）

  April 2, 2025

  • Liraglutide Injection (Currently In Shortage)

   

  April 1, 2025

  • Zileuton Tablet (Discontinuation)
• 2025.03.30
  ASHP供給不足情報（2025年3月24日～3月30日）

  Generic Name	Shortage Status	Revision Date
  Rifapentine Tablets	Current Shortages	28-Mar-25
  Mercaptopurine Tablets	Current Shortages	27-Mar-25
  Rifaximin Tablets	Current Shortages	27-Mar-25
  Cefotaxime Sodium Injection	Current Shortages	26-Mar-25
  Dihydroergotamine Mesylate Injection	Current Shortages	25-Mar-25
  Doxorubicin Injection	Current Shortages	25-Mar-25
  Insulin Degludec Injection	Current Shortages	25-Mar-25
  Levofloxacin Injection in 5% Dextrose	Current Shortages	25-Mar-25
  Liraglutide Injection	Current Shortages	25-Mar-25
  Meperidine Hydrochloride Injection	Current Shortages	25-Mar-25
  Mitomycin Injection	Current Shortages	25-Mar-25
  Pantoprazole Injection	Current Shortages	25-Mar-25
  Phentolamine Mesylate for Injection	Current Shortages	25-Mar-25
  Pimecrolimus 1% Topical Cream	Current Shortages	25-Mar-25
  Sodium Acetate Injection	Current Shortages	25-Mar-25
  Desiccated Thyroid Tablets	Current Shortages	24-Mar-25
  Dorzolamide Ophthalmic Solution	Current Shortages	24-Mar-25
  Doxorubicin Liposomal Injection	Current Shortages	24-Mar-25
  Dulaglutide Injection	Current Shortages	24-Mar-25
  Fentanyl Citrate Injection	Current Shortages	24-Mar-25
  Heparin Sodium Premixed Bags	Current Shortages	24-Mar-25
  Hydromorphone Hydrochloride Injection	Current Shortages	24-Mar-25
  Indocyanine Green	Current Shortages	24-Mar-25
  Ketamine Injection	Current Shortages	24-Mar-25
  Midazolam Injection	Current Shortages	24-Mar-25
  Nafcillin Sodium Injection	Current Shortages	24-Mar-25
  Nitrofurantoin Oral Suspension	Current Shortages	24-Mar-25
  Sodium Ferric Gluconate Complex	Current Shortages	24-Mar-25

• 2025.03.30
  FDA供給不足情報：新規（2025年3月24日～3月30日）

  March 28, 2025

  • Carboplatin Injection (Discontinuation)

  • Ursodiol Tablet (Discontinuation)

   

  March 24, 2025

  • Hydrocortisone Cream (Discontinuation)

  • Montelukast Sodium Granule (Discontinuation)
• 2025.03.23
  ASHP供給不足情報（2025年3月17日～3月23日）

  Generic Name	Shortage Status	Revision Date
  Alteplase Injection	Current Shortages	22-Mar-25
  Desmopressin Acetate Nasal Spray	Current Shortages	22-Mar-25
  Linezolid Injection	Current Shortages	22-Mar-25
  Oxycodone Hydrochloride Immediate-Release Tablets	Current Shortages	22-Mar-25
  Acetylcysteine Oral and Inhalation Solution	Current Shortages	21-Mar-25
  Amiodarone Injection	Current Shortages	21-Mar-25
  Bupivacaine Injection	Current Shortages	21-Mar-25
  Capecitabine Tablets	Current Shortages	21-Mar-25
  Cefazolin Injection	Current Shortages	21-Mar-25
  Ciprofloxacin Injection	Current Shortages	21-Mar-25
  Neomycin and Polymyxin B Sulfates Genitourinary Irrigant	Current Shortages	21-Mar-25
  Penicillin G Benzathine	Current Shortages	21-Mar-25
  Promethazine Injection	Current Shortages	21-Mar-25
  Propranolol Hydrochloride Oral Solution	Current Shortages	21-Mar-25
  Rocuronium Injection	Current Shortages	21-Mar-25
  Sucralfate Tablets	Current Shortages	21-Mar-25
  Sulfasalazine Enteric-Coated and Immediate-Release Tablets	Current Shortages	21-Mar-25
  Varenicline tablets (Chantix)	Current Shortages	21-Mar-25
  Diazepam Oral Solution	Current Shortages	20-Mar-25
  Hydrocodone and Acetaminophen Tablets	Current Shortages	20-Mar-25
  Morphine Oral Solution	Current Shortages	20-Mar-25
  Nelarabine Injection	Current Shortages	20-Mar-25
  Oxycodone Hydrochloride and Acetaminophen Tablets	Current Shortages	20-Mar-25
  Acetaminophen Injection	Current Shortages	19-Mar-25
  Adenosine Injection	Current Shortages	19-Mar-25
  Aminocaproic Acid Injection	Current Shortages	19-Mar-25
  Dopamine Hydrochloride Injection	Current Shortages	19-Mar-25
  Dronabinol Capsules	Current Shortages	19-Mar-25
  Esmolol Injection	Current Shortages	19-Mar-25
  Etomidate Injection	Current Shortages	19-Mar-25
  Remifentanil Injection	Current Shortages	19-Mar-25
  Insulin Aspart Injection	Current Shortages	18-Mar-25
  Methylphenidate Extended Release Oral Presentations	Current Shortages	18-Mar-25
  Prednisone Oral Tablets	Current Shortages	18-Mar-25
  Rho(D) Immune Globulin (Human)	Current Shortages	18-Mar-25
  Timolol Ophthalmic Gel Forming Solution	Current Shortages	18-Mar-25
  Acamprosate Calcium Tablets	Current Shortages	17-Mar-25
  Amoxicillin and Clavulanate Oral Presentations	Current Shortages	17-Mar-25
  Amphetamine Extended-Release Oral Presentations	Current Shortages	17-Mar-25
  Amphetamine Mixed Salts, Immediate-Release Tablets	Current Shortages	17-Mar-25
  Clonazepam Oral Tablets	Current Shortages	17-Mar-25
  Theophylline 24-Hour Extended Release Capsules and Tablets	Current Shortages	17-Mar-25

• 2025.03.23
  FDA供給不足情報：新規（2025年3月17日～3月23日）

  March 18, 2025

  • Travoprost Solution/Drops (Discontinuation)

   

  March 17, 2025

  • Glipizide Tablet, Extended Release (Discontinuation)
• 2025.03.17
  ASHP供給不足情報（2025年3月10日～3月16日）

  Generic Name	Shortage Status	Revision Date
  Eptifibatide Injection	Current Shortages	14-Mar-25
  Irbesartan Tablets	Current Shortages	14-Mar-25
  Lithium Oral Solution	Resolved Shortages	14-Mar-25
  Dexmethylphenidate Extended Release Capsules	Current Shortages	13-Mar-25
  Insulin Degludec Injection	Current Shortages	13-Mar-25
  Morphine Sulfate Extended-Release Tablets	Current Shortages	13-Mar-25
  Acetaminophen Injection	Current Shortages	12-Mar-25
  Amphotericin B Lipid Complex	Current Shortages	12-Mar-25
  Bivalirudin Injection	Current Shortages	12-Mar-25
  Chlorothiazide Sodium Injection	Current Shortages	12-Mar-25
  Epinephrine Auto-Injectors	Current Shortages	12-Mar-25
  Amiodarone Injection	Current Shortages	11-Mar-25
  23.4% Sodium Chloride Injection	Current Shortages	10-Mar-25
  Carboplatin Solution for Injection	Current Shortages	10-Mar-25
  Clindamycin Phosphate Injection	Current Shortages	10-Mar-25
  Etomidate Injection	Current Shortages	10-Mar-25
  Fluorouracil Injection	Current Shortages	10-Mar-25
  Furosemide Injection	Current Shortages	10-Mar-25
  Hydromorphone Hydrochloride Injection	Current Shortages	10-Mar-25
  Propofol Emulsion Injection	Current Shortages	10-Mar-25
  Sterile Water for Injection – Small Volume Vials	Current Shortages	10-Mar-25
  Terbutaline Sulfate Injection	Current Shortages	10-Mar-25
  Heparin Injection	Current Shortages	9-Mar-25
  Hydromorphone Immediate-Release Oral Presentations	Current Shortages	9-Mar-25
  Minoxidil 2.5 mg Tablets	Current Shortages	9-Mar-25
  Nystatin Oral Suspension	Current Shortages	9-Mar-25

• 2025.03.17
  FDA供給不足情報：新規（2025年3月10日～3月16日）

  この期間中に、FDAホームページに新規不足情報は公開されていません。

• 2025.03.09
  ASHP供給不足情報（2025年3月3日～3月9日）

  Generic Name	Shortage Status	Revision Date
  Aminophylline Injection	Resolved Shortages	8-Mar-25
  BCG Live Intravesical	Current Shortages	8-Mar-25
  Bumetanide Injection	Resolved Shortages	8-Mar-25
  Anticoagulant Citrate Dextrose Formula A (ACD-A)	Current Shortages	7-Mar-25
  Insulin Glargine Injection (Recombinant)	Current Shortages	7-Mar-25
  Oxycodone Hydrochloride Immediate-Release Tablets	Current Shortages	7-Mar-25
  Diazepam Injection	Current Shortages	6-Mar-25
  Diphenhydramine Injection	Current Shortages	6-Mar-25
  Leucovorin Calcium Injection	Current Shortages	6-Mar-25
  Levofloxacin Injection in 5% Dextrose	Current Shortages	6-Mar-25
  Lisdexamfetamine Dimesylate Capsules	Current Shortages	6-Mar-25
  Methadone Hydrochloride Oral Solution	Current Shortages	6-Mar-25
  Somatropin Injection	Current Shortages	6-Mar-25
  Lenalidomide Capsules	Current Shortages	5-Mar-25
  Lidocaine 5% Transdermal Patch	Current Shortages	5-Mar-25
  Methylphenidate Extended Release Oral Presentations	Current Shortages	5-Mar-25
  Methylphenidate Immediate-Release Tablets	Current Shortages	5-Mar-25
  Semaglutide Injection	Resolved Shortages	5-Mar-25
  Tirzepatide Injection	Resolved Shortages	5-Mar-25
  Lidocaine Hydrochloride Oral Topical Solution (Viscous) 2%	Current Shortages	4-Mar-25
  Alteplase Injection	Current Shortages	3-Mar-25
  Cisplatin Injection	Current Shortages	3-Mar-25
  Dobutamine Injection	Current Shortages	3-Mar-25
  Dopamine Hydrochloride Injection	Current Shortages	3-Mar-25
  Furosemide Injection	Current Shortages	3-Mar-25
  Heparin Lock Flush Syringes	Current Shortages	3-Mar-25
  Ibrexafungerp Tablets	Current Shortages	3-Mar-25
  Isoniazid Tablets	Current Shortages	3-Mar-25
  Lanreotide Acetate Injection	Current Shortages	3-Mar-25
  Mannitol Injection	Current Shortages	3-Mar-25
  Methotrexate Injection	Current Shortages	3-Mar-25
  Methylphenidate Transdermal System	Current Shortages	3-Mar-25
  Paclitaxel Injection	Current Shortages	3-Mar-25
  Peginterferon Alfa-2a Injection	Current Shortages	3-Mar-25
  Sterile Water for Injection – Small Volume Vials	Current Shortages	3-Mar-25

• 2025.03.09
  FDA供給不足情報：新規（2025年3月3日～3月9日）

  March 5, 2025

  • Ibandronate Sodium Injection (Discontinuation)

  • Ibutilide Fumarate Injection (Discontinuation)

   

  March 4, 2025

  • Amlodipine Besylate; Benazepril Hydrochloride Capsule (Discontinuation)

   

  March 3, 2025

  • Acyclovir Ointment (Discontinuation)

  • Adalimumab-adbm Injection (Discontinuation)

  • Dapagliflozin; Saxaglipitin Hydrochloride Tablet (Discontinuation)
• 2025.03.03
  ASHP供給不足情報（2025年2月24日～3月2日）

  Generic Name	Shortage Status	Revision Date
  Aprepitant Oral Suspension	Current Shortages	28-Feb-25
  Methylphenidate Transdermal System	Current Shortages	28-Feb-25
  Pimecrolimus 1% Topical Cream	Current Shortages	28-Feb-25
  Propranolol Hydrochloride Oral Solution	Current Shortages	25-Feb-25
  Rifapentine Tablets	Current Shortages	25-Feb-25
  Semaglutide Injection	Current Shortages	25-Feb-25
  Acetylcysteine Oral and Inhalation Solution	Current Shortages	24-Feb-25
  Ampicillin Injection	Resolved Shortages	24-Feb-25
  Azathioprine Sodium Injection	Current Shortages	24-Feb-25
  Bacteriostatic 0.9% Sodium Chloride Vials	Current Shortages	24-Feb-25
  Bumetanide Injection	Current Shortages	24-Feb-25
  Ciprofloxacin Injection	Current Shortages	24-Feb-25
  Decitabine Injection	Current Shortages	24-Feb-25
  Docetaxel Injection	Current Shortages	24-Feb-25
  Dopamine Hydrochloride Injection	Current Shortages	24-Feb-25
  Esmolol Injection	Current Shortages	24-Feb-25
  Idarubicin Injection	Current Shortages	24-Feb-25
  Liraglutide Injection	Current Shortages	24-Feb-25
  Meperidine Hydrochloride Injection	Current Shortages	24-Feb-25
  Methotrexate Injection	Current Shortages	24-Feb-25
  Methylprednisolone Sodium Succinate Injection	Current Shortages	24-Feb-25
  Metronidazole Hydrochloride Injection	Current Shortages	24-Feb-25
  Morphine Injection	Current Shortages	24-Feb-25
  Peginterferon Alfa-2a Injection	Current Shortages	24-Feb-25
  Penicillin G Benzathine	Current Shortages	24-Feb-25
  Penicillin G Benzathine / Penicillin G Procaine	Current Shortages	24-Feb-25
  Potassium Chloride Injection	Current Shortages	24-Feb-25
  Rocuronium Injection	Current Shortages	24-Feb-25
  Sodium Bicarbonate Injection	Current Shortages	24-Feb-25
  Somatropin Injection	Current Shortages	24-Feb-25
  Succinylcholine Injection	Current Shortages	24-Feb-25

• 2025.03.03
  FDA供給不足情報：新規（2025年2月24日～3月2日）

  February 28, 2025

  • Methylphenidate Film, Extended Release (Currently In Shortage)

  • Pimecrolimus Cream (Discontinuation)

   

  February 26, 2025

  • Tolterodine Tartrate Capsule, Extended Release (Discontinuation)

  • Tolterodine Tartrate Tablet (Discontinuation)
• 2025.02.25
  ASHP供給不足情報（2025年2月17日～2月23日）

  Generic Name	Shortage Status	Revision Date
  Oxycodone Hydrochloride and Acetaminophen Tablets	Current Shortages	23-Feb-25
  Penicillin V Potassium Oral Presentations	Current Shortages	23-Feb-25
  Pyridostigmine Bromide Extended-Release Tablets	Current Shortages	23-Feb-25
  Capecitabine Tablets	Current Shortages	21-Feb-25
  Dobutamine Injection	Current Shortages	21-Feb-25
  Labetalol Injection	Current Shortages	21-Feb-25
  Leucovorin Calcium Injection	Current Shortages	21-Feb-25
  Dexamethasone Sodium Phosphate Injection	Current Shortages	20-Feb-25
  Fentanyl Citrate Injection	Current Shortages	20-Feb-25
  Furosemide Injection	Current Shortages	20-Feb-25
  Heparin Sodium Premixed Bags	Current Shortages	20-Feb-25
  Insulin Glargine Injection (Recombinant)	Current Shortages	20-Feb-25
  Iron Sucrose Injection	Resolved Shortages	20-Feb-25
  Nalbuphine Injection	Current Shortages	20-Feb-25
  Sterile Water for Injection – Small Volume Vials	Current Shortages	20-Feb-25
  Adenosine Injection	Current Shortages	19-Feb-25
  Bupivacaine Injection	Current Shortages	19-Feb-25
  Bupivacaine with Epinephrine Injection	Current Shortages	19-Feb-25
  Fluvoxamine Maleate Extended-Release Capsules	Current Shortages	19-Feb-25
  Lidocaine Injection	Current Shortages	19-Feb-25
  Lidocaine with Epinephrine Injection	Current Shortages	19-Feb-25
  Mesna Injection	Current Shortages	19-Feb-25
  Morphine Oral Solution	Current Shortages	19-Feb-25
  Morphine Sulfate Extended-Release Tablets	Current Shortages	19-Feb-25
  Oseltamivir Oral Suspension and Capsules	Current Shortages	19-Feb-25
  Potassium Chloride Injection	Current Shortages	19-Feb-25
  Disulfiram Tablets	Current Shortages	18-Feb-25
  Epinephrine Auto-Injectors	Current Shortages	18-Feb-25
  Flurazepam Capsules	Resolved Shortages	18-Feb-25
  Insulin Aspart Injection	Current Shortages	18-Feb-25
  Pantoprazole Injection	Current Shortages	18-Feb-25
  Phenylephrine Ophthalmic Solution	Current Shortages	18-Feb-25
  Oxymorphone Immediate-Release Tablets	Current Shortages	17-Feb-25

• 2025.02.25
  FDA供給不足情報：新規（2025年2月17日～2月23日）

  February 20, 2025

  • Silodosin Capsule (Discontinuation)

   

  February 19, 2025

  • Atropine Sulfate Injection (Discontinuation)
• 2025.02.17
  ASHP供給不足情報（2025年2月10日～2025年2月16日）

  Generic Name	Shortage Status	Revision Date
  Amoxapine Tablets	Current Shortages	16-Feb-25
  Azithromycin Powder for Oral Suspension Packets	Current Shortages	16-Feb-25
  Calcitriol Oral Solution	Current Shortages	16-Feb-25
  Clonazepam Oral Tablets	Current Shortages	16-Feb-25
  Epinephrine Auto-Injectors	Current Shortages	15-Feb-25
  Losartan and Hydrochlorothiazide Tablets	Current Shortages	15-Feb-25
  Dexmethylphenidate Extended Release Capsules	Current Shortages	13-Feb-25
  Dofetilide Capsules	Current Shortages	13-Feb-25
  Anticoagulant Citrate Dextrose Formula A (ACD-A)	Current Shortages	12-Feb-25
  Calcium Chloride Injection	Current Shortages	12-Feb-25
  Acetylcysteine Oral and Inhalation Solution	Current Shortages	10-Feb-25
  Amiodarone Injection	Current Shortages	10-Feb-25
  Atropine Sulfate Injection	Current Shortages	10-Feb-25
  Cisplatin Injection	Current Shortages	10-Feb-25
  Exenatide Extended-Release Suspension for Injection	Discontinued Drugs	10-Feb-25
  Furosemide Injection	Current Shortages	10-Feb-25
  Gentamicin Injection	Current Shortages	10-Feb-25
  Leucovorin Calcium Injection	Current Shortages	10-Feb-25
  Methylprednisolone Sodium Succinate Injection	Current Shortages	10-Feb-25
  Mitomycin Injection	Current Shortages	10-Feb-25
  Pantoprazole Injection	Current Shortages	10-Feb-25
  Pyridostigmine Bromide Extended-Release Tablets	Current Shortages	10-Feb-25
  Ropivacaine Injection	Current Shortages	10-Feb-25

• 2025.02.17
  FDA供給不足情報：新規（2025年2月10日～2025年2月16日）

  February 14, 2025

  • Erythromycin Topical Gel (Discontinuation)

   

  February 12, 2025

  • Amantadine Hydrochloride Capsule (Discontinuation)
• 2025.02.10
  ASHP供給不足情報（2025年2月3日～2025年2月9日）

  Generic Name	Shortage Status	Revision Date
  Heparin Injection	Current Shortages	9-Feb-25
  Heparin Lock Flush Syringes	Current Shortages	9-Feb-25
  Moxifloxacin Tablets	Current Shortages	9-Feb-25
  Naltrexone Tablets	Current Shortages	9-Feb-25
  Prednisone Oral Tablets	Current Shortages	9-Feb-25
  Amphetamine Extended-Release Oral Presentations	Current Shortages	8-Feb-25
  Dexmethylphenidate Extended Release Capsules	Current Shortages	8-Feb-25
  Albuterol sulfate and Ipratropium Bromide Inhalation Solution	Current Shortages	7-Feb-25
  Heparin Sodium Premixed Bags	Current Shortages	7-Feb-25
  Hydromorphone Hydrochloride Injection	Current Shortages	7-Feb-25
  Hydroxocobalamin Injection	Current Shortages	7-Feb-25
  Nitroglycerin Injection	Current Shortages	7-Feb-25
  Pyridostigmine Bromide Extended-Release Tablets	Current Shortages	7-Feb-25
  Remifentanil Injection	Current Shortages	7-Feb-25
  Sterile Water for Injection – Small Volume Vials	Current Shortages	7-Feb-25
  Streptozocin Injection	Current Shortages	7-Feb-25
  Sufentanil Injection	Resolved Shortages	7-Feb-25
  Terbutaline Sulfate Injection	Current Shortages	7-Feb-25
  Amoxicillin Oral Presentations	Current Shortages	6-Feb-25
  Becaplermin Topical Gel	Current Shortages	6-Feb-25
  Bevacizumab-bvzr Injection	Resolved Shortages	6-Feb-25
  Cefdinir Oral Presentations	Current Shortages	6-Feb-25
  Diltiazem Hydrochloride Injection	Current Shortages	6-Feb-25
  Droperidol Injection	Current Shortages	6-Feb-25
  Etomidate Injection	Current Shortages	6-Feb-25
  Etoposide Solution for Injection	Current Shortages	6-Feb-25
  Levofloxacin Injection in 5% Dextrose	Current Shortages	6-Feb-25
  Levothyroxine Sodium Injection	Current Shortages	6-Feb-25
  Lorazepam Injection	Current Shortages	6-Feb-25
  Mefloquine Hydrochloride Tablets	Current Shortages	6-Feb-25
  Methotrexate Injection	Current Shortages	6-Feb-25
  Midazolam Injection	Current Shortages	6-Feb-25
  Adenosine Injection	Current Shortages	5-Feb-25
  Aminophylline Injection	Current Shortages	5-Feb-25
  Amoxicillin and Clavulanate Oral Presentations	Current Shortages	5-Feb-25
  Amphetamine Mixed Salts, Immediate-Release Tablets	Current Shortages	5-Feb-25
  Bezlotoxumab Injection	Discontinued Drugs	5-Feb-25
  Bumetanide Injection	Current Shortages	5-Feb-25
  Calcium Chloride Injection	Current Shortages	5-Feb-25
  Dexamethasone Sodium Phosphate Injection	Current Shortages	5-Feb-25
  Dexmedetomidine Hydrochloride 100 mcg/mL Vials for Injection	Current Shortages	5-Feb-25
  Dobutamine Injection	Current Shortages	5-Feb-25
  Epoetin Alfa Injection	Current Shortages	5-Feb-25
  Fentanyl Citrate Injection	Current Shortages	5-Feb-25
  Labetalol Injection	Current Shortages	5-Feb-25
  Lactated Ringer’s Injection	Current Shortages	5-Feb-25
  Lactated Ringer’s Irrigation	Current Shortages	5-Feb-25
  Magnesium Sulfate Injection	Current Shortages	5-Feb-25
  Metoprolol Injection	Current Shortages	5-Feb-25
  Paclitaxel Injection	Current Shortages	5-Feb-25
  Potassium Phosphate Injection	Current Shortages	5-Feb-25
  Sodium Acetate Injection	Current Shortages	5-Feb-25
  Sterile Water for Injection – Large Volume Bags	Current Shortages	5-Feb-25
  Sterile Water for Irrigation	Current Shortages	5-Feb-25
  Basiliximab Injection	Current Shortages	3-Feb-25
  Cefazolin Injection	Current Shortages	3-Feb-25
  Clindamycin Phosphate Injection	Current Shortages	3-Feb-25
  Dacarbazine Injection	Current Shortages	3-Feb-25
  Ofloxacin Ophthalmic Solution	Resolved Shortages	3-Feb-25
  Progesterone Capsules	Current Shortages	3-Feb-25
  Ribavirin Inhalation	Current Shortages	3-Feb-25
  Tretinoin Capsules	Resolved Shortages	3-Feb-25

• 2025.02.10
  FDA供給不足情報：新規（2025年2月3日～2025年2月9日）

  February 7, 2025

  • Benazepril Hydrochloride Tablet (Discontinuation)

   

  February 6, 2025

  • Glipizide Tablet, Extended Release (Discontinuation)

  • Idarubicin Hydrochloride Injection (Discontinuation)

  • Varenicline Tartrate Tablet (Discontinuation)

   

  February 5, 2025

  • Amantadine Hydrochloride Tablet (Discontinuation)

  • Gefitinib Tablet (Discontinuation)

  • Pirfenidone Capsule (Discontinuation)

   

  February 4, 2025

  • Tretinoin Cream (Discontinuation)
• 2025.02.03
  ASHP供給不足情報（2025年1月27日～2025年2月2日）

  Generic Name	Shortage Status	Revision Date
  Amifostine Injection	Current Shortages	1-Feb-25
  Budesonide Suspension for Inhalation	Current Shortages	1-Feb-25
  Dicyclomine Oral Presentations	Current Shortages	1-Feb-25
  Dronabinol Capsules	Current Shortages	1-Feb-25
  Haloperidol Lactate Injection	Current Shortages	1-Feb-25
  Hydromorphone Immediate-Release Oral Presentations	Current Shortages	1-Feb-25
  Dextran Low Molecular Weight (Dextran 40), 10% Injection	Current Shortages	31-Jan-25
  Methylphenidate Extended Release Oral Presentations	Current Shortages	31-Jan-25
  Phentolamine Mesylate for Injection	Current Shortages	31-Jan-25
  Trihexyphenidyl Hydrochloride Oral Solution	Resolved Shortages	31-Jan-25
  Ciprofloxacin Injection	Current Shortages	29-Jan-25
  Clindamycin Phosphate Injection	Current Shortages	29-Jan-25
  Diltiazem Hydrochloride Injection	Current Shortages	29-Jan-25
  Mercaptopurine Tablets	Current Shortages	29-Jan-25
  0.45% Sodium Chloride Injection Bags	Current Shortages	27-Jan-25
  0.9% Sodium Chloride Irrigation	Current Shortages	27-Jan-25
  0.9% Sodium Chloride Large Volume Bags	Current Shortages	27-Jan-25
  0.9% Sodium Chloride Small Volume Bags (< 150 mL)	Current Shortages	27-Jan-25
  10% Dextrose Injection	Current Shortages	27-Jan-25
  23.4% Sodium Chloride Injection	Current Shortages	27-Jan-25
  5% Dextrose Injection (PVC-free and DEHP-free)	Current Shortages	27-Jan-25
  5% Dextrose Injection Large Volume Bags	Current Shortages	27-Jan-25
  5% Dextrose Injection Small Volume Bags	Current Shortages	27-Jan-25
  70% Dextrose Injection Large Volume Bags	Current Shortages	27-Jan-25
  Adenosine Injection	Current Shortages	27-Jan-25
  Bacteriostatic 0.9% Sodium Chloride Vials	Current Shortages	27-Jan-25
  Bumetanide Injection	Current Shortages	27-Jan-25
  Cefazolin Injection	Current Shortages	27-Jan-25
  Cromolyn Oral Solution	Current Shortages	27-Jan-25
  Dexmethylphenidate Extended Release Capsules	Current Shortages	27-Jan-25
  Diphenhydramine Injection	Current Shortages	27-Jan-25
  Furosemide Injection	Current Shortages	27-Jan-25
  Heparin Sodium Premixed Bags	Current Shortages	27-Jan-25
  Hydrocortisone Sodium Succinate Injection	Current Shortages	27-Jan-25
  Insulin Aspart Injection	Current Shortages	27-Jan-25
  Liraglutide Injection	Current Shortages	27-Jan-25
  Phenytoin Sodium Injection	Current Shortages	27-Jan-25
  Rifaximin Tablets	Current Shortages	27-Jan-25
  Rocuronium Injection	Current Shortages	27-Jan-25
  Tramadol Tablets	Resolved Shortages	27-Jan-25

• 2025.02.03
  FDA供給不足情報：新規（2025年1月27日～2025年2月2日）

  January 30, 2025

  • Ramipril Capsule (Discontinuation)

   

  January 28, 2025

  • Donepezil Hydrochloride Tablet (Discontinuation)

  • LIdocaine Ointment (Discontinuation)

  • Lidocaine Ointment (Discontinuation)

  • Teriflunomide Tablet (Discontinuation)

   

  January 27, 2025

  • Bendamustine Hydrochloride Injection (Discontinuation)
• 2025.01.27
  ASHP供給不足情報（2025年1月20日～2025年1月26日）

  Generic Name	Shortage Status	Revision Date
  3% and 5% Sodium Chloride Large Volume Injection	Current Shortages	24-Jan-25
  Dexmethylphenidate Extended Release Capsules	Current Shortages	24-Jan-25
  Prednisolone Acetate 1% Ophthalmic Suspension	Resolved Shortages	24-Jan-25
  Ampicillin Injection	Current Shortages	23-Jan-25
  Atropine Sulfate Injection	Current Shortages	23-Jan-25
  Fentanyl Citrate Injection	Current Shortages	23-Jan-25
  Fluorouracil Injection	Current Shortages	23-Jan-25
  Hydromorphone Hydrochloride Injection	Current Shortages	23-Jan-25
  Iron Sucrose Injection	Current Shortages	23-Jan-25
  Levofloxacin Injection in 5% Dextrose	Current Shortages	23-Jan-25
  Mesna Injection	Current Shortages	23-Jan-25
  Midazolam Injection	Current Shortages	23-Jan-25
  Morphine Injection	Current Shortages	23-Jan-25
  Pantoprazole Injection	Current Shortages	23-Jan-25
  Bupivacaine Injection	Current Shortages	22-Jan-25
  Fluconazole Injection	Current Shortages	22-Jan-25
  Vasopressin Injection	Current Shortages	22-Jan-25
  23.4% Sodium Chloride Injection	Current Shortages	21-Jan-25
  Carboplatin Solution for Injection	Current Shortages	21-Jan-25
  Dexamethasone Sodium Phosphate Injection	Current Shortages	21-Jan-25
  Difluprednate Ophthalmic Emulsion	Current Shortages	21-Jan-25
  Docetaxel Injection	Current Shortages	21-Jan-25
  Doxorubicin Injection	Current Shortages	21-Jan-25
  Hydrocodone and Acetaminophen Tablets	Current Shortages	21-Jan-25
  Leucovorin Calcium Injection	Current Shortages	21-Jan-25
  Lisdexamfetamine Dimesylate Capsules	Current Shortages	21-Jan-25
  Ondansetron Hydrochloride Injection	Resolved Shortages	21-Jan-25
  Penicillin V Potassium Oral Presentations	Current Shortages	21-Jan-25
  Potassium Chloride in Large Volume for Injection	Current Shortages	21-Jan-25
  Potassium Chloride Injection	Current Shortages	21-Jan-25
  Promethazine Injection	Current Shortages	21-Jan-25
  Terbutaline Sulfate Injection	Current Shortages	21-Jan-25

• 2025.01.27
  FDA供給不足情報：新規（2025年1月20日～2025年1月26日）

  January 24, 2025

  • Peginterferon alfa-2a Injection (Currently In Shortage)

   

  January 23, 2025

  • Verapamil Hydrochloride Capsule, Extended Release (Discontinuation)

   

  January 22, 2025

  • Febuxostat Tablet (Discontinuation)

  • Minocycline Hydrochloride Tablet (Discontinuation)

  • Sertraline Hydrochloride Tablet (Discontinuation)
• 2025.01.20
  ASHP供給不足情報（2025年1月13日～2025年1月19日）

  Generic Name	Shortage Status	Revision Date
  Alteplase Injection	Current Shortages	17-Jan-25
  Cidofovir Injection	Current Shortages	17-Jan-25
  Amphotericin B Lipid Complex	Current Shortages	16-Jan-25
  Fluorescein Sodium and Proparacaine Hydrochloride Ophthalmic Solution	Current Shortages	16-Jan-25
  Morphine Sulfate Extended-Release Tablets	Current Shortages	16-Jan-25
  Oxycodone Hydrochloride Immediate-Release Tablets	Current Shortages	16-Jan-25
  Prednisone Oral Tablets	Current Shortages	16-Jan-25
  Lenalidomide Capsules	Current Shortages	15-Jan-25
  Minoxidil 2.5 mg Tablets	Current Shortages	15-Jan-25
  Atropine Sulfate Injection	Current Shortages	14-Jan-25
  Azathioprine Sodium Injection	Current Shortages	14-Jan-25
  Bivalirudin Injection	Current Shortages	14-Jan-25
  Dexamethasone Sodium Phosphate Injection	Current Shortages	14-Jan-25
  Dorzolamide Ophthalmic Solution	Current Shortages	14-Jan-25
  Iloprost Inhalation Solution (Ventavis)	Current Shortages	14-Jan-25
  Isoniazid Tablets	Current Shortages	14-Jan-25
  Lidocaine 5% Transdermal Patch	Current Shortages	14-Jan-25
  Methotrexate Injection	Current Shortages	14-Jan-25
  Methylphenidate Immediate-Release Tablets	Current Shortages	14-Jan-25
  Nalbuphine Injection	Current Shortages	14-Jan-25
  Paclitaxel Injection	Current Shortages	14-Jan-25
  Quinapril Tablets	Current Shortages	14-Jan-25
  Semaglutide Injection	Current Shortages	14-Jan-25
  Timolol Ophthalmic Gel Forming Solution	Current Shortages	14-Jan-25
  Acetylcysteine Oral and Inhalation Solution	Current Shortages	13-Jan-25
  Amino Acid Products	Current Shortages	13-Jan-25
  Antivenin Latrodectus Mactans (Black Widow Spider Antivenin)	Current Shortages	13-Jan-25
  BCG Live Intravesical	Current Shortages	13-Jan-25
  Bupivacaine with Epinephrine Injection	Current Shortages	13-Jan-25
  Ciprofloxacin Injection	Current Shortages	13-Jan-25
  Heparin Injection	Current Shortages	13-Jan-25
  Heparin Sodium Premixed Bags	Current Shortages	13-Jan-25
  Hydromorphone Hydrochloride Injection	Current Shortages	13-Jan-25
  Idarubicin Injection	Current Shortages	13-Jan-25
  Insulin Detemir Injection	Discontinued Drugs	13-Jan-25
  Midazolam Injection	Current Shortages	13-Jan-25
  Remifentanil Injection	Current Shortages	13-Jan-25
  Sodium Bicarbonate Injection	Current Shortages	13-Jan-25

• 2025.01.20
  FDA供給不足情報：新規（2025年1月13日～2025年1月19日）

  January 17, 2025

  • Cyanocobalamin Injection (Discontinuation)

  • Mitomycin Injection (Discontinuation)

  • Tigecycline Injection (Discontinuation)

   

  January 15, 2025

  • Docetaxel Injection (Discontinuation)

   

  January 14, 2025

  • Ambrisentan Tablet (Discontinuation)

  • Clonazepam Tablet (Currently In Shortage)

   

  January 13, 2025

  • Azelaic Acid Gel (Discontinuation)

  • Talazoparib Tosylate Capsule (Discontinuation)
• 2025.01.13
  ASHP供給不足情報（2025年1月6日～2025年1月12日）

  Generic Name	Shortage Status	Revision Date
  Dofetilide Capsules	Current Shortages	10-Jan-25
  Peginterferon Alfa-2a Injection	Current Shortages	10-Jan-25
  Aminophylline Injection	Current Shortages	9-Jan-25
  Bumetanide Injection	Current Shortages	9-Jan-25
  Clindamycin Phosphate Injection	Current Shortages	9-Jan-25
  Diazepam Injection	Current Shortages	9-Jan-25
  Droperidol Injection	Current Shortages	9-Jan-25
  Dulaglutide Injection	Current Shortages	9-Jan-25
  Etomidate Injection	Current Shortages	9-Jan-25
  Fentanyl Citrate Injection	Current Shortages	9-Jan-25
  Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution	Resolved Shortages	9-Jan-25
  Fluorouracil Injection	Current Shortages	9-Jan-25
  Leucovorin Calcium Injection	Current Shortages	9-Jan-25
  Lidocaine with Epinephrine Injection	Current Shortages	9-Jan-25
  Lorazepam Injection	Current Shortages	9-Jan-25
  Morphine Injection	Current Shortages	9-Jan-25
  Penicillin G Benzathine	Current Shortages	9-Jan-25
  Penicillin G Benzathine / Penicillin G Procaine	Current Shortages	9-Jan-25
  Tirzepatide Injection	Current Shortages	9-Jan-25
  Acetylcysteine Oral and Inhalation Solution	Current Shortages	8-Jan-25
  Adenosine Injection	Current Shortages	8-Jan-25
  Dopamine Hydrochloride Injection	Current Shortages	8-Jan-25
  Epinephrine Injection	Current Shortages	8-Jan-25
  Hydroxocobalamin Injection	Current Shortages	8-Jan-25
  Nitroglycerin Injection	Current Shortages	8-Jan-25
  Ondansetron Hydrochloride Injection	Current Shortages	8-Jan-25
  Orphenadrine Citrate Injection	Current Shortages	8-Jan-25
  50% Dextrose Injection	Current Shortages	7-Jan-25
  Dextran Low Molecular Weight (Dextran 40), 10% Injection	Current Shortages	7-Jan-25
  Heparin Sodium Premixed Bags	Current Shortages	7-Jan-25
  Sodium Acetate Injection	Current Shortages	7-Jan-25
  23.4% Sodium Chloride Injection	Current Shortages	6-Jan-25
  Heparin Lock Flush Syringes	Current Shortages	6-Jan-25
  Insulin Aspart Injection	Current Shortages	6-Jan-25

• 2025.01.13
  FDA供給不足情報：新規（2025年1月6日～2025年1月12日）

  January 10, 2025

  • Bupivacaine Hydrochloride Injection (Discontinuation)

  • Ethinyl Estradiol; Norethindrone Tablet, Chewable (Discontinuation)

   

  January 8, 2025

  • Methotrexate Sodium Injection (Discontinuation)

  • Ramelteon Tablet (Discontinuation)

   

  January 6, 2025

  • Adalimumab-adbm Injection (Discontinuation)

  • Cisatracurium Besylate Injection (Discontinuation)

  • Ezetimibe; Simvastatin Tablet (Discontinuation)
• 2025.01.06
  ASHP供給不足情報（2024年12月30日～2025年1月5日）

  Generic Name	Shortage Status	Revision Date
  Gadobenate Dimeglumine Injection	Current Shortages	3-Jan-25
  Lisdexamfetamine Dimesylate Capsules	Current Shortages	3-Jan-25
  Oseltamivir Oral Suspension and Capsules	Current Shortages	3-Jan-25
  Dexmedetomidine Hydrochloride 100 mcg/mL Vials for Injection	Current Shortages	2-Jan-25
  Magnesium Sulfate Injection	Current Shortages	2-Jan-25
  Furosemide Injection	Current Shortages	31-Dec-24
  Magnesium Citrate Oral Solution	Current Shortages	31-Dec-24
  Lanreotide Acetate Injection	Current Shortages	30-Dec-24
  Lidocaine Injection	Current Shortages	30-Dec-24
  Theophylline 24-Hour Extended Release Capsules and Tablets	Current Shortages	30-Dec-24

• 2025.01.06
  FDA供給不足情報：新規（2024年12月30日～2025年1月5日）

  January 3, 2025

  • Lisdexamfetamine Dimesylate Capsule (Currently In Shortage)

カナダの情報はありません。

• 2025.04.27
  TGAオーストラリア供給不足情報（2025年4月21日～4月27日）

  Active ingredients	Dosage form	Quantity of active ingredients	Shortage status	Availability	Reason	Last updated
  oxytocin	Injection, solution	10 IU/mL	Discontinued	Reduction in supply until supply is exhausted	Unexpected increase in consumer demand	24/04/2025
  oxytocin	Injection, solution	5 IU/mL	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	24/04/2025
  clonazepam	Oral Liquid, solution	2.5 mg/mL	Current	Limited Availability	Manufacturing	24/04/2025
  indapamide hemihydrate	Tablet, modified release	1.5 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	24/04/2025
  pentetic acid	Injection, powder for	5 mg	Current	Unavailable	Manufacturing	24/04/2025
  sodium pyrophosphate	Injection, powder for	30 mg	Current	Unavailable	Manufacturing	24/04/2025
  medronic acid	Injection, powder for	10 mg	Current	Unavailable	Manufacturing	24/04/2025
  sodium fluoride	Injection, concentrated	1 mg/mL	Current	Unavailable	Manufacturing	24/04/2025
  trimethoprim~sulfamethoxazole	Tablet	160 mg~800 mg	Current	Limited Availability	Unexpected increase in consumer demand	24/04/2025
  oxytocin	Injection, solution	10 IU	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	24/04/2025
  bisoprolol fumarate	Tablet	2.5 mg	Resolved	Available	Manufacturing	24/04/2025
  clopidogrel hydrogen sulfate	Tablet, film coated	97.9 mg	Anticipated	Available	Manufacturing	24/04/2025
  montelukast sodium	Tablet, chewable	5.2 mg	Anticipated	Available	Unexpected increase in consumer demand	24/04/2025
  azithromycin dihydrate	Tablet, film coated	524.05 mg	Current	Unavailable	Manufacturing	24/04/2025
  naproxen	Oral Liquid, suspension	25 mg/mL	Current	Limited Availability	Manufacturing	24/04/2025
  trandolapril	Capsule, hard	1 mg	Current	Unavailable	Manufacturing	24/04/2025
  trandolapril	Capsule, hard	2 mg	Current	Unavailable	Manufacturing	24/04/2025
  trandolapril	Capsule, hard	4 mg	Current	Unavailable	Manufacturing	24/04/2025
  quetiapine fumarate	Tablet, modified release	345.39 mg	Anticipated	Available	Unexpected increase in consumer demand	24/04/2025
  oxytocin	Injection, solution	5 IU/mL	Current	Limited Availability	Unexpected increase in consumer demand	24/04/2025
  oxytocin	Injection, solution	10 IU/mL	Anticipated	Available	Manufacturing	24/04/2025
  celecoxib	Capsule, hard	100 mg	Resolved	Available	Manufacturing	24/04/2025
  escitalopram oxalate	Tablet, film coated	25.47 mg	Resolved	Available	Manufacturing	24/04/2025
  bosentan monohydrate	Tablet, film coated	129.08 mg	Current	Unavailable	Transport / Logistic issues / Storage capacity issues	24/04/2025
  betahistine dihydrochloride	Tablet	16 mg	Resolved	Available	Manufacturing	24/04/2025
  tadalafil	Tablet, film coated	10 mg	Resolved	Available	Manufacturing	24/04/2025
  tadalafil	Tablet, film coated	20 mg	Resolved	Available	Manufacturing	24/04/2025
  metformin hydrochloride	Tablet, film coated	500 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	24/04/2025
  busulfan	Injection, concentrated	60 mg	Current	Limited Availability	Manufacturing	24/04/2025
  risperidone	Tablet, film coated	3 mg	Current	Unavailable	Transport / Logistic issues / Storage capacity issues	24/04/2025
  nebivolol hydrochloride	Tablet	5.45 mg	Current	Unavailable	Manufacturing	24/04/2025
  tamoxifen citrate	Tablet	30.34 mg	Current	Limited Availability	Manufacturing	24/04/2025
  sitagliptin hydrochloride monohydrate	Tablet, film coated	56.69 mg	Current	Unavailable	Manufacturing	24/04/2025
  sildenafil citrate	Tablet, film coated	70.24 mg	Current	Unavailable	Unexpected increase in consumer demand	24/04/2025
  melatonin	Capsule, hard	3 mg	Resolved	Available	Unexpected increase in consumer demand	24/04/2025
  cabergoline	Tablet, uncoated	1 mg	Anticipated	Available	Manufacturing	24/04/2025
  balsalazide sodium	Capsule	750 mg	Resolved	Available	Manufacturing	24/04/2025
  gefitinib	Tablet, film coated	250 mg	Resolved	Available	Commercial Changes / Commercial viability	24/04/2025
  methylphenidate hydrochloride	Tablet, uncoated	10 mg	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	23/04/2025
  fentanyl	Drug delivery system, transdermal	4.2 mg	Discontinued	Unavailable	Manufacturing	23/04/2025
  fentanyl	Drug delivery system, transdermal	8.4 mg	Discontinued	Unavailable	Manufacturing	23/04/2025
  fentanyl	Drug delivery system, transdermal	12.6 mg	Discontinued	Unavailable	Manufacturing	23/04/2025
  fentanyl	Drug delivery system, transdermal	16.8 mg	Discontinued	Unavailable	Manufacturing	23/04/2025
  bupivacaine hydrochloride monohydrate	Injection, solution	52.7 mg	Current	Limited Availability	Unexpected increase in consumer demand	23/04/2025
  fentanyl	Drug delivery system, transdermal	2.1 mg	Discontinued	Unavailable	Manufacturing	23/04/2025
  benzathine benzylpenicillin tetrahydrate	Injection, suspension	1200000 USP Unit	Current	Limited Availability	Manufacturing	23/04/2025
  amiodarone hydrochloride	Injection, solution	150 mg	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	23/04/2025
  methylphenidate hydrochloride	Capsule, modified release	10 mg	Anticipated	Available	Manufacturing	23/04/2025
  pramipexole dihydrochloride monohydrate	Tablet	.125 mg	Anticipated	Available	Manufacturing	23/04/2025
  risedronate sodium hemipentahydrate	Tablet, film coated	173.4 mg	Anticipated	Available	Manufacturing	23/04/2025
  montelukast sodium	Tablet, chewable	5.2 mg	Resolved	Available	Manufacturing	23/04/2025
  montelukast sodium	Tablet, film coated	10.4 mg	Anticipated	Available	Manufacturing	23/04/2025
  montelukast sodium	Tablet, film coated	10.4 mg	Anticipated	Available	Manufacturing	23/04/2025
  isotretinoin	Capsule, soft	10 mg	Current	Unavailable	Manufacturing	23/04/2025
  propofol	Injection, emulsion	10 g/L	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	23/04/2025
  candesartan cilexetil	Tablet, uncoated	16 mg	Anticipated	Available	Manufacturing	23/04/2025
  raloxifene hydrochloride	Tablet, film coated	60 mg	Current	Unavailable	Unexpected increase in consumer demand	23/04/2025
  estradiol~dydrogesterone	Tablet, film coated	1 mg~10 mg	Current	Limited Availability	Manufacturing	23/04/2025
  acarbose	Tablet	100 mg	Anticipated	Available	Manufacturing	23/04/2025
  flecainide acetate	Tablet, uncoated	100 mg	Current	Limited Availability	Manufacturing	23/04/2025
  methylphenidate hydrochloride	Capsule, modified release	60 mg	Anticipated	Available	Manufacturing	23/04/2025
  noradrenaline (norepinephrine) acid tartrate monohydrate	Injection, concentrated	2 mg/mL	Anticipated	Available	Transport / Logistic issues / Storage capacity issues	23/04/2025
  teriflunomide	Tablet, film coated	14 mg	Current	Limited Availability	Manufacturing	23/04/2025
  olanzapine	Tablet, uncoated	5 mg	Current	Limited Availability	Manufacturing	23/04/2025
  montelukast sodium	Tablet, chewable	5.2 mg	Current	Unavailable	Manufacturing	23/04/2025
  methylphenidate hydrochloride	Capsule, hard	40 mg	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	23/04/2025
  methylphenidate hydrochloride	Capsule, hard	20 mg	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	23/04/2025
  methylphenidate hydrochloride	Capsule, hard	30 mg	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	23/04/2025
  methylphenidate hydrochloride	Capsule, hard	10 mg	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	23/04/2025
  methylphenidate hydrochloride	Capsule, hard	60 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	23/04/2025
  bicisate dihydrochloride	Injection, powder for	.9 mg	Resolved	Available	Manufacturing	23/04/2025
  estradiol hemihydrate	Tablet, film coated	2.06 mg	Resolved	Available	Manufacturing	23/04/2025
  methylphenidate hydrochloride	Capsule, modified release	20 mg	Anticipated	Available	Manufacturing	23/04/2025
  methylphenidate hydrochloride	Capsule, modified release	30 mg	Anticipated	Available	Manufacturing	23/04/2025
  methylphenidate hydrochloride	Capsule, modified release	40 mg	Anticipated	Available	Manufacturing	23/04/2025
  gentamicin	Injection, solution	80 mg	Current	Unavailable	Manufacturing	22/04/2025
  acetylcysteine	Injection, concentrated	2 g	Resolved	Available	Manufacturing	22/04/2025
  fentanyl	Drug delivery system, transdermal	16.8 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	22/04/2025
  azithromycin dihydrate	Tablet, film coated	524.1 mg	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	22/04/2025
  vincristine sulfate	Injection, solution	1 mg/mL	Anticipated	Available	Manufacturing	22/04/2025
  bisoprolol fumarate	Tablet	10 mg	Resolved	Available	Manufacturing	22/04/2025
  valsartan~hydrochlorothiazide	Tablet, film coated	320 mg~25 mg	Current	Limited Availability	Manufacturing	22/04/2025
  sildenafil citrate	Tablet, film coated	28.1 mg	Resolved	Available	Manufacturing	22/04/2025
  risperidone	Tablet, film coated	1 mg	Resolved	Available	Unexpected increase in consumer demand	22/04/2025
  capecitabine	Tablet, film coated	500 mg	Current	Unavailable	Manufacturing	22/04/2025
  ezetimibe~rosuvastatin calcium	Tablet~Tablet, film coated	10 mg~41.583 mg	Current	Limited Availability	Manufacturing	22/04/2025
  ezetimibe~rosuvastatin calcium	Tablet~Tablet, film coated	10 mg~5.198 mg	Resolved	Available	Manufacturing	22/04/2025
  capecitabine	Tablet, film coated	500 mg	Current	Limited Availability	Unexpected increase in consumer demand	22/04/2025
  clonidine hydrochloride	Tablet	100 microgram	Current	Unavailable	Unexpected increase in consumer demand	22/04/2025
  hydrocortisone	Tablet, uncoated	20 mg	Current	Limited Availability	Manufacturing	22/04/2025
  hydrocortisone	Tablet, uncoated	20 mg	Current	Limited Availability	Manufacturing	22/04/2025
  avibactam sodium~ceftazidime pentahydrate	Injection, powder for	543.5 mg~2329.7 mg	Anticipated	Available	Unexpected increase in consumer demand	22/04/2025
  carmustine~ethanol absolute	Diluent, not applicable~Injection, powder for	100 mg~3 mL	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	22/04/2025
  daptomycin	Injection, powder for	500 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	22/04/2025
  daptomycin	Inhalation, powder for	350 mg	Current	Unavailable	Manufacturing	22/04/2025
  levothyroxine sodium	Tablet	75 microgram	Current	Unavailable	Manufacturing	22/04/2025
  lorazepam	Tablet	2.5 mg	Resolved	Available	Manufacturing	22/04/2025
  gentamicin sulfate	Injection, solution	135.6 mg	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	22/04/2025
  cytarabine	Injection, solution	100 mg/mL	Anticipated	Available	Manufacturing	22/04/2025
  estradiol~norethisterone acetate	Drug delivery system, transdermal	.512 mg~4.8 mg	Current	Unavailable	Manufacturing	22/04/2025
  hydrochlorothiazide~quinapril hydrochloride	Tablet, film coated	12.5 mg~10.832 mg	Current	Unavailable	Manufacturing	22/04/2025
  quinapril hydrochloride~hydrochlorothiazide	Tablet, film coated	21.664 mg~12.5 mg	Current	Unavailable	Manufacturing	22/04/2025

• 2025.04.21
  TGAオーストラリア供給不足情報（2025年4月14日～4月20日）

  Active ingredients	Dosage form	Quantity of active ingredients	Shortage status	Availability	Reason	Last updated
  clopidogrel hydrogen sulfate	Tablet, film coated	97.875 mg	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	18/04/2025
  clopidogrel hydrogen sulfate	Tablet, film coated	97.875 mg	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	18/04/2025
  gabapentin	Capsule, hard	300 mg	Current	Limited Availability	Manufacturing	17/04/2025
  zolpidem tartrate	Tablet, film coated	10 mg	Resolved	Available	Manufacturing	17/04/2025
  midazolam	Injection, solution	5 mg/mL	Anticipated	Available	Manufacturing	17/04/2025
  venlafaxine	Capsule, modified release	75 mg	Current	Limited Availability	Manufacturing	17/04/2025
  venlafaxine	Capsule, modified release	150 mg	Current	Limited Availability	Manufacturing	17/04/2025
  clomipramine hydrochloride	Tablet, film coated	25 mg	Resolved	Available	Manufacturing	17/04/2025
  losartan potassium	Tablet, film coated	50 mg	Current	Limited Availability	Manufacturing	17/04/2025
  losartan potassium	Tablet, film coated	25 mg	Current	Limited Availability	Manufacturing	17/04/2025
  mirtazapine	Tablet, film coated	45 mg	Current	Unavailable	Manufacturing	17/04/2025
  donepezil hydrochloride	Tablet, film coated	10 mg	Current	Unavailable	Manufacturing	17/04/2025
  rocuronium bromide	Injection, solution	50 mg	Anticipated	Available	Manufacturing	17/04/2025
  pramipexole dihydrochloride monohydrate	Tablet	1 mg	Current	Unavailable	Manufacturing	17/04/2025
  pramipexole dihydrochloride monohydrate	Tablet	.25 mg	Current	Unavailable	Transport / Logistic issues / Storage capacity issues	17/04/2025
  amlodipine besilate~olmesartan medoxomil~hydrochlorothiazide	Tablet	6.944 mg~40 mg~12.5 mg	Current	Limited Availability	Manufacturing	17/04/2025
  ezetimibe~rosuvastatin calcium	Tablet~Tablet, film coated	10 mg~41.583 mg	Current	Limited Availability	Manufacturing	17/04/2025
  ezetimibe~rosuvastatin calcium	Tablet~Tablet, film coated	10 mg~10.396 mg	Current	Unavailable	Manufacturing	17/04/2025
  metoprolol succinate	Tablet, modified release	95 mg	Current	Limited Availability	Manufacturing	17/04/2025
  metoprolol succinate	Tablet, modified release	47.5 mg	Current	Unavailable	Manufacturing	17/04/2025
  metoprolol succinate	Tablet, modified release	190 mg	Current	Unavailable	Manufacturing	17/04/2025
  metoprolol succinate	Tablet, modified release	23.75 mg	Current	Limited Availability	Manufacturing	17/04/2025
  capecitabine	Tablet, film coated	500 mg	Current	Limited Availability	Unexpected increase in consumer demand	17/04/2025
  ezetimibe~atorvastatin calcium trihydrate	Tablet, multilayer	10 mg~86.8 mg	Current	Limited Availability	Manufacturing	17/04/2025
  esomeprazole	Capsule, enteric	20 mg	Current	Limited Availability	Manufacturing	17/04/2025
  anastrozole	Tablet, film coated	1 mg	Current	Unavailable	Manufacturing	17/04/2025
  atorvastatin calcium trihydrate	Tablet, film coated	43.376 mg	Current	Unavailable	Manufacturing	17/04/2025
  spironolactone	Tablet, uncoated	25 mg	Current	Limited Availability	Manufacturing	17/04/2025
  piroxicam	Capsule, hard	10 mg	Discontinued	Unavailable	Commercial Changes / Commercial viability	17/04/2025
  piroxicam	Capsule, hard	20 mg	Discontinued	Unavailable	Commercial Changes / Commercial viability	17/04/2025
  spironolactone	Tablet, film coated	100 mg	Anticipated	Available	Manufacturing	17/04/2025
  iopromide	Injection, solution	498.72 mg/mL	Current	Unavailable	Manufacturing	17/04/2025
  reboxetine mesilate	Tablet, uncoated	5.224 mg	Anticipated	Available	Manufacturing	17/04/2025
  primidone	Tablet, uncoated	250 mg	Current	Unavailable	Manufacturing	16/04/2025
  olanzapine	Tablet, film coated	7.5 mg	Resolved	Available	Manufacturing	16/04/2025
  clonidine hydrochloride	Tablet, uncoated	100 microgram	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	16/04/2025
  risperidone	Tablet, film coated	1 mg	Current	Limited Availability	Unexpected increase in consumer demand	16/04/2025
  risperidone	Tablet, film coated	.5 mg	Current	Limited Availability	Manufacturing	16/04/2025
  duloxetine hydrochloride	Capsule, enteric	67.3 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	16/04/2025
  pramipexole dihydrochloride monohydrate	Tablet	.25 mg	Anticipated	Available	Unexpected increase in consumer demand	16/04/2025
  fenofibrate	Tablet	48 mg	Resolved	Available	Manufacturing	16/04/2025
  betahistine dihydrochloride	Tablet	16 mg	Current	Unavailable	Manufacturing	16/04/2025
  clonidine hydrochloride	Tablet	100 microgram	Resolved	Available	Manufacturing	16/04/2025
  anastrozole	Tablet, film coated	1 mg	Current	Limited Availability	Manufacturing	16/04/2025
  mercaptopurine monohydrate	Tablet	50 mg	Anticipated	Available	Manufacturing	16/04/2025
  dexmedetomidine hydrochloride	Injection, concentrated	118 microgram/mL	Anticipated	Available	Manufacturing	16/04/2025
  Semaglutide	Injection, solution	1.34 mg/mL	Current	Limited Availability	Unexpected increase in consumer demand	16/04/2025
  naloxone hydrochloride dihydrate	Spray, nasal	2.2 mg/actuation	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	16/04/2025
  nebivolol hydrochloride	Tablet	10.9 mg	Resolved	Available	Manufacturing	16/04/2025
  Semaglutide	Injection, solution	1.34 mg/mL	Current	Limited Availability	Unexpected increase in consumer demand	16/04/2025
  bortezomib	Injection, solution	3.5 mg	Anticipated	Available	Manufacturing	16/04/2025
  melatonin	Capsule, hard	3 mg	Current	Unavailable	Unexpected increase in consumer demand	16/04/2025
  carbidopa monohydrate~levodopa	Tablet, uncoated	26.9 mg~100 mg	Current	Limited Availability	Manufacturing	16/04/2025
  balsalazide sodium	Capsule	750 mg	Current	Limited Availability	Manufacturing	16/04/2025
  clonidine hydrochloride	Tablet, uncoated	150 microgram	Resolved	Available	Unexpected increase in consumer demand	16/04/2025
  methylphenidate hydrochloride	Tablet, uncoated	10 mg	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	15/04/2025
  methylphenidate hydrochloride	Tablet, uncoated	10 mg	Resolved	Available	Transport / Logistic issues / Storage capacity issues	15/04/2025
  adrenaline (epinephrine) acid tartrate	Injection, solution	1.82 mg/mL	Current	Unavailable	Manufacturing	15/04/2025
  amlodipine besilate	Tablet, uncoated	7 mg	Resolved	Available	Manufacturing	15/04/2025
  Hepatitis a virus antigen~Hepatitis B surface antigen recombinant	Injection, suspension	720 ELISA unit/mL~20 microgram/mL	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	15/04/2025
  risedronate sodium	Tablet, film coated	35 mg	Resolved	Available	Manufacturing	15/04/2025
  azithromycin dihydrate	Tablet, film coated	524.1 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	15/04/2025
  clopidogrel hydrogen sulfate	Tablet, film coated	97.9 mg	Anticipated	Available	Manufacturing	15/04/2025
  propranolol hydrochloride	Tablet, film coated	40 mg	Current	Limited Availability	Manufacturing	15/04/2025
  perindopril erbumine	Tablet	8 mg	Anticipated	Available	Manufacturing	15/04/2025
  sildenafil citrate	Tablet, film coated	28.1 mg	Current	Limited Availability	Manufacturing	15/04/2025
  azithromycin dihydrate	Tablet, film coated	524 mg	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	15/04/2025
  hydromorphone hydrochloride	Injection, solution	2 mg/mL	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	15/04/2025
  ivabradine hydrochloride	Tablet, film coated	8.085 mg	Current	Limited Availability	Manufacturing	15/04/2025
  acamprosate calcium	Tablet, enteric coated	333 mg	Current	Limited Availability	Manufacturing	15/04/2025
  fluconazole	Capsule, hard	200 mg	Resolved	Available	Manufacturing	15/04/2025
  ropinirole hydrochloride	Tablet, film coated	.57 mg	Current	Limited Availability	Manufacturing	15/04/2025
  Pegfilgrastim	Injection, solution	6 mg	Current	Limited Availability	Manufacturing	15/04/2025
  tamoxifen citrate	Tablet	30.34 mg	Current	Limited Availability	Manufacturing	15/04/2025
  deferasirox	Tablet, film coated	90 mg	Anticipated	Available	Manufacturing	15/04/2025
  rivaroxaban	Tablet, film coated	10 mg	Resolved	Available	Manufacturing	15/04/2025
  podophyllotoxin	Solution	5 mg/mL	Discontinued	Reduction in supply until supply is exhausted	Manufacturing	15/04/2025
  deferasirox	Tablet, film coated	360 mg	Resolved	Available	Manufacturing	15/04/2025
  azithromycin dihydrate	Tablet, film coated	524 mg	Resolved	Available	Unexpected increase in consumer demand	15/04/2025
  ketamine hydrochloride	Injection, solution	115.3 mg/mL	Resolved	Available	Manufacturing	15/04/2025
  dydrogesterone~estradiol	Tablet, film coated	10 mg~2 mg	Current	Limited Availability	Manufacturing	15/04/2025
  alprostadil	Injection, powder for	20 microgram/mL	Current	Limited Availability	Unexpected increase in consumer demand	15/04/2025
  metformin hydrochloride	Tablet, film coated	500 mg	Current	Unavailable	Manufacturing	14/04/2025
  risperidone	Tablet, film coated	3 mg	Resolved	Available	Manufacturing	14/04/2025
  risperidone	Tablet, film coated	4 mg	Resolved	Available	Manufacturing	14/04/2025
  risperidone	Tablet, film coated	1 mg	Resolved	Available	Manufacturing	14/04/2025
  risperidone	Tablet, film coated	.5 mg	Resolved	Available	Manufacturing	14/04/2025
  risperidone	Tablet, film coated	2 mg	Resolved	Available	Manufacturing	14/04/2025
  pramipexole dihydrochloride monohydrate	Tablet	.125 mg	Resolved	Available	Manufacturing	14/04/2025
  midazolam	Injection, solution	5 mg	Current	Limited Availability	Manufacturing	14/04/2025
  methotrexate	Injection, solution	100 mg/mL	Current	Unavailable	Manufacturing	14/04/2025
  noradrenaline (norepinephrine) acid tartrate monohydrate	Injection, concentrated	4 mg	Resolved	Available	Manufacturing	14/04/2025
  prasugrel	Tablet, film coated	5 mg	Current	Unavailable	Manufacturing	14/04/2025
  sildenafil citrate	Tablet, film coated	140.48 mg	Current	Limited Availability	Manufacturing	14/04/2025
  fentanyl citrate	Injection, solution	785 microgram	Anticipated	Available	Manufacturing	14/04/2025
  flecainide acetate	Tablet, uncoated	100 mg	Current	Limited Availability	Manufacturing	14/04/2025
  propofol	Injection, emulsion	10 mg/mL	Current	Limited Availability	Manufacturing	14/04/2025
  clarithromycin	Tablet, film coated	250 mg	Resolved	Available	Manufacturing	14/04/2025

• 2025.04.14
  TGAオーストラリア供給不足情報（2025年4月7日～4月13日）

  Active ingredients	Dosage form	Quantity of active ingredients	Shortage status	Availability	Reason	Last updated
  norethisterone	Tablet, uncoated	350 microgram	Current	Limited Availability	Unexpected increase in consumer demand	11/04/2025
  tramadol hydrochloride	Capsule	50 mg	Current	Limited Availability	Manufacturing	11/04/2025
  sumatriptan succinate	Tablet, film coated	140 mg	Current	Unavailable	Manufacturing	11/04/2025
  metformin hydrochloride	Tablet, film coated	850 mg	Current	Limited Availability	Manufacturing	11/04/2025
  ramipril	Capsule, hard	5 mg	Current	Limited Availability	Manufacturing	11/04/2025
  benzathine benzylpenicillin tetrahydrate	Injection, suspension	1200000 USP Unit	Anticipated	Available	Manufacturing	11/04/2025
  metformin hydrochloride	Tablet, film coated	500 mg	Current	Unavailable	Manufacturing	11/04/2025
  sulfamethoxazole~trimethoprim	Injection, concentrated	80 mg/mL~16 mg/mL	Current	Limited Availability	Manufacturing	11/04/2025
  fluorouracil	Injection, solution	5000 mg	Current	Unavailable	Unexpected increase in consumer demand	11/04/2025
  perindopril erbumine	Tablet	8 mg	Anticipated	Available	Manufacturing	11/04/2025
  lansoprazole	Tablet, orally disintegrating	15 mg	Current	Limited Availability	Manufacturing	11/04/2025
  risperidone	Tablet, film coated	.5 mg	Anticipated	Available	Manufacturing	11/04/2025
  capecitabine	Tablet, film coated	500 mg	Current	Unavailable	Manufacturing	11/04/2025
  metoprolol succinate	Tablet, modified release	23.75 mg	Current	Limited Availability	Manufacturing	11/04/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Unavailable	Manufacturing	11/04/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Unavailable	Manufacturing	11/04/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Unavailable	Manufacturing	11/04/2025
  metformin hydrochloride	Tablet, film coated	1000 mg	Current	Unavailable	Manufacturing	11/04/2025
  isavuconazonium sulfate	Capsule, hard	186.3 mg	Anticipated	Available	Manufacturing	11/04/2025
  deferasirox	Tablet, film coated	360 mg	Anticipated	Available	Manufacturing	11/04/2025
  atorvastatin calcium trihydrate	Tablet, film coated	10.844 mg	Current	Limited Availability	Manufacturing	11/04/2025
  atorvastatin calcium trihydrate	Tablet, film coated	86.751 mg	Current	Limited Availability	Manufacturing	11/04/2025
  Fremanezumab	Injection, solution	225 mg	Anticipated	Available	Unexpected increase in consumer demand	11/04/2025
  perindopril arginine	Tablet, film coated	2.5 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	11/04/2025
  perindopril arginine	Tablet, film coated	5 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	11/04/2025
  perindopril arginine	Tablet, film coated	10 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	11/04/2025
  cisplatin	Injection, solution	1 mg/mL	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	11/04/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	11/04/2025
  salbutamol sulfate	Inhalation, conventional	3 mg	Current	Unavailable	Manufacturing	10/04/2025
  zolpidem tartrate	Tablet, film coated	10 mg	Current	Limited Availability	Manufacturing	10/04/2025
  adrenaline (epinephrine) acid tartrate~lidocaine hydrochloride monohydrate	Injection, solution	22.7 microgram/mL~21.3 mg/mL	Current	Unavailable	Manufacturing	10/04/2025
  clomipramine hydrochloride	Tablet, film coated	25 mg	Current	Limited Availability	Manufacturing	10/04/2025
  hydroxocobalamin chloride	Injection, solution	1 mg/mL	Resolved	Available	Manufacturing	10/04/2025
  letrozole	Tablet, film coated	2.5 mg	Current	Limited Availability	Manufacturing	10/04/2025
  propofol	Injection, emulsion	10 g/L	Resolved	Available	Transport / Logistic issues / Storage capacity issues	10/04/2025
  capecitabine	Tablet, film coated	500 mg	Current	Limited Availability	Unexpected increase in consumer demand	10/04/2025
  Follitropin alfa	Injection, solution	75 IU	Current	Unavailable	Manufacturing	10/04/2025
  Follitropin alfa	Injection, solution	150 IU	Current	Unavailable	Manufacturing	10/04/2025
  hydrocortisone	Tablet, uncoated	20 mg	Current	Limited Availability	Manufacturing	10/04/2025
  hydrocortisone	Tablet, uncoated	4 mg	Resolved	Available	Manufacturing	10/04/2025
  hydrocortisone	Tablet, uncoated	20 mg	Current	Limited Availability	Manufacturing	10/04/2025
  celecoxib	Capsule, hard	100 mg	Current	Unavailable	Manufacturing	10/04/2025
  deferasirox	Tablet, film coated	90 mg	Anticipated	Available	Manufacturing	10/04/2025
  methotrexate	Tablet	2.5 mg	Resolved	Available	Manufacturing	10/04/2025
  naproxen	Tablet, uncoated	250 mg	Anticipated	Available	Manufacturing	10/04/2025
  gemfibrozil	Tablet, film coated	600 mg	Current	Unavailable	Manufacturing	10/04/2025
  tobramycin	Injection, solution	40 mg/mL	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	10/04/2025
  citalopram hydrobromide	Tablet, film coated	49.96 mg	Current	Limited Availability	Manufacturing	10/04/2025
  fenofibrate	Tablet, film coated	145 mg	Resolved	Available	Manufacturing	9/04/2025
  clonazepam	Oral Liquid, solution	2.5 mg/mL	Anticipated	Available	Manufacturing	9/04/2025
  vinblastine sulfate	Injection, solution	1 mg/mL	Resolved	Available	Manufacturing	9/04/2025
  timolol maleate	Eye Drops, solution	6.83 mg/mL	Current	Limited Availability	Commercial Changes / Commercial viability	9/04/2025
  atorvastatin calcium trihydrate~ezetimibe	Tablet, film coated	41.363 mg~10 mg	Resolved	Available	Manufacturing	9/04/2025
  doxepin hydrochloride	Capsule, hard	11.3 mg	Resolved	Available	Manufacturing	9/04/2025
  quinagolide hydrochloride	Tablet, uncoated	.0819 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	9/04/2025
  timolol maleate	Eye Drops, solution	6.84 mg/mL	Current	Limited Availability	Commercial Changes / Commercial viability	9/04/2025
  dorzolamide hydrochloride	Eye Drops, solution	22.26 mg/mL	Current	Limited Availability	Unexpected increase in consumer demand	9/04/2025
  primidone	Tablet, uncoated	250 mg	Current	Limited Availability	Manufacturing	8/04/2025
  lidocaine hydrochloride~adrenaline (epinephrine) acid tartrate	Injection, solution	10 mg/mL~9.1 microgram/mL	Resolved	Available	Commercial Changes / Commercial viability	8/04/2025
  methylphenidate hydrochloride	Capsule, modified release	10 mg	Anticipated	Available	Manufacturing	8/04/2025
  naproxen	Oral Liquid, suspension	25 mg/mL	Anticipated	Available	Manufacturing	8/04/2025
  paclitaxel	Injection, concentrated	300 mg	Current	Limited Availability	Manufacturing	8/04/2025
  prilocaine hydrochloride~felypressin	Injection, solution	30 mg/mL~.54 microgram/mL	Current	Unavailable	Manufacturing	8/04/2025
  pemetrexed disodium	Injection, powder for	551.4 mg	Current	Limited Availability	Manufacturing	8/04/2025
  methylphenidate hydrochloride	Capsule, modified release	60 mg	Anticipated	Available	Manufacturing	8/04/2025
  metformin hydrochloride	Tablet, film coated	1000 mg	Resolved	Available	Manufacturing	8/04/2025
  mesalazine	Tablet, enteric coated	250 mg	Current	Unavailable	Manufacturing	8/04/2025
  busulfan	Injection, concentrated	60 mg	Anticipated	Available	Manufacturing	8/04/2025
  enoxaparin sodium	Injection, solution	80 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	8/04/2025
  methylphenidate hydrochloride	Capsule, modified release	20 mg	Anticipated	Available	Manufacturing	8/04/2025
  methylphenidate hydrochloride	Capsule, modified release	30 mg	Anticipated	Available	Manufacturing	8/04/2025
  methylphenidate hydrochloride	Capsule, modified release	40 mg	Anticipated	Available	Manufacturing	8/04/2025
  metformin hydrochloride	Tablet, film coated	500 mg	Resolved	Available	Manufacturing	8/04/2025
  methylphenidate hydrochloride	Tablet, uncoated	10 mg	Anticipated	Available	Transport / Logistic issues / Storage capacity issues	7/04/2025
  salbutamol sulfate	Inhalation, conventional	6 mg	Current	Unavailable	Manufacturing	7/04/2025
  methylphenidate hydrochloride	Tablet, uncoated	10 mg	Anticipated	Available	Transport / Logistic issues / Storage capacity issues	7/04/2025
  oxytocin	Injection, solution	10 IU/mL	Current	Limited Availability	Unexpected increase in consumer demand	7/04/2025
  buprenorphine hydrochloride	Injection, solution	324 microgram/mL	Current	Unavailable	Manufacturing	7/04/2025
  propranolol hydrochloride	Tablet, film coated	40 mg	Anticipated	Available	Manufacturing	7/04/2025
  metronidazole	Tablet, uncoated	400 mg	Current	Limited Availability	Manufacturing	7/04/2025
  escitalopram oxalate	Tablet, film coated	25.548 mg	Current	Limited Availability	Manufacturing	7/04/2025
  dulaglutide	Injection, solution	1.5 mg	Current	Limited Availability	Manufacturing	7/04/2025
  flecainide acetate	Tablet, uncoated	50 mg	Current	Unavailable	Manufacturing	7/04/2025
  amiodarone hydrochloride	Injection, solution	150 mg	Current	Unavailable	Manufacturing	7/04/2025
  citalopram hydrobromide	Tablet, film coated	49.98 mg	Anticipated	Available	Manufacturing	7/04/2025
  ezetimibe	Tablet, uncoated	10 mg	Resolved	Available	Unexpected increase in consumer demand	7/04/2025
  irbesartan~hydrochlorothiazide	Tablet, film coated	300 mg~12.5 mg	Current	Unavailable	Manufacturing	7/04/2025
  irbesartan~hydrochlorothiazide	Tablet, film coated	300 mg~25 mg	Current	Unavailable	Manufacturing	7/04/2025
  hydrochlorothiazide~olmesartan medoxomil	Tablet	25 mg~40 mg	Current	Unavailable	Manufacturing	7/04/2025
  dasatinib	Tablet, film coated	20 mg	Resolved	Available	Unexpected increase in consumer demand	7/04/2025
  pegaspargase	Solution, powder for	750 U/mL	Current	Limited Availability	Manufacturing	7/04/2025
  risperidone	Tablet, film coated	2 mg	Resolved	Available	Manufacturing	7/04/2025
  risperidone	Tablet, film coated	4 mg	Resolved	Available	Manufacturing	7/04/2025
  latanoprost~timolol maleate	Eye Drops, solution	.05 mg/mL~6.83 mg/mL	Resolved	Available	Manufacturing	7/04/2025
  atorvastatin calcium trihydrate~ezetimibe	Tablet, film coated	82.725 mg~10 mg	Current	Unavailable	Manufacturing	7/04/2025
  potassium chloride	Injection, concentrated	75 mg/mL	Current	Unavailable	Commercial Changes / Commercial viability	7/04/2025
  ethanol absolute~carmustine	Diluent, not applicable~Injection, powder for	3 mL~100 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	7/04/2025
  nitrofurantoin	Capsule, hard	100 mg	Current	Limited Availability	Manufacturing	7/04/2025
  alprazolam	Tablet, uncoated	2 mg	Current	Limited Availability	Manufacturing	7/04/2025
  mirtazapine	Tablet, film coated	30 mg	Current	Limited Availability	Manufacturing	7/04/2025

• 2025.04.07
  TGAオーストラリア供給不足情報（2025年3月31日～4月6日）

  Active ingredients	Dosage form	Quantity of active ingredients	Shortage status	Availability	Reason	Last updated
  flecainide acetate	Injection, solution	10 mg/mL	Current	Unavailable	Manufacturing	4/04/2025
  midazolam	Injection, solution	5 mg/mL	Current	Limited Availability	Manufacturing	4/04/2025
  benzathine benzylpenicillin tetrahydrate	Injection, suspension	1200000 USP Unit	Anticipated	Available	Manufacturing	4/04/2025
  olanzapine	Tablet, film coated	10 mg	Current	Limited Availability	Manufacturing	4/04/2025
  midazolam	Injection, solution	5 mg	Current	Limited Availability	Manufacturing	4/04/2025
  glyceryl trinitrate	Injection, concentrated	50 mg	Resolved	Available	Manufacturing	4/04/2025
  Belimumab	Injection, powder for	120 mg	Resolved	Available	Manufacturing	4/04/2025
  pramipexole dihydrochloride monohydrate	Tablet	1 mg	Current	Unavailable	Manufacturing	4/04/2025
  montelukast sodium	Tablet, film coated	10.4 mg	Anticipated	Available	Manufacturing	4/04/2025
  praziquantel	Tablet, film coated	600 mg	Discontinued	Reduction in supply until supply is exhausted	Manufacturing	4/04/2025
  naproxen	Oral Liquid, suspension	25 mg/mL	Anticipated	Available	Manufacturing	4/04/2025
  simvastatin	Tablet, film coated	80 mg	Current	Unavailable	Manufacturing	4/04/2025
  rabeprazole sodium	Tablet, enteric coated	20 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	4/04/2025
  ezetimibe	Tablet, uncoated	10 mg	Current	Limited Availability	Unexpected increase in consumer demand	4/04/2025
  ezetimibe	Tablet, uncoated	10 mg	Current	Unavailable	Unexpected increase in consumer demand	4/04/2025
  ezetimibe	Tablet, uncoated	10 mg	Current	Unavailable	Manufacturing	4/04/2025
  clonidine hydrochloride	Tablet	100 microgram	Current	Unavailable	Unexpected increase in consumer demand	4/04/2025
  risperidone	Tablet, film coated	1 mg	Resolved	Available	Manufacturing	4/04/2025
  levothyroxine sodium	Tablet	.05 mg	Current	Unavailable	Manufacturing	4/04/2025
  levothyroxine sodium	Tablet	.2 mg	Current	Unavailable	Manufacturing	4/04/2025
  levothyroxine sodium	Tablet	.1 mg	Current	Unavailable	Manufacturing	4/04/2025
  levothyroxine sodium	Tablet	.075 mg	Current	Unavailable	Manufacturing	4/04/2025
  atorvastatin calcium trihydrate	Tablet, film coated	21.688 mg	Current	Limited Availability	Manufacturing	4/04/2025
  rivaroxaban	Tablet, film coated	20 mg	Current	Unavailable	Manufacturing	4/04/2025
  metoprolol tartrate	Tablet, uncoated	50 mg	Anticipated	Available	Manufacturing	4/04/2025
  sodium chloride	Injection, intravenous infusion	9 g/L	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	4/04/2025
  sodium chloride	Injection, solution	90 mg	Current	Limited Availability	Manufacturing	4/04/2025
  midazolam	Injection, solution	5 mg/mL	Current	Limited Availability	Unexpected increase in consumer demand	4/04/2025
  ropivacaine hydrochloride~fentanyl citrate	Injection, solution	2 mg/mL~3.14 microgram/mL	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	4/04/2025
  ropivacaine hydrochloride~fentanyl citrate	Injection, solution	2 mg/mL~3.14 microgram/mL	Discontinued	Unavailable	Commercial Changes / Commercial viability	4/04/2025
  ropivacaine hydrochloride~fentanyl citrate	Injection, solution	2 mg/mL~6.28 microgram/mL	Discontinued	Unavailable	Commercial Changes / Commercial viability	4/04/2025
  fentanyl citrate~ropivacaine hydrochloride	Injection, solution	6.28 microgram/mL~2 mg/mL	Discontinued	Unavailable	Commercial Changes / Commercial viability	4/04/2025
  propofol	Injection, emulsion	10 mg/mL	Anticipated	Available	Manufacturing	4/04/2025
  clarithromycin	Tablet, film coated	250 mg	Current	Unavailable	Manufacturing	4/04/2025
  nizatidine	Capsule	150 mg	Current	Limited Availability	Manufacturing	4/04/2025
  bupivacaine hydrochloride monohydrate	Injection, solution	52.7 mg	Current	Unavailable	Unexpected increase in consumer demand	3/04/2025
  gentamicin	Injection, solution	80 mg	Current	Unavailable	Manufacturing	3/04/2025
  olanzapine pamoate monohydrate	Injection, powder for	931 mg	Resolved	Available	Transport / Logistic issues / Storage capacity issues	3/04/2025
  olanzapine pamoate monohydrate	Injection, powder for	690 mg	Resolved	Available	Transport / Logistic issues / Storage capacity issues	3/04/2025
  olanzapine pamoate monohydrate	Injection, powder for	483 mg	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	3/04/2025
  anastrozole	Tablet, film coated	1 mg	Resolved	Available	Manufacturing	3/04/2025
  mycophenolate mofetil	Tablet, film coated	500 mg	Current	Limited Availability	Manufacturing	3/04/2025
  clonidine hydrochloride	Tablet, uncoated	100 microgram	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	3/04/2025
  trandolapril	Capsule, hard	1 mg	Current	Unavailable	Manufacturing	3/04/2025
  trandolapril	Capsule, hard	2 mg	Current	Unavailable	Manufacturing	3/04/2025
  trandolapril	Capsule, hard	4 mg	Current	Unavailable	Manufacturing	3/04/2025
  amlodipine besilate~atorvastatin calcium trihydrate	Tablet, film coated	13.88 mg~21.688 mg	Resolved	Available	Manufacturing	3/04/2025
  noradrenaline (norepinephrine) acid tartrate monohydrate	Injection, concentrated	4 mg	Current	Limited Availability	Manufacturing	3/04/2025
  atomoxetine hydrochloride	Capsule, hard	45.72 mg	Current	Unavailable	Manufacturing	3/04/2025
  dosulepin (dothiepin) hydrochloride	Tablet, film coated	75 mg	Resolved	Available	Manufacturing	3/04/2025
  acamprosate calcium	Tablet, enteric coated	333 mg	Resolved	Available	Unexpected increase in consumer demand	3/04/2025
  ezetimibe~atorvastatin calcium trihydrate	Tablet, film coated	10 mg~82.725 mg	Current	Unavailable	Manufacturing	3/04/2025
  ezetimibe~atorvastatin calcium trihydrate	Tablet, film coated	10 mg~41.363 mg	Current	Unavailable	Manufacturing	3/04/2025
  ezetimibe~atorvastatin calcium trihydrate	Tablet, film coated	10 mg~20.681 mg	Current	Unavailable	Manufacturing	3/04/2025
  Semaglutide	Injection, solution	1.34 mg/mL	Current	Limited Availability	Unexpected increase in consumer demand	3/04/2025
  Semaglutide	Injection, solution	1.34 mg/mL	Current	Limited Availability	Unexpected increase in consumer demand	3/04/2025
  deferasirox	Tablet, film coated	90 mg	Anticipated	Available	Manufacturing	3/04/2025
  estradiol~norethisterone acetate~estradiol	Drug delivery system, transdermal	.78 mg~2.7 mg~.62 mg	Current	Unavailable	Manufacturing	3/04/2025
  estradiol	Drug delivery system, transdermal	.39 mg	Current	Unavailable	Manufacturing	3/04/2025
  estradiol	Drug delivery system, transdermal	1.56 mg	Current	Unavailable	Manufacturing	3/04/2025
  paracetamol	Tablet, modified release	665 mg	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	3/04/2025
  tirzepatide	Injection, solution	5 mg	Current	Unavailable	Commercial Changes / Commercial viability	3/04/2025
  tirzepatide	Injection, solution	7.5 mg	Current	Unavailable	Commercial Changes / Commercial viability	3/04/2025
  tirzepatide	Injection, solution	12.5 mg	Current	Unavailable	Commercial Changes / Commercial viability	3/04/2025
  tirzepatide	Injection, solution	10 mg	Current	Unavailable	Commercial Changes / Commercial viability	3/04/2025
  tirzepatide	Injection, solution	15 mg	Current	Unavailable	Commercial Changes / Commercial viability	3/04/2025
  tirzepatide	Injection, solution	2.5 mg	Current	Unavailable	Commercial Changes / Commercial viability	3/04/2025
  carboplatin	Injection, solution	10 mg/mL	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	3/04/2025
  doxorubicin hydrochloride	Injection, concentrated	20 mg	Anticipated	Available	Manufacturing	3/04/2025
  gemfibrozil	Tablet, film coated	600 mg	Current	Unavailable	Manufacturing	3/04/2025
  estradiol hemihydrate	Drug delivery system, transdermal	3.09 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	3/04/2025
  clonidine hydrochloride	Tablet, uncoated	150 microgram	Current	Limited Availability	Unexpected increase in consumer demand	3/04/2025
  reboxetine mesilate	Tablet, uncoated	5.224 mg	Anticipated	Available	Manufacturing	3/04/2025
  betiatide	Injection, powder for	1 mg	Current	Limited Availability	Manufacturing	2/04/2025
  adrenaline (epinephrine) acid tartrate	Injection, solution	1.82 mg/mL	Current	Unavailable	Manufacturing	2/04/2025
  sugammadex sodium	Injection, solution	217.6 mg	Discontinued	Unavailable	Commercial Changes / Commercial viability	2/04/2025
  sugammadex sodium	Injection, solution	544 mg	Discontinued	Unavailable	Commercial Changes / Commercial viability	2/04/2025
  fentanyl	Drug delivery system, transdermal	8.4 mg	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	2/04/2025
  azithromycin dihydrate	Tablet, film coated	524.1 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	2/04/2025
  levetiracetam	Tablet, film coated	1000 mg	Resolved	Available	Manufacturing	2/04/2025
  carbidopa monohydrate~entacapone~levodopa	Tablet, film coated	33.75 mg~200 mg~125 mg	Current	Limited Availability	Manufacturing	2/04/2025
  hydrochlorothiazide~olmesartan medoxomil~amlodipine besilate	Tablet	12.5 mg~20 mg~6.944 mg	Resolved	Available	Manufacturing	2/04/2025
  olmesartan medoxomil~amlodipine besilate~hydrochlorothiazide	Tablet	40 mg~6.944 mg~12.5 mg	Current	Limited Availability	Manufacturing	2/04/2025
  adrenaline (epinephrine) acid tartrate	Injection, solution	182 microgram/mL	Current	Unavailable	Manufacturing	2/04/2025
  morphine hydrochloride trihydrate	Injection, solution	20 mg/mL	Resolved	Available	Manufacturing	2/04/2025
  atomoxetine hydrochloride	Capsule, hard	91.44 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	2/04/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Unavailable	Manufacturing	2/04/2025
  emtricitabine~tenofovir disoproxil succinate	Tablet, film coated	200 mg~300.6 mg	Resolved	Available	Manufacturing	2/04/2025
  deferasirox	Tablet, film coated	360 mg	Current	Unavailable	Manufacturing	2/04/2025
  enoxaparin sodium	Injection, solution	150 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	2/04/2025
  heparin sodium	Injection, solution	1000 IU/mL	Resolved	Available	Manufacturing	2/04/2025
  clopidogrel hydrogen sulfate	Tablet, film coated	97.875 mg	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	1/04/2025
  fentanyl	Drug delivery system, transdermal	16.8 mg	Resolved	Available	Manufacturing	1/04/2025
  risedronate sodium	Tablet, film coated	35 mg	Current	Unavailable	Manufacturing	1/04/2025
  propofol	Injection, emulsion	10 g/L	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	1/04/2025
  amlodipine besilate~olmesartan medoxomil~hydrochlorothiazide	Tablet	6.944 mg~40 mg~25 mg	Resolved	Available	Manufacturing	1/04/2025
  duloxetine hydrochloride	Capsule, enteric	67.3 mg	Resolved	Available	Manufacturing	1/04/2025
  sodium iodide(131I)	Oral Liquid, solution	50 MBq	Anticipated	Available	Manufacturing	1/04/2025
  sodium iodide(131I)	Capsule, hard	50 MBq	Anticipated	Available	Manufacturing	1/04/2025
  fenofibrate	Tablet, film coated	145 mg	Resolved	Available	Manufacturing	1/04/2025
  emtricitabine~efavirenz~tenofovir disoproxil maleate	Tablet, film coated	200 mg~600 mg~300 mg	Current	Unavailable	Manufacturing	1/04/2025
  timolol maleate	Eye Drops, solution	6.83 mg/mL	Current	Unavailable	Commercial Changes / Commercial viability	1/04/2025
  benzathine benzylpenicillin tetrahydrate	Injection, suspension	600000 USP Unit	Current	Unavailable	Manufacturing	1/04/2025
  rivaroxaban	Tablet, film coated	10 mg	Current	Unavailable	Manufacturing	1/04/2025
  dasatinib propylene glycol	Tablet, film coated	58 mg	Resolved	Available	Manufacturing	1/04/2025
  dasatinib propylene glycol	Tablet, film coated	81.2 mg	Resolved	Available	Manufacturing	1/04/2025
  dasatinib propylene glycol	Tablet, film coated	116 mg	Resolved	Available	Manufacturing	1/04/2025
  adrenaline (epinephrine)	Injection, solution	500 microgram	Anticipated	Available	Manufacturing	1/04/2025
  rifampicin	Capsule, hard	300 mg	Current	Unavailable	Manufacturing	1/04/2025
  sodium iodide(131I)	Oral Liquid, solution	1201 MBq	Anticipated	Available	Manufacturing	1/04/2025
  sodium pertechnetate(99mTc)	Injection, solution	20 GBq	Anticipated	Available	Manufacturing	1/04/2025
  bicisate dihydrochloride	Injection, powder for	.9 mg	Current	Unavailable	Manufacturing	1/04/2025
  sodium pertechnetate(99mTc)	Injection	370 GBq	Anticipated	Available	Manufacturing	1/04/2025
  olanzapine	Injection, powder for	10 mg	Current	Limited Availability	Unexpected increase in consumer demand	1/04/2025
  clopidogrel hydrogen sulfate	Tablet, film coated	97.875 mg	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	1/04/2025
  bupivacaine hydrochloride	Injection, solution	2.5 mg/mL	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	31/03/2025
  amlodipine besilate	Tablet, uncoated	7 mg	Anticipated	Available	Manufacturing	31/03/2025
  bicalutamide	Tablet, film coated	50 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	31/03/2025
  venlafaxine hydrochloride	Capsule, modified release	169.71 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	31/03/2025
  bisoprolol fumarate	Tablet	2.5 mg	Current	Limited Availability	Manufacturing	31/03/2025
  ondansetron hydrochloride dihydrate	Tablet, film coated	9.972 mg	Resolved	Available	Unexpected increase in consumer demand	31/03/2025
  finasteride	Tablet, film coated	1 mg	Anticipated	Available	Manufacturing	31/03/2025
  quetiapine fumarate	Tablet, modified release	57.565 mg	Anticipated	Available	Unexpected increase in consumer demand	31/03/2025
  raloxifene hydrochloride	Tablet, film coated	60 mg	Current	Unavailable	Unexpected increase in consumer demand	31/03/2025
  acarbose	Tablet	100 mg	Resolved	Available	Manufacturing	31/03/2025
  acarbose	Tablet	50 mg	Resolved	Available	Manufacturing	31/03/2025
  amiodarone hydrochloride	Injection, solution	150 mg	Current	Limited Availability	Manufacturing	31/03/2025
  tenofovir disoproxil maleate	Tablet, film coated	300 mg	Current	Unavailable	Manufacturing	31/03/2025
  tenofovir disoproxil maleate~emtricitabine	Tablet, film coated	300 mg~200 mg	Current	Limited Availability	Manufacturing	31/03/2025
  armodafinil	Tablet, uncoated	50 mg	Current	Limited Availability	Manufacturing	31/03/2025
  prasugrel	Tablet, film coated	5 mg	Current	Unavailable	Manufacturing	31/03/2025
  spironolactone	Tablet, uncoated	25 mg	Current	Unavailable	Manufacturing	31/03/2025
  ropivacaine hydrochloride	Injection, solution	2 mg/mL	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	31/03/2025

• 2025.03.30
  TGAオーストラリア供給不足情報（2025年3月24日～3月30日）

  Active ingredients	Dosage form	Quantity of active ingredients	Shortage status	Availability	Reason	Last updated
  fenofibrate	Tablet, film coated	145 mg	Current	Limited Availability	Manufacturing	28/03/2025
  ciprofloxacin hydrochloride	Tablet, film coated	277.5 mg	Current	Limited Availability	Manufacturing	28/03/2025
  risperidone	Tablet, film coated	3 mg	Current	Unavailable	Manufacturing	28/03/2025
  levetiracetam	Tablet, film coated	1000 mg	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	28/03/2025
  galantamine hydrobromide	Capsule, modified release	10.252 mg	Current	Unavailable	Manufacturing	28/03/2025
  galantamine hydrobromide	Capsule, modified release	10.252 mg	Current	Unavailable	Manufacturing	28/03/2025
  galantamine hydrobromide	Capsule, modified release	20.504 mg	Current	Unavailable	Manufacturing	28/03/2025
  isotretinoin	Capsule, soft	10 mg	Current	Limited Availability	Manufacturing	28/03/2025
  neostigmine methylsulfate	Injection, solution	2.5 mg	Current	Unavailable	Manufacturing	28/03/2025
  simvastatin	Tablet, film coated	80 mg	Current	Unavailable	Manufacturing	28/03/2025
  linezolid	Tablet, film coated	600 mg	Current	Limited Availability	Manufacturing	28/03/2025
  ezetimibe	Tablet, uncoated	10 mg	Current	Unavailable	Manufacturing	28/03/2025
  anastrozole	Tablet, film coated	1 mg	Current	Limited Availability	Manufacturing	28/03/2025
  acamprosate calcium	Tablet, enteric coated	333 mg	Current	Limited Availability	Manufacturing	28/03/2025
  dosulepin (dothiepin) hydrochloride	Capsule, hard	25 mg	Current	Limited Availability	Manufacturing	28/03/2025
  sodium nitroprusside	Injection, concentrated	50 mg	Anticipated	Available	Commercial Changes / Commercial viability	28/03/2025
  fentanyl citrate~ropivacaine hydrochloride	Injection, solution	3.14 microgram/mL~2 mg/mL	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	28/03/2025
  fentanyl citrate~ropivacaine hydrochloride	Injection, solution	3.14 microgram/mL~2 mg/mL	Discontinued	Unavailable	Commercial Changes / Commercial viability	28/03/2025
  ropivacaine hydrochloride~fentanyl citrate	Injection, solution	2 mg/mL~6.28 microgram/mL	Discontinued	Unavailable	Commercial Changes / Commercial viability	28/03/2025
  ropivacaine hydrochloride~fentanyl citrate	Injection, solution	2 mg/mL~6.28 microgram/mL	Discontinued	Unavailable	Commercial Changes / Commercial viability	28/03/2025
  metformin hydrochloride	Tablet, film coated	1000 mg	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	28/03/2025
  gabapentin	Capsule, hard	300 mg	Current	Limited Availability	Manufacturing	27/03/2025
  adrenaline (epinephrine) acid tartrate~lidocaine hydrochloride monohydrate	Injection, solution	22.7 microgram/mL~21.3 mg/mL	Current	Limited Availability	Manufacturing	27/03/2025
  sumatriptan succinate	Tablet, film coated	140 mg	Current	Unavailable	Manufacturing	27/03/2025
  venlafaxine	Capsule, modified release	75 mg	Current	Limited Availability	Manufacturing	27/03/2025
  clomipramine hydrochloride	Tablet, film coated	25 mg	Current	Limited Availability	Manufacturing	27/03/2025
  mycophenolate mofetil	Tablet, film coated	500 mg	Current	Unavailable	Manufacturing	27/03/2025
  clopidogrel hydrogen sulfate	Tablet, film coated	97.9 mg	Current	Limited Availability	Unexpected increase in consumer demand	27/03/2025
  risperidone	Tablet, film coated	1 mg	Current	Unavailable	Unexpected increase in consumer demand	27/03/2025
  metformin hydrochloride	Tablet, film coated	1000 mg	Current	Unavailable	Manufacturing	27/03/2025
  capecitabine	Tablet, film coated	500 mg	Current	Limited Availability	Unexpected increase in consumer demand	27/03/2025
  entecavir	Tablet, film coated	.5 mg	Current	Unavailable	Manufacturing	27/03/2025
  prilocaine hydrochloride~felypressin	Injection, solution	30 mg/mL~.54 microgram/mL	Current	Unavailable	Manufacturing	27/03/2025
  dexmedetomidine hydrochloride	Injection, concentrated	118 microgram/mL	Current	Unavailable	Manufacturing	27/03/2025
  emtricitabine~efavirenz~tenofovir disoproxil maleate	Tablet, film coated	200 mg~600 mg~300 mg	Current	Limited Availability	Manufacturing	27/03/2025
  atorvastatin calcium trihydrate	Tablet, film coated	43.376 mg	Current	Unavailable	Manufacturing	27/03/2025
  naproxen	Tablet	500 mg	Current	Unavailable	Manufacturing	27/03/2025
  metformin hydrochloride	Tablet, film coated	850 mg	Current	Unavailable	Manufacturing	27/03/2025
  metformin hydrochloride	Tablet, film coated	1000 mg	Current	Unavailable	Manufacturing	27/03/2025
  letrozole	Tablet, film coated	2.5 mg	Current	Unavailable	Manufacturing	26/03/2025
  fluorouracil	Injection, solution	5000 mg	Current	Unavailable	Unexpected increase in consumer demand	26/03/2025
  pramipexole dihydrochloride monohydrate	Tablet	.125 mg	Current	Unavailable	Manufacturing	26/03/2025
  clonidine hydrochloride	Tablet, uncoated	100 microgram	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	26/03/2025
  atorvastatin calcium trihydrate~amlodipine besilate	Tablet, film coated	21.688 mg~13.88 mg	Current	Limited Availability	Manufacturing	26/03/2025
  rosuvastatin calcium~ezetimibe	Tablet~Tablet, film coated	41.583 mg~10 mg	Anticipated	Available	Manufacturing	26/03/2025
  rosuvastatin calcium~ezetimibe	Tablet~Tablet, film coated	10.396 mg~10 mg	Current	Unavailable	Manufacturing	26/03/2025
  ezetimibe~rosuvastatin calcium	Tablet~Tablet, film coated	10 mg~20.791 mg	Resolved	Available	Manufacturing	26/03/2025
  pramipexole dihydrochloride monohydrate	Tablet	.125 mg	Current	Limited Availability	Unexpected increase in consumer demand	26/03/2025
  oxycodone hydrochloride	Capsule, hard	10 mg	Current	Unavailable	Commercial Changes / Commercial viability	26/03/2025
  oxycodone hydrochloride	Capsule, hard	20 mg	Current	Unavailable	Commercial Changes / Commercial viability	26/03/2025
  emtricitabine~tenofovir disoproxil fumarate	Tablet, film coated	200 mg~300 mg	Resolved	Available	Manufacturing	26/03/2025
  Pegfilgrastim	Injection, solution	6 mg	Anticipated	Available	Manufacturing	26/03/2025
  emtricitabine~tenofovir disoproxil fumarate	Tablet, film coated	200 mg~300 mg	Current	Limited Availability	Manufacturing	26/03/2025
  melatonin	Oral Liquid, solution	1 mg/mL	Resolved	Available	Unexpected increase in consumer demand	26/03/2025
  gentamicin sulfate	Injection, solution	135.6 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	26/03/2025
  ethinylestradiol~norethisterone	Tablet, uncoated	36 microgram~500 microgram	Current	Unavailable	Unexpected increase in consumer demand	26/03/2025
  iopromide	Injection, solution	498.72 mg/mL	Current	Unavailable	Manufacturing	26/03/2025
  clonidine hydrochloride	Tablet, uncoated	150 microgram	Resolved	Available	Transport / Logistic issues / Storage capacity issues	26/03/2025
  zoledronic acid	Injection, concentrated	4 mg	Resolved	Available	Commercial Changes / Commercial viability	26/03/2025
  nizatidine	Capsule	150 mg	Current	Limited Availability	Manufacturing	26/03/2025
  isosorbide dinitrate	Tablet, uncoated	5 mg	Anticipated	Available	Manufacturing	25/03/2025
  trihexyphenidyl (benzhexol) hydrochloride	Tablet, uncoated	5 mg	Current	Limited Availability	Unexpected increase in consumer demand	25/03/2025
  venlafaxine hydrochloride	Capsule, modified release	169.71 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	25/03/2025
  venlafaxine hydrochloride	Capsule, modified release	84.86 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	25/03/2025
  mycophenolate mofetil	Capsule	250 mg	Anticipated	Available	Manufacturing	25/03/2025
  galantamine hydrobromide	Capsule, modified release	30.756 mg	Anticipated	Available	Manufacturing	25/03/2025
  ondansetron	Tablet, orally disintegrating	8 mg	Current	Limited Availability	Manufacturing	25/03/2025
  quetiapine fumarate	Tablet, modified release	57.565 mg	Anticipated	Available	Unexpected increase in consumer demand	25/03/2025
  ketorolac trometamol	Injection, solution	30 mg/mL	Anticipated	Available	Commercial Changes / Commercial viability	25/03/2025
  pemetrexed disodium	Injection, powder for	1102.9 mg	Current	Limited Availability	Manufacturing	25/03/2025
  tobramycin	Injection, solution	40 mg/mL	Resolved	Available	Unexpected increase in consumer demand	25/03/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Unavailable	Manufacturing	25/03/2025
  hydrocortisone	Tablet, uncoated	4 mg	Anticipated	Available	Manufacturing	25/03/2025
  olanzapine	Tablet, uncoated	5 mg	Current	Unavailable	Manufacturing	25/03/2025
  thiotepa	Injection, powder for	15 mg	Current	Unavailable	Commercial Changes / Commercial viability	25/03/2025
  thiotepa	Injection, powder for	100 mg	Current	Unavailable	Commercial Changes / Commercial viability	25/03/2025
  thiotepa	Injection, powder for	400 mg	Current	Unavailable	Commercial Changes / Commercial viability	25/03/2025
  clopidogrel hydrogen sulfate	Tablet, film coated	97.875 mg	Current	Unavailable	Manufacturing	25/03/2025
  lorazepam	Tablet	2.5 mg	Current	Unavailable	Manufacturing	25/03/2025
  cisatracurium besilate	Injection, solution	13.4 mg	Resolved	Available	Manufacturing	25/03/2025
  spironolactone	Tablet, film coated	100 mg	Anticipated	Available	Manufacturing	25/03/2025
  hydroxocobalamin chloride	Injection, solution	1 mg/mL	Current	Unavailable	Manufacturing	24/03/2025
  metoprolol succinate	Tablet, modified release	47.5 mg	Resolved	Available	Manufacturing	24/03/2025
  metoprolol succinate	Tablet, modified release	190 mg	Resolved	Available	Manufacturing	24/03/2025
  metoprolol succinate	Tablet, modified release	95 mg	Resolved	Available	Manufacturing	24/03/2025
  trandolapril	Capsule, hard	1 mg	Current	Unavailable	Manufacturing	24/03/2025
  trandolapril	Capsule, hard	4 mg	Current	Unavailable	Manufacturing	24/03/2025
  quetiapine fumarate	Tablet, modified release	172.695 mg	Anticipated	Available	Unexpected increase in consumer demand	24/03/2025
  quetiapine fumarate	Tablet, modified release	57.565 mg	Anticipated	Available	Unexpected increase in consumer demand	24/03/2025
  methotrexate	Injection, solution	100 mg/mL	Current	Unavailable	Manufacturing	24/03/2025
  citalopram hydrobromide	Tablet, film coated	49.98 mg	Resolved	Available	Manufacturing	24/03/2025
  metformin hydrochloride	Tablet, film coated	500 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	24/03/2025
  deferasirox	Tablet, film coated	90 mg	Anticipated	Available	Manufacturing	24/03/2025
  atorvastatin calcium trihydrate	Tablet, film coated	21.688 mg	Current	Limited Availability	Manufacturing	24/03/2025
  ethanol absolute~carmustine	Diluent, not applicable~Injection, powder for	3 mL~100 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	24/03/2025
  deferasirox	Tablet, film coated	360 mg	Current	Unavailable	Manufacturing	24/03/2025
  metoclopramide hydrochloride monohydrate	Injection, solution	10.54 mg	Anticipated	Available	Unexpected increase in consumer demand	24/03/2025
  permethrin	Cream	50 mg/g	Current	Limited Availability	Commercial Changes / Commercial viability	24/03/2025
  dydrogesterone~estradiol	Tablet, film coated	10 mg~2 mg	Current	Unavailable	Manufacturing	24/03/2025

• 2025.03.23
  TGAオーストラリア供給不足情報（2025年3月17日～3月23日）

  Active ingredients	Dosage form	Quantity of active ingredients	Shortage status	Availability	Reason	Last updated
  morphine hydrochloride trihydrate	Oral Liquid, solution	10 mg/mL	Current	Unavailable	Commercial Changes / Commercial viability	21/03/2025
  olanzapine	Tablet, film coated	7.5 mg	Current	Limited Availability	Manufacturing	21/03/2025
  sulfamethoxazole~trimethoprim	Injection, concentrated	80 mg/mL~16 mg/mL	Anticipated	Available	Manufacturing	21/03/2025
  hydrocortisone sodium succinate	Injection, powder for	334.25 mg	Anticipated	Available	Manufacturing	21/03/2025
  pramipexole dihydrochloride monohydrate	Tablet	.125 mg	Resolved	Available	Manufacturing	21/03/2025
  Belimumab	Injection, powder for	120 mg	Current	Limited Availability	Manufacturing	21/03/2025
  propranolol hydrochloride	Tablet, film coated	40 mg	Anticipated	Available	Manufacturing	21/03/2025
  risperidone	Tablet, film coated	.5 mg	Anticipated	Available	Manufacturing	21/03/2025
  quetiapine fumarate	Tablet, modified release	345.39 mg	Resolved	Available	Manufacturing	21/03/2025
  morphine hydrochloride trihydrate	Injection, solution	20 mg/mL	Current	Limited Availability	Manufacturing	21/03/2025
  esomeprazole	Capsule, enteric	20 mg	Current	Limited Availability	Manufacturing	21/03/2025
  ezetimibe	Tablet, uncoated	10 mg	Current	Unavailable	Unexpected increase in consumer demand	21/03/2025
  atorvastatin calcium trihydrate	Tablet, film coated	86.751 mg	Anticipated	Available	Manufacturing	21/03/2025
  trimethoprim	Tablet, uncoated	300 mg	Anticipated	Available	Manufacturing	21/03/2025
  sodium nitroprusside	Injection, concentrated	50 mg	Anticipated	Available	Commercial Changes / Commercial viability	21/03/2025
  tamoxifen citrate	Tablet, uncoated	30.4 mg	Current	Limited Availability	Manufacturing	21/03/2025
  naproxen	Tablet, uncoated	250 mg	Anticipated	Available	Manufacturing	21/03/2025
  fluorouracil	Injection, solution	50 mg/mL	Resolved	Available	Manufacturing	21/03/2025
  dorzolamide hydrochloride	Eye Drops, solution	22.26 mg/mL	Resolved	Available	Manufacturing	21/03/2025
  dalteparin sodium	Injection, solution	18000 anti-Xa IU	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	21/03/2025
  dalteparin sodium	Injection, solution	15000 anti-Xa IU	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	21/03/2025
  dalteparin sodium	Injection, solution	12500 anti-Xa IU	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	21/03/2025
  temazepam	Tablet, uncoated	10 mg	Discontinued	Unavailable	Commercial Changes / Commercial viability	21/03/2025
  timolol maleate~dorzolamide hydrochloride	Eye Drops, solution	6.83 mg/mL~22.26 mg/mL	Resolved	Available	Manufacturing	21/03/2025
  minocycline hydrochloride dihydrate	Tablet, film coated	54 mg	Current	Limited Availability	Manufacturing	21/03/2025
  fentanyl citrate~ropivacaine hydrochloride	Injection, solution	3.14 microgram/mL~2 mg/mL	Discontinued	Unavailable	Commercial Changes / Commercial viability	21/03/2025
  prazosin hydrochloride	Tablet, uncoated	1.095 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	20/03/2025
  prazosin hydrochloride	Tablet, uncoated	2.19 mg	Anticipated	Available	Transport / Logistic issues / Storage capacity issues	20/03/2025
  fentanyl	Drug delivery system, transdermal	4.2 mg	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	20/03/2025
  fentanyl	Drug delivery system, transdermal	16.8 mg	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	20/03/2025
  olanzapine	Tablet, film coated	10 mg	Current	Limited Availability	Manufacturing	20/03/2025
  amisulpride	Tablet	100 mg	Resolved	Available	Manufacturing	20/03/2025
  losartan potassium	Tablet, film coated	50 mg	Current	Unavailable	Manufacturing	20/03/2025
  losartan potassium	Tablet, film coated	25 mg	Current	Unavailable	Manufacturing	20/03/2025
  pioglitazone hydrochloride	Tablet, uncoated	49.59 mg	Current	Limited Availability	Manufacturing	20/03/2025
  pioglitazone hydrochloride	Tablet, uncoated	33.06 mg	Current	Limited Availability	Manufacturing	20/03/2025
  pioglitazone hydrochloride	Tablet, uncoated	16.53 mg	Current	Limited Availability	Manufacturing	20/03/2025
  pramipexole dihydrochloride monohydrate	Tablet	.125 mg	Current	Unavailable	Manufacturing	20/03/2025
  sulfamethoxazole~trimethoprim	Tablet, uncoated	800 mg~160 mg	Current	Limited Availability	Manufacturing	20/03/2025
  salmeterol xinafoate~fluticasone propionate	Inhalation, powder for	72.5 microgram/actuation~100 microgram/actuation	Resolved	Available	Unexpected increase in consumer demand	20/03/2025
  capecitabine	Tablet, film coated	500 mg	Current	Limited Availability	Unexpected increase in consumer demand	20/03/2025
  drospirenone~ethinylestradiol	Tablet	3 mg~.03 mg	Discontinued	Unavailable	Commercial Changes / Commercial viability	20/03/2025
  ethinylestradiol~drospirenone	Tablet	.02 mg~3 mg	Discontinued	Unavailable	Commercial Changes / Commercial viability	20/03/2025
  flecainide acetate	Tablet, uncoated	100 mg	Current	Unavailable	Manufacturing	20/03/2025
  celecoxib	Capsule, hard	100 mg	Current	Unavailable	Manufacturing	20/03/2025
  acamprosate calcium	Tablet, enteric coated	333 mg	Current	Limited Availability	Unexpected increase in consumer demand	20/03/2025
  atorvastatin calcium trihydrate~ezetimibe	Tablet, film coated	82.725 mg~10 mg	Current	Unavailable	Manufacturing	20/03/2025
  atorvastatin calcium trihydrate~ezetimibe	Tablet, film coated	41.363 mg~10 mg	Current	Unavailable	Manufacturing	20/03/2025
  ezetimibe~atorvastatin calcium trihydrate	Tablet, film coated	10 mg~20.681 mg	Current	Unavailable	Manufacturing	20/03/2025
  doxepin hydrochloride	Capsule, hard	11.3 mg	Current	Limited Availability	Manufacturing	20/03/2025
  rivaroxaban	Tablet, film coated	10 mg	Current	Unavailable	Manufacturing	20/03/2025
  dosulepin (dothiepin) hydrochloride	Capsule, hard	25 mg	Anticipated	Available	Manufacturing	20/03/2025
  tamoxifen citrate	Tablet, uncoated	15.2 mg	Current	Unavailable	Manufacturing	20/03/2025
  iopromide	Injection, solution	498.72 mg/mL	Anticipated	Available	Manufacturing	20/03/2025
  citalopram hydrobromide	Tablet, film coated	49.96 mg	Current	Limited Availability	Manufacturing	20/03/2025
  risperidone	Tablet, film coated	.5 mg	Anticipated	Available	Manufacturing	19/03/2025
  clopidogrel hydrogen sulfate	Tablet, film coated	97.9 mg	Current	Limited Availability	Unexpected increase in consumer demand	19/03/2025
  fenofibrate	Tablet, film coated	145 mg	Current	Limited Availability	Manufacturing	19/03/2025
  cisplatin	Injection, concentrated	1 mg/mL	Resolved	Available	Unexpected increase in consumer demand	19/03/2025
  pegaspargase	Solution, powder for	750 U/mL	Anticipated	Available	Manufacturing	19/03/2025
  gemfibrozil	Tablet, film coated	600 mg	Current	Unavailable	Manufacturing	19/03/2025
  clonidine hydrochloride	Tablet, uncoated	150 microgram	Current	Unavailable	Transport / Logistic issues / Storage capacity issues	19/03/2025
  primidone	Tablet, uncoated	250 mg	Current	Limited Availability	Manufacturing	18/03/2025
  calcitonin salmon	Injection, solution	100 IU/mL	Current	Limited Availability	Commercial Changes / Commercial viability	18/03/2025
  duloxetine hydrochloride	Capsule, enteric	67.3 mg	Current	Limited Availability	Manufacturing	18/03/2025
  rosuvastatin calcium~ezetimibe	Tablet~Tablet, film coated	41.583 mg~10 mg	Current	Unavailable	Manufacturing	18/03/2025
  bimatoprost	Eye Drops	.3 mg/mL	Current	Unavailable	Manufacturing	18/03/2025
  mupirocin	Ointment	20 mg/g	Current	Limited Availability	Unexpected increase in consumer demand	18/03/2025
  flecainide acetate	Tablet	50 mg	Discontinued	Unavailable	Manufacturing	18/03/2025
  amlodipine besilate~olmesartan medoxomil~hydrochlorothiazide	Tablet, film coated	6.95 mg~40 mg~12.5 mg	Resolved	Available	Manufacturing	18/03/2025
  mycophenolate sodium	Tablet, enteric coated	384.7 mg	Resolved	Available	Manufacturing	18/03/2025
  Bevacizumab	Injection, concentrated	25 mg/mL	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	18/03/2025
  cisatracurium besilate	Injection, solution	2.68 mg/mL	Resolved	Available	Manufacturing	18/03/2025
  norethisterone~ethinylestradiol	Tablet, uncoated	500 microgram~36 microgram	Current	Limited Availability	Unexpected increase in consumer demand	18/03/2025
  famotidine	Tablet, film coated	40 mg	Resolved	Available	Manufacturing	18/03/2025
  donepezil hydrochloride	Tablet, film coated	5 mg	Resolved	Available	Transport / Logistic issues / Storage capacity issues	17/03/2025
  tacrolimus monohydrate	Capsule, hard	1.022 mg	Resolved	Available	Unexpected increase in consumer demand	17/03/2025
  olanzapine	Tablet, orally disintegrating	5 mg	Resolved	Available	Manufacturing	17/03/2025
  clonidine hydrochloride	Tablet, uncoated	100 microgram	Resolved	Available	Transport / Logistic issues / Storage capacity issues	17/03/2025
  trandolapril	Capsule, hard	4 mg	Current	Unavailable	Manufacturing	17/03/2025
  quetiapine fumarate	Tablet, modified release	57.565 mg	Anticipated	Available	Unexpected increase in consumer demand	17/03/2025
  midazolam	Injection, solution	15 mg	Current	Limited Availability	Manufacturing	17/03/2025
  carboplatin	Injection, solution	450 mg	Resolved	Available	Manufacturing	17/03/2025
  pramipexole dihydrochloride monohydrate	Tablet	.125 mg	Anticipated	Available	Unexpected increase in consumer demand	17/03/2025
  tacrolimus monohydrate	Capsule	.767 mg	Resolved	Available	Manufacturing	17/03/2025
  tobramycin	Injection, solution	40 mg/mL	Current	Unavailable	Unexpected increase in consumer demand	17/03/2025
  Influenza virus haemagglutinin	Injection, suspension	15 microgram	Discontinued	Unavailable	Commercial Changes / Commercial viability	17/03/2025
  clonidine hydrochloride	Tablet	100 microgram	Current	Limited Availability	Unexpected increase in consumer demand	17/03/2025
  clonidine hydrochloride	Tablet	100 microgram	Current	Unavailable	Manufacturing	17/03/2025
  hydrocortisone	Tablet, uncoated	20 mg	Current	Limited Availability	Manufacturing	17/03/2025
  hydrocortisone	Tablet, uncoated	20 mg	Current	Limited Availability	Manufacturing	17/03/2025
  permethrin	Cream	50 mg/g	Current	Limited Availability	Commercial Changes / Commercial viability	17/03/2025
  carbidopa monohydrate~levodopa	Tablet, uncoated	26.9 mg~100 mg	Resolved	Available	Manufacturing	17/03/2025
  cisatracurium besilate	Injection, solution	6.7 mg/mL	Resolved	Available	Manufacturing	17/03/2025
  cabergoline	Tablet, uncoated	2 mg	Resolved	Available	Manufacturing	17/03/2025
  ethinylestradiol~norethisterone	Tablet, uncoated	36 microgram~1 mg	Current	Limited Availability	Manufacturing	17/03/2025

• 2025.03.17
  TGAオーストラリア供給不足情報（2025年3月10日～3月16日）

  Active ingredients	Dosage form	Quantity of active ingredients	Shortage status	Availability	Reason	Last updated
  clonidine hydrochloride	Tablet, uncoated	100 microgram	Resolved	Available	Transport / Logistic issues / Storage capacity issues	17/03/2025
  clonidine hydrochloride	Tablet	100 microgram	Current	Limited Availability	Unexpected increase in consumer demand	17/03/2025
  clonidine hydrochloride	Tablet	100 microgram	Current	Unavailable	Manufacturing	17/03/2025
  carbidopa monohydrate~levodopa	Tablet, uncoated	26.9 mg~100 mg	Resolved	Available	Manufacturing	17/03/2025
  cabergoline	Tablet, uncoated	2 mg	Resolved	Available	Manufacturing	17/03/2025
  zolpidem tartrate	Tablet, film coated	10 mg	Current	Unavailable	Manufacturing	14/03/2025
  fluticasone furoate	Spray, suspension	27.5 microgram	Resolved	Available	Unexpected increase in consumer demand	14/03/2025
  fluconazole	Injection, solution	2 mg/mL	Discontinued	Reduction in supply until supply is exhausted	Manufacturing	14/03/2025
  fluconazole	Injection, solution	2 mg/mL	Discontinued	Reduction in supply until supply is exhausted	Manufacturing	14/03/2025
  calcitonin salmon	Injection, solution	100 IU/mL	Current	Limited Availability	Commercial Changes / Commercial viability	14/03/2025
  furosemide	Injection, solution	20 mg	Anticipated	Available	Manufacturing	14/03/2025
  clopidogrel hydrogen sulfate	Tablet, film coated	97.875 mg	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	14/03/2025
  mycophenolate mofetil	Capsule	250 mg	Resolved	Available	Unexpected increase in consumer demand	14/03/2025
  pramipexole dihydrochloride monohydrate	Tablet	.125 mg	Current	Unavailable	Manufacturing	14/03/2025
  galantamine hydrobromide	Capsule, modified release	30.756 mg	Current	Unavailable	Manufacturing	14/03/2025
  ezetimibe	Tablet, uncoated	10 mg	Current	Limited Availability	Unexpected increase in consumer demand	14/03/2025
  ezetimibe	Tablet, uncoated	10 mg	Current	Unavailable	Manufacturing	14/03/2025
  tadalafil	Tablet, film coated	10 mg	Resolved	Available	Manufacturing	14/03/2025
  ivabradine hydrochloride	Tablet, film coated	8.085 mg	Anticipated	Available	Manufacturing	14/03/2025
  acamprosate calcium	Tablet, enteric coated	333 mg	Current	Limited Availability	Manufacturing	14/03/2025
  spironolactone	Tablet, uncoated	25 mg	Current	Unavailable	Manufacturing	14/03/2025
  daptomycin	Injection, powder for	500 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	14/03/2025
  daptomycin	Inhalation, powder for	350 mg	Current	Limited Availability	Manufacturing	14/03/2025
  naproxen	Tablet	500 mg	Current	Unavailable	Manufacturing	14/03/2025
  metformin hydrochloride	Tablet, film coated	850 mg	Resolved	Available	Manufacturing	14/03/2025
  bicisate dihydrochloride	Injection, powder for	.9 mg	Anticipated	Available	Manufacturing	14/03/2025
  estradiol~dydrogesterone	Tablet, film coated	2 mg~10 mg	Current	Unavailable	Manufacturing	14/03/2025
  clopidogrel hydrogen sulfate	Tablet, film coated	97.875 mg	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	14/03/2025
  methylphenidate hydrochloride	Capsule, modified release	40 mg	Anticipated	Available	Manufacturing	14/03/2025
  alprostadil	Injection, powder for	20 microgram/mL	Anticipated	Available	Unexpected increase in consumer demand	14/03/2025
  gabapentin	Capsule, hard	300 mg	Current	Limited Availability	Manufacturing	13/03/2025
  flecainide acetate	Injection, solution	10 mg/mL	Current	Unavailable	Manufacturing	13/03/2025
  zolpidem tartrate	Tablet, film coated	10 mg	Current	Limited Availability	Manufacturing	13/03/2025
  dexamethasone~gramicidin~framycetin sulfate	Ear Drops	.5 mg/mL~.05 mg/mL~5 mg/mL	Current	Limited Availability	Manufacturing	13/03/2025
  fentanyl	Drug delivery system, transdermal	8.4 mg	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	13/03/2025
  fentanyl	Drug delivery system, transdermal	16.8 mg	Current	Unavailable	Manufacturing	13/03/2025
  hydroxocobalamin chloride	Injection, solution	1 mg/mL	Anticipated	Available	Manufacturing	13/03/2025
  glycopyrronium bromide	Injection, solution	.2 mg/mL	Resolved	Available	Manufacturing	13/03/2025
  donepezil hydrochloride	Tablet, film coated	10 mg	Current	Limited Availability	Manufacturing	13/03/2025
  clopidogrel hydrogen sulfate	Tablet, film coated	97.9 mg	Current	Limited Availability	Unexpected increase in consumer demand	13/03/2025
  Belimumab	Injection, powder for	120 mg	Anticipated	Available	Manufacturing	13/03/2025
  pramipexole dihydrochloride monohydrate	Tablet	.125 mg	Current	Unavailable	Manufacturing	13/03/2025
  clopidogrel hydrogen sulfate	Tablet, film coated	97.875 mg	Current	Unavailable	Unexpected increase in consumer demand	13/03/2025
  praziquantel	Tablet, film coated	600 mg	Discontinued	Reduction in supply until supply is exhausted	Manufacturing	13/03/2025
  chloramphenicol	Eye Drops	5 mg/mL	Resolved	Available	Manufacturing	13/03/2025
  trandolapril	Capsule, hard	2 mg	Current	Unavailable	Manufacturing	13/03/2025
  risperidone	Tablet, film coated	1 mg	Current	Unavailable	Unexpected increase in consumer demand	13/03/2025
  quetiapine fumarate	Tablet, film coated	28.784 mg	Current	Unavailable	Unexpected increase in consumer demand	13/03/2025
  levothyroxine sodium	Tablet	200 microgram	Resolved	Available	Manufacturing	13/03/2025
  salmeterol xinafoate~fluticasone propionate	Inhalation, powder for	72.5 microgram/actuation~100 microgram/actuation	Current	Limited Availability	Unexpected increase in consumer demand	13/03/2025
  escitalopram oxalate	Tablet, film coated	25.548 mg	Current	Limited Availability	Manufacturing	13/03/2025
  tobramycin	Injection, solution	40 mg/mL	Current	Unavailable	Unexpected increase in consumer demand	13/03/2025
  bimatoprost	Eye Drops	.3 mg/mL	Current	Limited Availability	Manufacturing	13/03/2025
  betahistine dihydrochloride	Tablet	16 mg	Current	Unavailable	Manufacturing	13/03/2025
  anastrozole	Tablet, film coated	1 mg	Current	Unavailable	Manufacturing	13/03/2025
  bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrate	Injection, solution	2.64 mg/mL~4.5 microgram/mL	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	13/03/2025
  nebivolol hydrochloride	Tablet	10.9 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	13/03/2025
  rivaroxaban	Tablet, film coated	20 mg	Current	Unavailable	Manufacturing	13/03/2025
  sitagliptin fumarate	Tablet, film coated	32.124 mg	Resolved	Available	Manufacturing	13/03/2025
  rivaroxaban	Tablet, film coated	2.5 mg	Current	Unavailable	Unexpected increase in consumer demand	13/03/2025
  rivaroxaban	Tablet, film coated	10 mg	Current	Unavailable	Unexpected increase in consumer demand	13/03/2025
  framycetin sulfate~dexamethasone~gramicidin	Ear Drops	5 mg/mL~.5 mg/mL~.05 mg/mL	Current	Limited Availability	Manufacturing	13/03/2025
  citalopram hydrobromide	Tablet, film coated	24.98 mg	Resolved	Available	Manufacturing	13/03/2025
  primidone	Tablet, uncoated	250 mg	Anticipated	Available	Manufacturing	12/03/2025
  heparin sodium	Injection, solution	5000 IU/mL	Current	Limited Availability	Unexpected increase in consumer demand	12/03/2025
  venlafaxine hydrochloride	Capsule, modified release	169.71 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	12/03/2025
  hydrochlorothiazide~amlodipine besilate~olmesartan medoxomil	Tablet	12.5 mg~6.944 mg~20 mg	Current	Unavailable	Manufacturing	12/03/2025
  amlodipine besilate~hydrochlorothiazide~olmesartan medoxomil	Tablet	6.944 mg~12.5 mg~40 mg	Current	Limited Availability	Manufacturing	12/03/2025
  rosuvastatin calcium~ezetimibe	Tablet~Tablet, film coated	20.791 mg~10 mg	Current	Unavailable	Manufacturing	12/03/2025
  rizatriptan benzoate	Wafer	14.53 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	12/03/2025
  metformin hydrochloride	Tablet, film coated	1000 mg	Current	Unavailable	Manufacturing	12/03/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Unavailable	Manufacturing	12/03/2025
  cisplatin	Injection, concentrated	1 mg/mL	Current	Limited Availability	Unexpected increase in consumer demand	12/03/2025
  benzathine benzylpenicillin tetrahydrate	Injection, suspension	600000 USP Unit	Current	Unavailable	Manufacturing	12/03/2025
  solifenacin succinate	Tablet, film coated	5 mg	Current	Unavailable	Manufacturing	12/03/2025
  solifenacin succinate	Tablet, film coated	10 mg	Current	Unavailable	Manufacturing	12/03/2025
  aciclovir	Injection, solution	25 mg/mL	Resolved	Available	Manufacturing	12/03/2025
  dasatinib propylene glycol	Tablet, film coated	58 mg	Current	Unavailable	Manufacturing	12/03/2025
  dasatinib propylene glycol	Tablet, film coated	81.2 mg	Current	Unavailable	Manufacturing	12/03/2025
  dasatinib propylene glycol	Tablet, film coated	116 mg	Current	Unavailable	Manufacturing	12/03/2025
  mycophenolate sodium	Tablet, enteric coated	384.7 mg	Anticipated	Available	Manufacturing	12/03/2025
  mupirocin calcium	Cream	21.5 mg/g	Resolved	Available	Manufacturing	12/03/2025
  melatonin	Capsule, hard	3 mg	Current	Limited Availability	Unexpected increase in consumer demand	12/03/2025
  balsalazide sodium	Capsule	750 mg	Current	Limited Availability	Manufacturing	12/03/2025
  alendronate sodium trihydrate	Tablet, uncoated	91.35 mg	Anticipated	Available	Manufacturing	11/03/2025
  oxytocin	Injection, solution	10 IU/mL	Current	Unavailable	Unexpected increase in consumer demand	11/03/2025
  aripiprazole	Tablet, uncoated	10 mg	Resolved	Available	Manufacturing	11/03/2025
  azithromycin dihydrate	Tablet, film coated	524.1 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	11/03/2025
  risperidone	Tablet, film coated	4 mg	Current	Unavailable	Manufacturing	11/03/2025
  montelukast sodium	Tablet, film coated	10.4 mg	Anticipated	Available	Manufacturing	11/03/2025
  montelukast sodium	Tablet, chewable	4.16 mg	Anticipated	Available	Manufacturing	11/03/2025
  isotretinoin	Capsule, soft	10 mg	Anticipated	Available	Manufacturing	11/03/2025
  candesartan cilexetil	Tablet, uncoated	4 mg	Resolved	Available	Manufacturing	11/03/2025
  azithromycin dihydrate	Tablet, film coated	524.05 mg	Current	Unavailable	Manufacturing	11/03/2025
  quetiapine fumarate	Tablet, modified release	460.52 mg	Anticipated	Available	Manufacturing	11/03/2025
  azithromycin dihydrate	Tablet, film coated	524 mg	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	11/03/2025
  anastrozole	Tablet, film coated	1 mg	Current	Limited Availability	Manufacturing	11/03/2025
  hydrochlorothiazide~irbesartan	Tablet, film coated	12.5 mg~300 mg	Current	Unavailable	Manufacturing	11/03/2025
  hydrochlorothiazide~irbesartan	Tablet, film coated	25 mg~300 mg	Current	Unavailable	Manufacturing	11/03/2025
  atomoxetine hydrochloride	Capsule, hard	114 mg	Resolved	Available	Manufacturing	11/03/2025
  fluconazole	Capsule, hard	200 mg	Anticipated	Available	Manufacturing	11/03/2025
  olanzapine	Tablet, uncoated	5 mg	Current	Unavailable	Manufacturing	11/03/2025
  azithromycin dihydrate	Tablet, film coated	524 mg	Current	Unavailable	Unexpected increase in consumer demand	11/03/2025
  melatonin	Oral Liquid, solution	1 mg/mL	Current	Limited Availability	Unexpected increase in consumer demand	11/03/2025
  heparin sodium	Injection, solution	1000 IU/mL	Current	Limited Availability	Manufacturing	11/03/2025
  pioglitazone hydrochloride	Tablet, uncoated	49.59 mg	Current	Limited Availability	Manufacturing	10/03/2025
  pioglitazone hydrochloride	Tablet, uncoated	33.06 mg	Current	Limited Availability	Manufacturing	10/03/2025
  pioglitazone hydrochloride	Tablet, uncoated	16.53 mg	Current	Limited Availability	Manufacturing	10/03/2025
  donepezil hydrochloride	Tablet, film coated	5 mg	Current	Unavailable	Transport / Logistic issues / Storage capacity issues	10/03/2025
  irinotecan hydrochloride trihydrate	Injection, concentrated	500 mg	Current	Limited Availability	Manufacturing	10/03/2025
  carboplatin	Injection, solution	10 mg/mL	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	10/03/2025

• 2025.03.09
  TGAオーストラリア供給不足情報（2025年3月3日～3月9日）

  Active ingredients	Dosage form	Quantity of active ingredients	Shortage status	Availability	Reason	Last updated
  fenofibrate	Tablet, film coated	145 mg	Anticipated	Available	Manufacturing	7/03/2025
  zolpidem tartrate	Tablet, film coated	10 mg	Anticipated	Available	Manufacturing	7/03/2025
  olanzapine pamoate monohydrate	Injection, powder for	931 mg	Anticipated	Available	Transport / Logistic issues / Storage capacity issues	7/03/2025
  olanzapine pamoate monohydrate	Injection, powder for	690 mg	Anticipated	Available	Transport / Logistic issues / Storage capacity issues	7/03/2025
  olanzapine pamoate monohydrate	Injection, powder for	483 mg	Anticipated	Available	Transport / Logistic issues / Storage capacity issues	7/03/2025
  hydroxocobalamin chloride	Injection, solution	1 mg/mL	Anticipated	Available	Commercial Changes / Commercial viability	7/03/2025
  donepezil hydrochloride	Tablet, film coated	10 mg	Current	Limited Availability	Manufacturing	7/03/2025
  clopidogrel hydrogen sulfate	Tablet, film coated	97.9 mg	Current	Limited Availability	Unexpected increase in consumer demand	7/03/2025
  olanzapine	Tablet, orally disintegrating	5 mg	Current	Limited Availability	Manufacturing	7/03/2025
  sulfamethoxazole~trimethoprim	Tablet, uncoated	800 mg~160 mg	Current	Limited Availability	Manufacturing	7/03/2025
  clonidine hydrochloride	Tablet, uncoated	100 microgram	Current	Unavailable	Transport / Logistic issues / Storage capacity issues	7/03/2025
  ezetimibe~atorvastatin calcium trihydrate	Tablet, multilayer	10 mg~86.8 mg	Current	Limited Availability	Manufacturing	7/03/2025
  amiodarone hydrochloride	Injection, solution	150 mg	Current	Limited Availability	Manufacturing	7/03/2025
  atomoxetine hydrochloride	Capsule, hard	45.72 mg	Current	Unavailable	Manufacturing	7/03/2025
  atomoxetine hydrochloride	Capsule, hard	91.44 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	7/03/2025
  clonidine hydrochloride	Tablet	100 microgram	Current	Limited Availability	Unexpected increase in consumer demand	7/03/2025
  dexmedetomidine hydrochloride	Injection, concentrated	118 microgram/mL	Current	Unavailable	Manufacturing	7/03/2025
  adenosine	Solution	30 mg	Resolved	Available	Manufacturing	7/03/2025
  escitalopram oxalate	Tablet, film coated	25.47 mg	Resolved	Available	Manufacturing	7/03/2025
  ezetimibe~atorvastatin calcium trihydrate	Tablet, film coated	10 mg~82.725 mg	Current	Unavailable	Manufacturing	7/03/2025
  atorvastatin calcium trihydrate~ezetimibe	Tablet, film coated	82.725 mg~10 mg	Current	Unavailable	Manufacturing	7/03/2025
  lorazepam	Tablet	2.5 mg	Current	Unavailable	Manufacturing	7/03/2025
  cabergoline	Tablet, uncoated	2 mg	Current	Unavailable	Manufacturing	7/03/2025
  clonidine hydrochloride	Tablet, uncoated	150 microgram	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	7/03/2025
  norethisterone	Tablet, uncoated	350 microgram	Resolved	Available	Manufacturing	6/03/2025
  adrenaline (epinephrine) acid tartrate	Injection, solution	1.82 mg/mL	Current	Unavailable	Manufacturing	6/03/2025
  olanzapine	Tablet, film coated	10 mg	Current	Limited Availability	Manufacturing	6/03/2025
  mycophenolate mofetil	Tablet, film coated	500 mg	Current	Unavailable	Manufacturing	6/03/2025
  tacrolimus monohydrate	Capsule, hard	1.022 mg	Anticipated	Available	Unexpected increase in consumer demand	6/03/2025
  levetiracetam	Tablet, film coated	1000 mg	Current	Unavailable	Manufacturing	6/03/2025
  trandolapril	Capsule, hard	1 mg	Current	Unavailable	Manufacturing	6/03/2025
  trandolapril	Capsule, hard	2 mg	Current	Unavailable	Manufacturing	6/03/2025
  olmesartan medoxomil~amlodipine besilate~hydrochlorothiazide	Tablet	20 mg~6.944 mg~12.5 mg	Current	Unavailable	Manufacturing	6/03/2025
  hydrochlorothiazide~olmesartan medoxomil~amlodipine besilate	Tablet	12.5 mg~40 mg~6.944 mg	Current	Limited Availability	Manufacturing	6/03/2025
  duloxetine hydrochloride	Capsule, enteric	33.65 mg	Resolved	Available	Manufacturing	6/03/2025
  tobramycin	Injection, solution	40 mg/mL	Current	Unavailable	Unexpected increase in consumer demand	6/03/2025
  mesalazine	Tablet, enteric coated	800 mg	Resolved	Available	Manufacturing	6/03/2025
  hydrocortisone	Tablet, uncoated	20 mg	Current	Limited Availability	Manufacturing	6/03/2025
  pregabalin	Capsule, hard	25 mg	Current	Limited Availability	Manufacturing	6/03/2025
  doxepin hydrochloride	Capsule, hard	11.3 mg	Current	Limited Availability	Manufacturing	6/03/2025
  mesalazine	Tablet, enteric coated	1.6 g	Resolved	Available	Manufacturing	6/03/2025
  adrenaline (epinephrine)	Injection, solution	500 microgram	Anticipated	Available	Manufacturing	6/03/2025
  spironolactone	Tablet, uncoated	25 mg	Current	Limited Availability	Manufacturing	6/03/2025
  dosulepin (dothiepin) hydrochloride	Capsule, hard	25 mg	Anticipated	Available	Manufacturing	6/03/2025
  levothyroxine sodium	Tablet, uncoated	50 microgram	Current	Unavailable	Manufacturing	6/03/2025
  levothyroxine sodium	Tablet, uncoated	.05 mg	Resolved	Available	Unexpected increase in consumer demand	6/03/2025
  naproxen	Tablet	500 mg	Current	Limited Availability	Manufacturing	6/03/2025
  ethinylestradiol~norethisterone	Tablet, uncoated	36 microgram~1 mg	Current	Limited Availability	Manufacturing	6/03/2025
  metformin hydrochloride	Tablet, film coated	850 mg	Current	Unavailable	Manufacturing	6/03/2025
  pioglitazone hydrochloride	Tablet, uncoated	33.06 mg	Current	Unavailable	Commercial Changes / Commercial viability	6/03/2025
  reboxetine mesilate	Tablet, uncoated	5.224 mg	Resolved	Available	Manufacturing	6/03/2025
  midazolam	Injection, solution	5 mg/mL	Current	Limited Availability	Manufacturing	5/03/2025
  acetazolamide sodium	Injection, powder for	549.5 mg	Current	Unavailable	Manufacturing	5/03/2025
  aripiprazole	Tablet, uncoated	10 mg	Anticipated	Available	Manufacturing	5/03/2025
  montelukast sodium	Tablet, film coated	10.4 mg	Anticipated	Available	Manufacturing	5/03/2025
  carboplatin	Injection, solution	450 mg	Current	Unavailable	Manufacturing	5/03/2025
  ivermectin	Cream	10 mg/g	Anticipated	Available	Manufacturing	5/03/2025
  tacrolimus monohydrate	Capsule	.767 mg	Current	Unavailable	Manufacturing	5/03/2025
  Follitropin alfa	Injection, solution	150 IU	Anticipated	Available	Manufacturing	5/03/2025
  citalopram hydrobromide	Tablet, film coated	49.98 mg	Resolved	Available	Manufacturing	5/03/2025
  ezetimibe	Tablet, uncoated	10 mg	Current	Limited Availability	Unexpected increase in consumer demand	5/03/2025
  ezetimibe	Tablet, uncoated	10 mg	Current	Unavailable	Unexpected increase in consumer demand	5/03/2025
  nebivolol hydrochloride	Tablet	5.45 mg	Resolved	Available	Manufacturing	5/03/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Limited Availability	Manufacturing	5/03/2025
  atorvastatin calcium trihydrate	Tablet, film coated	86.76 mg	Resolved	Available	Manufacturing	5/03/2025
  montelukast sodium	Tablet, chewable	5.2 mg	Current	Unavailable	Manufacturing	5/03/2025
  lamotrigine	Tablet, chewable	100 mg	Resolved	Available	Unexpected increase in consumer demand	5/03/2025
  sitagliptin hydrochloride monohydrate~metformin hydrochloride	Tablet, modified release	56.685 mg~1000 mg	Current	Unavailable	Manufacturing	5/03/2025
  fluorouracil	Cream	50 mg/g	Current	Unavailable	Manufacturing	5/03/2025
  dexamethasone~gramicidin~framycetin sulfate	Ear Drops	.5 mg/mL~.05 mg/mL~5 mg/mL	Current	Limited Availability	Manufacturing	5/03/2025
  losartan potassium	Tablet, film coated	50 mg	Current	Unavailable	Unexpected increase in consumer demand	5/03/2025
  cisatracurium besilate	Injection, solution	6.7 mg/mL	Current	Unavailable	Manufacturing	5/03/2025
  fentanyl	Drug delivery system, transdermal	8.4 mg	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	4/03/2025
  anastrozole	Tablet, film coated	1 mg	Current	Limited Availability	Manufacturing	4/03/2025
  letrozole	Tablet, film coated	2.5 mg	Current	Unavailable	Manufacturing	4/03/2025
  rocuronium bromide	Injection, solution	50 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	4/03/2025
  pramipexole dihydrochloride monohydrate	Tablet	1 mg	Resolved	Available	Manufacturing	4/03/2025
  galantamine hydrobromide	Capsule, modified release	10.252 mg	Anticipated	Available	Manufacturing	4/03/2025
  azithromycin dihydrate	Tablet, film coated	524.05 mg	Current	Unavailable	Manufacturing	4/03/2025
  phenoxymethylpenicillin potassium	Tablet, film coated	280 mg	Resolved	Available	Manufacturing	4/03/2025
  phenoxymethylpenicillin potassium	Tablet, film coated	560 mg	Resolved	Available	Manufacturing	4/03/2025
  gabapentin	Capsule, hard	100 mg	Current	Unavailable	Manufacturing	4/03/2025
  adrenaline (epinephrine) acid tartrate	Injection, solution	182 microgram/mL	Current	Unavailable	Manufacturing	4/03/2025
  noradrenaline (norepinephrine) acid tartrate monohydrate	Injection, concentrated	4 mg	Current	Limited Availability	Manufacturing	4/03/2025
  citalopram hydrobromide	Tablet, film coated	12.495 mg	Resolved	Available	Manufacturing	4/03/2025
  imatinib mesilate	Tablet, film coated	119.5 mg	Current	Unavailable	Unexpected increase in consumer demand	4/03/2025
  ivabradine hydrochloride	Tablet, film coated	8.085 mg	Anticipated	Available	Manufacturing	4/03/2025
  ivabradine hydrochloride	Tablet, film coated	5.39 mg	Anticipated	Available	Manufacturing	4/03/2025
  hydrochlorothiazide~olmesartan medoxomil	Tablet	25 mg~40 mg	Current	Unavailable	Manufacturing	4/03/2025
  fenofibrate	Tablet	145 mg	Current	Limited Availability	Manufacturing	4/03/2025
  Influenza virus haemagglutinin	Injection, suspension	15 microgram	Resolved	Available	Seasonal depletion of stock	4/03/2025
  dimethyl fumarate	Capsule, enteric	120 mg	Current	Unavailable	Manufacturing	4/03/2025
  Influenza virus haemagglutinin	Injection, suspension	15 microgram	Resolved	Available	Seasonal depletion of stock	4/03/2025
  montelukast sodium	Tablet, film coated	10.4 mg	Current	Limited Availability	Manufacturing	4/03/2025
  phenoxymethylpenicillin potassium	Capsule, hard	554.37 mg	Resolved	Available	Manufacturing	4/03/2025
  phenoxymethylpenicillin potassium	Capsule, hard	277.18 mg	Resolved	Available	Manufacturing	4/03/2025
  lamotrigine	Tablet, chewable	200 mg	Resolved	Available	Unexpected increase in consumer demand	4/03/2025
  lacosamide	Tablet, film coated	150 mg	Current	Unavailable	Manufacturing	4/03/2025
  melatonin	Capsule, hard	3 mg	Current	Limited Availability	Unexpected increase in consumer demand	4/03/2025
  methylphenidate hydrochloride	Tablet, uncoated	10 mg	Resolved	Available	Manufacturing	3/03/2025
  gabapentin	Tablet, film coated	800 mg	Current	Unavailable	Manufacturing	3/03/2025
  silver sulfadiazine	Cream	10 mg/g	Resolved	Available	Manufacturing	3/03/2025
  silver sulfadiazine	Cream	10 mg/g	Resolved	Available	Manufacturing	3/03/2025
  human menopausal gonadotrophin	Injection, powder for	600 IU	Current	Limited Availability	Manufacturing	3/03/2025
  human menopausal gonadotrophin	Injection, powder for	1200 IU	Current	Limited Availability	Manufacturing	3/03/2025
  progesterone	Pessary, compressed	100 mg	Resolved	Available	Manufacturing	3/03/2025
  midazolam	Injection, solution	5 mg	Resolved	Available	Manufacturing	3/03/2025
  methotrexate	Injection, solution	100 mg/mL	Current	Unavailable	Manufacturing	3/03/2025
  fenofibrate	Tablet	48 mg	Current	Limited Availability	Manufacturing	3/03/2025
  olmesartan medoxomil~hydrochlorothiazide	Tablet	20 mg~12.5 mg	Current	Unavailable	Manufacturing	3/03/2025
  acamprosate calcium	Tablet, enteric coated	333 mg	Current	Limited Availability	Unexpected increase in consumer demand	3/03/2025
  mefenamic acid	Capsule, hard	250 mg	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	3/03/2025
  lurasidone hydrochloride	Tablet, film coated	80 mg	Current	Unavailable	Manufacturing	3/03/2025
  carmustine~ethanol absolute	Diluent, not applicable~Injection, powder for	100 mg~3 mL	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	3/03/2025
  sitagliptin hydrochloride monohydrate~metformin hydrochloride	Tablet, film coated	56.69 mg~1000 mg	Current	Unavailable	Manufacturing	3/03/2025
  carboplatin	Injection, solution	10 mg/mL	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	3/03/2025
  timolol maleate~dorzolamide hydrochloride	Eye Drops, solution	6.83 mg/mL~22.26 mg/mL	Current	Unavailable	Manufacturing	3/03/2025
  tobramycin	Injection, solution	40 mg/mL	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	3/03/2025
  estradiol hemihydrate	Drug delivery system, transdermal	2.32 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	3/03/2025
  nizatidine	Capsule	150 mg	Current	Limited Availability	Manufacturing	3/03/2025

• 2025.03.03
  TGAオーストラリア供給不足情報（2025年2月24日～3月2日）

  Active ingredients	Dosage form	Quantity of active ingredients	Shortage status	Availability	Reason	Last updated
  gabapentin	Capsule, hard	300 mg	Anticipated	Available	Manufacturing	28/02/2025
  chlorhexidine gluconate	Solution, irrigation	30 mg	Current	Limited Availability	Manufacturing	28/02/2025
  risedronate sodium	Tablet, film coated	35 mg	Current	Limited Availability	Manufacturing	28/02/2025
  midazolam	Injection, solution	5 mg	Resolved	Available	Manufacturing	28/02/2025
  midazolam	Injection, solution	5 mg	Current	Limited Availability	Manufacturing	28/02/2025
  naproxen	Oral Liquid, suspension	25 mg/mL	Anticipated	Available	Manufacturing	28/02/2025
  trandolapril	Capsule, hard	1 mg	Current	Unavailable	Manufacturing	28/02/2025
  trandolapril	Capsule, hard	2 mg	Current	Unavailable	Manufacturing	28/02/2025
  trandolapril	Capsule, hard	4 mg	Current	Unavailable	Manufacturing	28/02/2025
  duloxetine hydrochloride	Capsule, enteric	33.66 mg	Current	Unavailable	Unexpected increase in consumer demand	28/02/2025
  capecitabine	Tablet, film coated	500 mg	Current	Limited Availability	Unexpected increase in consumer demand	28/02/2025
  bortezomib	Injection, powder for	3.5 mg	Resolved	Available	Manufacturing	28/02/2025
  pemetrexed disodium	Injection, powder for	1102.9 mg	Anticipated	Available	Manufacturing	28/02/2025
  clonidine hydrochloride	Tablet	100 microgram	Current	Limited Availability	Unexpected increase in consumer demand	28/02/2025
  hydrocortisone	Tablet, uncoated	20 mg	Current	Limited Availability	Manufacturing	28/02/2025
  Pegfilgrastim	Injection, solution	6 mg	Anticipated	Available	Manufacturing	28/02/2025
  clobazam	Tablet, uncoated	10 mg	Resolved	Available	Manufacturing	28/02/2025
  chloramphenicol	Eye Drops, solution	5 mg/mL	Current	Unavailable	Manufacturing	28/02/2025
  sitagliptin hydrochloride monohydrate	Tablet, film coated	109 mg	Current	Unavailable	Manufacturing	28/02/2025
  sitagliptin hydrochloride monohydrate	Tablet, film coated	54.5 mg	Current	Unavailable	Manufacturing	28/02/2025
  sitagliptin hydrochloride monohydrate	Tablet, film coated	27.25 mg	Current	Unavailable	Manufacturing	28/02/2025
  alprazolam	Tablet, uncoated	2 mg	Anticipated	Available	Manufacturing	28/02/2025
  metformin hydrochloride~sitagliptin hydrochloride monohydrate	Tablet, film coated	500 mg~56.69 mg	Current	Unavailable	Manufacturing	28/02/2025
  metformin hydrochloride~sitagliptin hydrochloride monohydrate	Tablet, film coated	850 mg~56.69 mg	Current	Unavailable	Manufacturing	28/02/2025
  nizatidine	Capsule	150 mg	Anticipated	Available	Manufacturing	28/02/2025
  ramipril	Capsule, hard	1.25 mg	Resolved	Available	Manufacturing	27/02/2025
  fentanyl	Drug delivery system, transdermal	16.8 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	27/02/2025
  mycophenolate mofetil	Tablet, film coated	500 mg	Current	Unavailable	Manufacturing	27/02/2025
  acetylcysteine	Injection, concentrated	2 g	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	27/02/2025
  ropivacaine hydrochloride	Injection, solution	2 mg/mL	Current	Unavailable	Commercial Changes / Commercial viability	27/02/2025
  risperidone	Tablet, film coated	1 mg	Current	Unavailable	Unexpected increase in consumer demand	27/02/2025
  risperidone	Tablet, film coated	2 mg	Resolved	Available	Unexpected increase in consumer demand	27/02/2025
  phenoxymethylpenicillin potassium	Tablet, film coated	280 mg	Anticipated	Available	Manufacturing	27/02/2025
  paroxetine hydrochloride	Tablet, film coated	22.21 mg	Resolved	Available	Manufacturing	27/02/2025
  atomoxetine hydrochloride	Capsule, hard	45.72 mg	Current	Unavailable	Manufacturing	27/02/2025
  atomoxetine hydrochloride	Capsule, hard	91.44 mg	Current	Unavailable	Manufacturing	27/02/2025
  isotretinoin	Capsule, soft	10 mg	Resolved	Available	Manufacturing	27/02/2025
  esomeprazole	Capsule, enteric	40 mg	Resolved	Available	Manufacturing	27/02/2025
  anastrozole	Tablet, film coated	1 mg	Current	Unavailable	Manufacturing	27/02/2025
  celecoxib	Capsule, hard	100 mg	Current	Unavailable	Manufacturing	27/02/2025
  irinotecan hydrochloride trihydrate	Injection, concentrated	500 mg	Anticipated	Available	Manufacturing	27/02/2025
  azithromycin dihydrate	Tablet, film coated	524 mg	Current	Unavailable	Unexpected increase in consumer demand	27/02/2025
  ropivacaine hydrochloride	Injection, solution	2 mg/mL	Discontinued	Unavailable	Commercial Changes / Commercial viability	27/02/2025
  midazolam	Injection, solution	5 mg/mL	Current	Limited Availability	Unexpected increase in consumer demand	27/02/2025
  metformin hydrochloride	Tablet, film coated	1000 mg	Current	Unavailable	Manufacturing	27/02/2025
  citalopram hydrobromide	Tablet, film coated	49.96 mg	Current	Limited Availability	Manufacturing	27/02/2025
  lincomycin hydrochloride monohydrate	Injection, solution	340.26 mg/mL	Current	Unavailable	Manufacturing	26/02/2025
  glycopyrronium bromide	Injection, solution	.2 mg/mL	Current	Limited Availability	Manufacturing	26/02/2025
  chloramphenicol	Eye Drops	5 mg/mL	Current	Unavailable	Manufacturing	26/02/2025
  levothyroxine sodium	Tablet	200 microgram	Current	Unavailable	Manufacturing	26/02/2025
  midazolam	Injection, solution	15 mg	Anticipated	Available	Manufacturing	26/02/2025
  fluticasone propionate~salmeterol xinafoate	Inhalation, powder for	100 microgram/actuation~72.5 microgram/actuation	Anticipated	Available	Unexpected increase in consumer demand	26/02/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Unavailable	Manufacturing	26/02/2025
  dosulepin (dothiepin) hydrochloride	Tablet, film coated	75 mg	Current	Limited Availability	Manufacturing	26/02/2025
  daptomycin	Injection, powder for	350 mg	Discontinued	Unavailable	Commercial Changes / Commercial viability	26/02/2025
  buprenorphine	Patch, dermal	30 mg	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	26/02/2025
  methotrexate	Tablet	10 mg	Current	Limited Availability	Manufacturing	26/02/2025
  metformin hydrochloride~sitagliptin hydrochloride monohydrate	Tablet, modified release	1000 mg~113.37 mg	Current	Unavailable	Manufacturing	26/02/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Unavailable	Manufacturing	26/02/2025
  lidocaine hydrochloride	Injection, solution	10 mg/mL	Current	Unavailable	Manufacturing	26/02/2025
  lidocaine hydrochloride	Injection, solution	10 mg/mL	Current	Unavailable	Manufacturing	25/02/2025
  adrenaline (epinephrine) acid tartrate~lidocaine hydrochloride	Injection, solution	9.1 microgram/mL~10 mg/mL	Current	Unavailable	Commercial Changes / Commercial viability	25/02/2025
  pentetic acid	Injection, powder for	5 mg	Current	Unavailable	Manufacturing	25/02/2025
  medronic acid	Injection, powder for	10 mg	Current	Unavailable	Manufacturing	25/02/2025
  sodium fluoride	Injection, concentrated	1 mg/mL	Current	Unavailable	Manufacturing	25/02/2025
  atropine sulfate monohydrate	Eye Drops, solution	9.9737 mg/mL	Current	Unavailable	Manufacturing	25/02/2025
  rosuvastatin calcium~ezetimibe	Tablet~Tablet, film coated	10.396 mg~10 mg	Current	Unavailable	Manufacturing	25/02/2025
  ezetimibe~rosuvastatin calcium	Tablet~Tablet, film coated	10 mg~20.791 mg	Current	Unavailable	Manufacturing	25/02/2025
  oxytocin	Injection, solution	5 IU/mL	Current	Limited Availability	Unexpected increase in consumer demand	25/02/2025
  carboplatin	Injection, solution	450 mg	Current	Unavailable	Manufacturing	25/02/2025
  acarbose	Tablet	100 mg	Current	Limited Availability	Manufacturing	25/02/2025
  acarbose	Tablet	50 mg	Current	Unavailable	Manufacturing	25/02/2025
  acarbose	Tablet	50 mg	Discontinued	Unavailable	Commercial Changes / Commercial viability	25/02/2025
  acarbose	Tablet	100 mg	Discontinued	Unavailable	Commercial Changes / Commercial viability	25/02/2025
  ezetimibe	Tablet, uncoated	10 mg	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	25/02/2025
  cisplatin	Injection, concentrated	1 mg/mL	Current	Limited Availability	Unexpected increase in consumer demand	25/02/2025
  ezetimibe~atorvastatin calcium trihydrate	Tablet, film coated	10 mg~41.363 mg	Current	Unavailable	Manufacturing	25/02/2025
  atorvastatin calcium trihydrate~ezetimibe	Tablet, film coated	20.681 mg~10 mg	Current	Unavailable	Manufacturing	25/02/2025
  atorvastatin calcium trihydrate~ezetimibe	Tablet, film coated	82.725 mg~10 mg	Current	Unavailable	Manufacturing	25/02/2025
  mupirocin calcium	Cream	21.5 mg/g	Current	Unavailable	Manufacturing	25/02/2025
  indometacin	Capsule, hard	25 mg	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	25/02/2025
  clonidine hydrochloride	Tablet, uncoated	150 microgram	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	25/02/2025
  sodium pyrophosphate	Injection, powder for	30 mg	Current	Unavailable	Manufacturing	24/02/2025
  duloxetine hydrochloride	Capsule, enteric	67.3 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	24/02/2025
  ezetimibe~rosuvastatin calcium	Tablet~Tablet, film coated	10 mg~41.583 mg	Current	Unavailable	Manufacturing	24/02/2025
  ezetimibe~rosuvastatin calcium	Tablet~Tablet, film coated	10 mg~5.198 mg	Current	Unavailable	Manufacturing	24/02/2025
  ezetimibe~atorvastatin calcium trihydrate	Tablet, multilayer	10 mg~21.7 mg	Resolved	Available	Manufacturing	24/02/2025
  olmesartan medoxomil	Tablet, film coated	40 mg	Current	Limited Availability	Manufacturing	24/02/2025
  tacrolimus monohydrate	Capsule	.767 mg	Current	Limited Availability	Manufacturing	24/02/2025
  amiodarone hydrochloride	Injection, solution	150 mg	Current	Limited Availability	Manufacturing	24/02/2025
  azithromycin dihydrate	Tablet, film coated	524 mg	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	24/02/2025
  nebivolol hydrochloride	Tablet	10.9 mg	Resolved	Available	Manufacturing	24/02/2025
  escitalopram oxalate	Tablet, film coated	12.74 mg	Current	Limited Availability	Commercial Changes / Commercial viability	24/02/2025
  naloxone hydrochloride dihydrate	Spray, nasal	2.2 mg/actuation	Current	Limited Availability	Unexpected increase in consumer demand	24/02/2025
  nebivolol hydrochloride	Tablet	1.363 mg	Resolved	Available	Manufacturing	24/02/2025
  nebivolol hydrochloride	Tablet	5.45 mg	Current	Unavailable	Manufacturing	24/02/2025

• 2025.02.25
  TGAオーストラリア供給不足情報（2025年2月17日～2月23日）

  Active ingredients	Dosage form	Quantity of active ingredients	Shortage status	Availability	Reason	Last updated
  isosorbide dinitrate	Tablet, uncoated	5 mg	Anticipated	Available	Manufacturing	21/02/2025
  ciprofloxacin hydrochloride	Tablet, film coated	277.5 mg	Anticipated	Available	Manufacturing	21/02/2025
  ropinirole hydrochloride	Tablet, film coated	.57 mg	Resolved	Available	Manufacturing	21/02/2025
  trihexyphenidyl (benzhexol) hydrochloride	Tablet, uncoated	2 mg	Resolved	Available	Unexpected increase in consumer demand	21/02/2025
  risperidone	Tablet, film coated	3 mg	Current	Unavailable	Manufacturing	21/02/2025
  risperidone	Tablet, film coated	1 mg	Current	Unavailable	Manufacturing	21/02/2025
  risperidone	Tablet, film coated	2 mg	Current	Unavailable	Manufacturing	21/02/2025
  letrozole	Tablet, film coated	2.5 mg	Anticipated	Available	Manufacturing	21/02/2025
  levetiracetam	Tablet, film coated	1000 mg	Current	Unavailable	Transport / Logistic issues / Storage capacity issues	21/02/2025
  pramipexole dihydrochloride monohydrate	Tablet	1 mg	Anticipated	Available	Manufacturing	21/02/2025
  olanzapine	Tablet, orally disintegrating	5 mg	Current	Limited Availability	Manufacturing	21/02/2025
  galantamine hydrobromide	Capsule, modified release	10.252 mg	Current	Unavailable	Manufacturing	21/02/2025
  galantamine hydrobromide	Capsule, modified release	20.504 mg	Current	Unavailable	Manufacturing	21/02/2025
  montelukast sodium	Tablet, chewable	5.2 mg	Anticipated	Available	Unexpected increase in consumer demand	21/02/2025
  sildenafil citrate	Tablet, film coated	28.1 mg	Anticipated	Available	Manufacturing	21/02/2025
  azithromycin dihydrate	Tablet, film coated	524.05 mg	Current	Unavailable	Manufacturing	21/02/2025
  quetiapine fumarate	Tablet, modified release	460.52 mg	Resolved	Available	Manufacturing	21/02/2025
  quetiapine fumarate	Tablet, modified release	57.565 mg	Anticipated	Available	Unexpected increase in consumer demand	21/02/2025
  metformin hydrochloride	Tablet, modified release	1000 mg	Discontinued	Unavailable	Commercial Changes / Commercial viability	21/02/2025
  dutasteride	Capsule, soft	500 microgram	Anticipated	Available	Manufacturing	21/02/2025
  linezolid	Tablet, film coated	600 mg	Anticipated	Available	Manufacturing	21/02/2025
  ezetimibe	Tablet	10 mg	Resolved	Available	Manufacturing	21/02/2025
  ezetimibe	Tablet, uncoated	10 mg	Current	Unavailable	Unexpected increase in consumer demand	21/02/2025
  ezetimibe	Tablet, uncoated	10 mg	Current	Unavailable	Manufacturing	21/02/2025
  risperidone	Tablet, film coated	1 mg	Current	Unavailable	Manufacturing	21/02/2025
  risperidone	Tablet, film coated	2 mg	Current	Unavailable	Manufacturing	21/02/2025
  risperidone	Tablet, film coated	3 mg	Current	Unavailable	Transport / Logistic issues / Storage capacity issues	21/02/2025
  risperidone	Tablet, film coated	4 mg	Current	Unavailable	Manufacturing	21/02/2025
  latanoprost~timolol maleate	Eye Drops, solution	.05 mg/mL~6.83 mg/mL	Current	Unavailable	Manufacturing	21/02/2025
  prasugrel	Tablet, film coated	5 mg	Current	Unavailable	Manufacturing	21/02/2025
  dosulepin (dothiepin) hydrochloride	Capsule, hard	25 mg	Anticipated	Available	Manufacturing	21/02/2025
  azithromycin dihydrate	Tablet, film coated	524 mg	Current	Unavailable	Unexpected increase in consumer demand	21/02/2025
  gramicidin~framycetin sulfate~dexamethasone	Ear Drops	.05 mg/mL~5 mg/mL~.5 mg/mL	Anticipated	Available	Manufacturing	21/02/2025
  estradiol~dydrogesterone	Tablet, film coated	2 mg~10 mg	Current	Unavailable	Manufacturing	21/02/2025
  ciprofloxacin hydrochloride	Tablet, film coated	873.32 mg	Resolved	Available	Manufacturing	21/02/2025
  flucloxacillin	Injection, powder for	1 g	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	21/02/2025
  famotidine	Tablet, film coated	20 mg	Resolved	Available	Manufacturing	21/02/2025
  mirtazapine	Tablet, film coated	30 mg	Anticipated	Available	Manufacturing	21/02/2025
  methylphenidate hydrochloride	Tablet, modified release	27 mg	Current	Limited Availability	Manufacturing	20/02/2025
  amisulpride	Tablet	100 mg	Current	Unavailable	Manufacturing	20/02/2025
  azithromycin dihydrate	Tablet, film coated	524.1 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	20/02/2025
  mycophenolate mofetil	Tablet, film coated	500 mg	Current	Unavailable	Manufacturing	20/02/2025
  mirtazapine	Tablet, film coated	45 mg	Current	Unavailable	Manufacturing	20/02/2025
  pramipexole dihydrochloride monohydrate	Tablet	1 mg	Current	Limited Availability	Manufacturing	20/02/2025
  pramipexole dihydrochloride monohydrate	Tablet	.25 mg	Current	Unavailable	Transport / Logistic issues / Storage capacity issues	20/02/2025
  pramipexole dihydrochloride monohydrate	Tablet	.125 mg	Anticipated	Available	Manufacturing	20/02/2025
  amlodipine besilate~hydrochlorothiazide~olmesartan medoxomil	Tablet	6.944 mg~25 mg~40 mg	Current	Limited Availability	Manufacturing	20/02/2025
  nicorandil	Tablet	10 mg	Current	Limited Availability	Manufacturing	20/02/2025
  rizatriptan benzoate	Wafer	14.53 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	20/02/2025
  tobramycin	Injection, solution	40 mg/mL	Current	Unavailable	Unexpected increase in consumer demand	20/02/2025
  esomeprazole	Capsule, enteric	20 mg	Resolved	Available	Manufacturing	20/02/2025
  anastrozole	Tablet, film coated	1 mg	Current	Unavailable	Manufacturing	20/02/2025
  hydrocortisone	Tablet, uncoated	20 mg	Current	Limited Availability	Manufacturing	20/02/2025
  mesalazine	Tablet, enteric coated	250 mg	Current	Unavailable	Manufacturing	20/02/2025
  celecoxib	Capsule, hard	100 mg	Current	Unavailable	Manufacturing	20/02/2025
  acamprosate calcium	Tablet, enteric coated	333 mg	Anticipated	Available	Unexpected increase in consumer demand	20/02/2025
  mefenamic acid	Capsule, hard	250 mg	Anticipated	Available	Transport / Logistic issues / Storage capacity issues	20/02/2025
  buprenorphine	Patch, dermal	30 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	20/02/2025
  deferasirox	Tablet, film coated	90 mg	Anticipated	Available	Manufacturing	20/02/2025
  norethisterone acetate~estradiol~estradiol	Drug delivery system, transdermal	4.8 mg~.78 mg~.512 mg	Current	Unavailable	Manufacturing	20/02/2025
  spironolactone	Tablet, uncoated	25 mg	Current	Limited Availability	Manufacturing	20/02/2025
  sitagliptin fumarate	Tablet, film coated	32.124 mg	Current	Unavailable	Manufacturing	20/02/2025
  alprazolam	Tablet, uncoated	2 mg	Anticipated	Available	Manufacturing	20/02/2025
  Peginterferon alfa2a	Injection, solution	135 microgram	Anticipated	Available	Unexpected increase in consumer demand	20/02/2025
  Peginterferon alfa2a	Injection, solution	180 microgram	Anticipated	Available	Unexpected increase in consumer demand	20/02/2025
  citalopram hydrobromide	Tablet, film coated	49.96 mg	Current	Limited Availability	Manufacturing	20/02/2025
  methylphenidate hydrochloride	Tablet, modified release	18 mg	Current	Limited Availability	Manufacturing	20/02/2025
  methylphenidate hydrochloride	Tablet, modified release	36 mg	Current	Limited Availability	Manufacturing	20/02/2025
  methylphenidate hydrochloride	Tablet, modified release	54 mg	Current	Limited Availability	Manufacturing	20/02/2025
  sumatriptan succinate	Tablet, film coated	140 mg	Current	Unavailable	Manufacturing	19/02/2025
  oxytocin	Injection, solution	5 IU/mL	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	19/02/2025
  duloxetine hydrochloride	Capsule, enteric	67.3 mg	Current	Limited Availability	Manufacturing	19/02/2025
  phenoxymethylpenicillin potassium	Tablet, film coated	280 mg	Resolved	Available	Manufacturing	19/02/2025
  olmesartan medoxomil~hydrochlorothiazide	Tablet	40 mg~25 mg	Anticipated	Available	Manufacturing	19/02/2025
  cinacalcet hydrochloride	Tablet	99.191 mg	Resolved	Available	Manufacturing	19/02/2025
  potassium chloride	Injection, concentrated	75 mg/mL	Current	Unavailable	Commercial Changes / Commercial viability	19/02/2025
  atorvastatin calcium trihydrate	Tablet, film coated	86.751 mg	Current	Limited Availability	Manufacturing	19/02/2025
  atorvastatin calcium trihydrate	Tablet, film coated	43.376 mg	Current	Limited Availability	Manufacturing	19/02/2025
  oxaliplatin	Injection, concentrated	100 mg	Resolved	Available	Manufacturing	19/02/2025
  nitrofurantoin	Capsule, hard	100 mg	Anticipated	Available	Manufacturing	19/02/2025
  tamoxifen citrate	Tablet, uncoated	15.2 mg	Current	Limited Availability	Manufacturing	19/02/2025
  doxycycline hyclate	Tablet, film coated	57.5 mg	Resolved	Available	Manufacturing	19/02/2025
  metformin hydrochloride	Tablet, film coated	1000 mg	Current	Unavailable	Manufacturing	19/02/2025
  bupivacaine hydrochloride	Injection, solution	5 mg/mL	Resolved	Available	Manufacturing	18/02/2025
  fluorouracil	Injection, solution	5000 mg	Current	Unavailable	Unexpected increase in consumer demand	18/02/2025
  donepezil hydrochloride	Tablet, film coated	5 mg	Current	Unavailable	Transport / Logistic issues / Storage capacity issues	18/02/2025
  amlodipine besilate	Tablet	6.93 mg	Resolved	Available	Manufacturing	18/02/2025
  cisatracurium besilate	Injection, solution	14.07 mg	Resolved	Available	Transport / Logistic issues / Storage capacity issues	18/02/2025
  isotretinoin	Capsule, soft	10 mg	Current	Unavailable	Manufacturing	18/02/2025
  ezetimibe	Tablet, uncoated	10 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	18/02/2025
  ivabradine hydrochloride	Tablet, film coated	8.085 mg	Anticipated	Available	Manufacturing	18/02/2025
  ivabradine hydrochloride	Tablet, film coated	5.39 mg	Anticipated	Available	Manufacturing	18/02/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Unavailable	Manufacturing	18/02/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Unavailable	Manufacturing	18/02/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Unavailable	Manufacturing	18/02/2025
  amlodipine besilate~olmesartan medoxomil~hydrochlorothiazide	Tablet, film coated	6.95 mg~40 mg~12.5 mg	Anticipated	Available	Manufacturing	18/02/2025
  tenofovir disoproxil succinate~emtricitabine	Tablet, film coated	300.6 mg~200 mg	Current	Unavailable	Manufacturing	18/02/2025
  mycophenolate sodium	Tablet, enteric coated	384.7 mg	Resolved	Available	Manufacturing	18/02/2025
  lamotrigine	Tablet, chewable	200 mg	Current	Limited Availability	Unexpected increase in consumer demand	18/02/2025
  deferasirox	Tablet, film coated	360 mg	Current	Unavailable	Manufacturing	18/02/2025
  levothyroxine sodium	Tablet, uncoated	.2 mg	Resolved	Available	Manufacturing	18/02/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Limited Availability	Manufacturing	18/02/2025
  norethisterone~ethinylestradiol	Tablet, uncoated	500 microgram~36 microgram	Current	Limited Availability	Unexpected increase in consumer demand	18/02/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	18/02/2025
  adrenaline (epinephrine) acid tartrate	Injection, solution	1.82 mg/mL	Current	Unavailable	Manufacturing	17/02/2025
  trihexyphenidyl (benzhexol) hydrochloride	Tablet, uncoated	5 mg	Current	Limited Availability	Unexpected increase in consumer demand	17/02/2025
  metronidazole	Tablet, uncoated	400 mg	Anticipated	Available	Manufacturing	17/02/2025
  galantamine hydrobromide	Capsule, modified release	20.504 mg	Current	Unavailable	Manufacturing	17/02/2025
  montelukast sodium	Tablet, chewable	4.16 mg	Anticipated	Available	Manufacturing	17/02/2025
  montelukast sodium	Tablet, chewable	4.16 mg	Anticipated	Available	Manufacturing	17/02/2025
  bicalutamide	Tablet, film coated	50 mg	Current	Unavailable	Manufacturing	17/02/2025
  quetiapine fumarate	Tablet, modified release	172.695 mg	Anticipated	Available	Unexpected increase in consumer demand	17/02/2025
  quetiapine fumarate	Tablet, film coated	28.78 mg	Resolved	Available	Manufacturing	17/02/2025
  candesartan cilexetil	Tablet, uncoated	4 mg	Current	Limited Availability	Manufacturing	17/02/2025
  escitalopram oxalate	Tablet, film coated	25.47 mg	Current	Limited Availability	Manufacturing	17/02/2025
  clopidogrel besilate	Tablet, film coated	112.1 mg	Current	Unavailable	Manufacturing	17/02/2025
  simvastatin	Tablet, film coated	10 mg	Resolved	Available	Manufacturing	17/02/2025
  simvastatin	Tablet, film coated	80 mg	Current	Unavailable	Manufacturing	17/02/2025
  morphine hydrochloride trihydrate	Injection, solution	20 mg/mL	Current	Limited Availability	Manufacturing	17/02/2025
  tadalafil	Tablet, film coated	20 mg	Resolved	Available	Manufacturing	17/02/2025
  ribociclib succinate	Tablet, film coated	254.4 mg	Resolved	Available	Transport / Logistic issues / Storage capacity issues	17/02/2025
  lacosamide	Tablet, film coated	100 mg	Anticipated	Available	Unexpected increase in consumer demand	17/02/2025
  pregabalin	Capsule, hard	75 mg	Resolved	Available	Unexpected increase in consumer demand	17/02/2025
  famotidine	Tablet, film coated	40 mg	Current	Unavailable	Manufacturing	17/02/2025

• 2025.02.17
  TGAオーストラリア供給不足情報（2025年2月10日～2月16日）

  Active ingredients	Dosage form	Quantity of active ingredients	Shortage status	Availability	Reason	Last updated
  fentanyl	Drug delivery system, transdermal	4.2 mg	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	14/02/2025
  morphine hydrochloride trihydrate	Injection, solution	10 mg/mL	Resolved	Available	Manufacturing	14/02/2025
  leuprorelin acetate~bicalutamide	Injection, modified release~Tablet, film coated	22.5 mg~50 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	14/02/2025
  leuprorelin acetate~bicalutamide	Injection, modified release~Tablet, film coated	7.5 mg~50 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	14/02/2025
  leuprorelin acetate~bicalutamide	Injection, modified release~Tablet, film coated	22.5 mg~50 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	14/02/2025
  mupirocin	Ointment	20 mg/g	Current	Limited Availability	Unexpected increase in consumer demand	14/02/2025
  ethanol absolute~carmustine	Diluent, not applicable~Injection, powder for	3 mL~100 mg	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	14/02/2025
  tramadol hydrochloride	Tablet, modified release	200 mg	Resolved	Available	Manufacturing	13/02/2025
  glyceryl trinitrate	Injection, concentrated	50 mg	Current	Limited Availability	Manufacturing	13/02/2025
  levetiracetam	Tablet, film coated	250 mg	Resolved	Available	Manufacturing	13/02/2025
  levodopa~entacapone~carbidopa monohydrate	Tablet, film coated	125 mg~200 mg~33.75 mg	Anticipated	Available	Manufacturing	13/02/2025
  pramipexole dihydrochloride monohydrate	Tablet	.25 mg	Anticipated	Available	Unexpected increase in consumer demand	13/02/2025
  daptomycin	Injection, powder for	500 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	13/02/2025
  melatonin	Oral Liquid, solution	1 mg/mL	Current	Limited Availability	Unexpected increase in consumer demand	13/02/2025
  heparin sodium	Injection, solution	10 IU/mL	Current	Unavailable	Manufacturing	13/02/2025
  tobramycin	Injection, solution	80 mg	Resolved	Available	Manufacturing	12/02/2025
  amlodipine besilate	Tablet, uncoated	6.94 mg	Resolved	Available	Manufacturing	12/02/2025
  topiramate	Tablet, film coated	200 mg	Resolved	Available	Manufacturing	12/02/2025
  letrozole	Tablet, film coated	2.5 mg	Current	Unavailable	Manufacturing	12/02/2025
  vinblastine sulfate	Injection, solution	1 mg/mL	Current	Limited Availability	Manufacturing	12/02/2025
  oxytocin	Injection, solution	10 IU/mL	Anticipated	Available	Manufacturing	12/02/2025
  tadalafil	Tablet, film coated	20 mg	Resolved	Available	Manufacturing	12/02/2025
  hydrochlorothiazide~olmesartan medoxomil	Tablet	12.5 mg~20 mg	Current	Unavailable	Manufacturing	12/02/2025
  dosulepin (dothiepin) hydrochloride	Tablet, film coated	75 mg	Current	Limited Availability	Manufacturing	12/02/2025
  Trastuzumab	Injection, powder for	156 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	12/02/2025
  mefenamic acid	Capsule, hard	250 mg	Anticipated	Available	Transport / Logistic issues / Storage capacity issues	12/02/2025
  naloxone hydrochloride dihydrate	Spray, nasal	2.2 mg/actuation	Current	Limited Availability	Unexpected increase in consumer demand	12/02/2025
  lurasidone hydrochloride	Tablet, film coated	80 mg	Current	Unavailable	Manufacturing	12/02/2025
  atorvastatin calcium trihydrate	Tablet, film coated	86.751 mg	Current	Limited Availability	Manufacturing	12/02/2025
  sitagliptin hydrochloride monohydrate	Tablet, film coated	109 mg	Current	Unavailable	Manufacturing	12/02/2025
  sitagliptin hydrochloride monohydrate	Tablet, film coated	54.5 mg	Current	Unavailable	Manufacturing	12/02/2025
  sitagliptin hydrochloride monohydrate	Tablet, film coated	27.25 mg	Current	Unavailable	Manufacturing	12/02/2025
  midazolam	Injection, solution	5 mg/mL	Current	Limited Availability	Unexpected increase in consumer demand	12/02/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	12/02/2025
  balsalazide sodium	Capsule	750 mg	Anticipated	Available	Manufacturing	12/02/2025
  nizatidine	Capsule	150 mg	Anticipated	Available	Manufacturing	12/02/2025
  exemestane	Tablet, film coated	25 mg	Current	Limited Availability	Manufacturing	11/02/2025
  acetylcysteine	Injection, concentrated	2 g	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	11/02/2025
  armodafinil	Tablet, uncoated	50 mg	Anticipated	Available	Manufacturing	11/02/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Unavailable	Manufacturing	11/02/2025
  ezetimibe~atorvastatin calcium trihydrate	Tablet, film coated	10 mg~10.341 mg	Current	Unavailable	Manufacturing	11/02/2025
  Bevacizumab	Injection, concentrated	25 mg/mL	Current	Unavailable	Commercial Changes / Commercial viability	11/02/2025
  mupirocin calcium	Cream	21.5 mg/g	Current	Limited Availability	Manufacturing	11/02/2025
  ioversol	Injection, solution	509 mg/mL	Discontinued	Unavailable	Commercial Changes / Commercial viability	11/02/2025
  ioversol	Injection, solution	678 mg/mL	Discontinued	Unavailable	Manufacturing	11/02/2025
  ioversol	Injection, solution	678 mg/mL	Discontinued	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	11/02/2025
  carboplatin	Injection, solution	10 mg/mL	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	11/02/2025
  ioversol	Injection, solution	741 mg/mL	Discontinued	Unavailable	Manufacturing	11/02/2025
  ioversol	Injection, solution	678 mg/mL	Discontinued	Unavailable	Manufacturing	11/02/2025
  ioversol	Injection, solution	741 mg/mL	Discontinued	Unavailable	Manufacturing	11/02/2025
  ioversol	Injection, solution	741 mg/mL	Discontinued	Unavailable	Manufacturing	11/02/2025
  ethinylestradiol~norethisterone	Tablet, uncoated	36 microgram~500 microgram	Anticipated	Available	Unexpected increase in consumer demand	11/02/2025
  ioversol	Injection, solution	678 mg/mL	Discontinued	Unavailable	Manufacturing	11/02/2025
  primidone	Tablet, uncoated	250 mg	Anticipated	Available	Manufacturing	10/02/2025
  trihexyphenidyl (benzhexol) hydrochloride	Tablet, uncoated	2 mg	Anticipated	Available	Unexpected increase in consumer demand	10/02/2025
  neostigmine methylsulfate	Injection, solution	2.5 mg	Current	Unavailable	Manufacturing	10/02/2025
  ribociclib succinate	Tablet, film coated	254.4 mg	Anticipated	Available	Transport / Logistic issues / Storage capacity issues	10/02/2025
  montelukast sodium	Tablet, chewable	5.2 mg	Current	Unavailable	Manufacturing	10/02/2025
  cisatracurium besilate	Injection, solution	13.4 mg	Anticipated	Available	Manufacturing	10/02/2025
  pioglitazone hydrochloride	Tablet, uncoated	16.53 mg	Anticipated	Available	Commercial Changes / Commercial viability	10/02/2025
  pioglitazone hydrochloride	Tablet, uncoated	33.06 mg	Anticipated	Available	Commercial Changes / Commercial viability	10/02/2025
  oxycodone hydrochloride	Oral Liquid, solution	1 mg/mL	Resolved	Available	Unexpected increase in consumer demand	10/02/2025
  dinoprostone	Gel	.6667 mg/g	Resolved	Available	Manufacturing	10/02/2025

• 2025.02.10
  TGAオーストラリア供給不足情報（2025年2月3日～2025年2月9日）

  Active ingredients	Dosage form	Quantity of active ingredients	Shortage status	Availability	Reason	Last updated
  paclitaxel	Injection, concentrated	6 mg/mL	Resolved	Available	Manufacturing	7/02/2025
  colistimethate sodium	Injection, powder for	IU	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	7/02/2025
  olanzapine	Tablet, orally disintegrating	20 mg	Anticipated	Available	Manufacturing	7/02/2025
  levetiracetam	Tablet, film coated	250 mg	Current	Unavailable	Manufacturing	7/02/2025
  capecitabine	Tablet, film coated	500 mg	Current	Limited Availability	Unexpected increase in consumer demand	7/02/2025
  nicorandil	Tablet	10 mg	Anticipated	Available	Manufacturing	7/02/2025
  ivabradine hydrochloride	Tablet, film coated	5.39 mg	Resolved	Available	Manufacturing	7/02/2025
  fentanyl citrate	Injection, solution	157 microgram	Resolved	Available	Manufacturing	7/02/2025
  fluorouracil	Cream	50 mg/g	Current	Unavailable	Manufacturing	7/02/2025
  clindamycin phosphate	Lotion	10 mg/mL	Resolved	Available	Manufacturing	7/02/2025
  ropivacaine hydrochloride~fentanyl citrate	Injection, solution	2 mg/mL~6.28 microgram/mL	Discontinued	Unavailable	Commercial Changes / Commercial viability	7/02/2025
  ropivacaine hydrochloride~fentanyl citrate	Injection, solution	2 mg/mL~6.28 microgram/mL	Discontinued	Unavailable	Commercial Changes / Commercial viability	7/02/2025
  citalopram hydrobromide	Tablet, film coated	49.96 mg	Anticipated	Available	Manufacturing	7/02/2025
  carvedilol	Tablet, film coated	6.25 mg	Resolved	Available	Manufacturing	6/02/2025
  ramipril	Capsule, hard	1.25 mg	Current	Limited Availability	Manufacturing	6/02/2025
  octreotide	Injection, solution	100 microgram	Current	Limited Availability	Manufacturing	6/02/2025
  octreotide	Injection, solution	500 microgram	Current	Unavailable	Manufacturing	6/02/2025
  octreotide	Injection, solution	50 microgram	Current	Limited Availability	Manufacturing	6/02/2025
  topiramate	Tablet, film coated	200 mg	Current	Unavailable	Manufacturing	6/02/2025
  olanzapine	Tablet, film coated	10 mg	Current	Limited Availability	Manufacturing	6/02/2025
  amisulpride	Tablet	100 mg	Current	Limited Availability	Manufacturing	6/02/2025
  galantamine hydrobromide	Capsule, modified release	10.252 mg	Anticipated	Available	Manufacturing	6/02/2025
  montelukast sodium	Tablet, chewable	4.16 mg	Anticipated	Available	Manufacturing	6/02/2025
  trandolapril	Capsule, hard	.5 mg	Resolved	Available	Manufacturing	6/02/2025
  trandolapril	Capsule, hard	1 mg	Current	Unavailable	Manufacturing	6/02/2025
  trandolapril	Capsule, hard	2 mg	Current	Unavailable	Manufacturing	6/02/2025
  trandolapril	Capsule, hard	4 mg	Current	Unavailable	Manufacturing	6/02/2025
  risperidone	Tablet, film coated	2 mg	Current	Unavailable	Unexpected increase in consumer demand	6/02/2025
  quetiapine fumarate	Tablet, modified release	345.39 mg	Anticipated	Available	Unexpected increase in consumer demand	6/02/2025
  quetiapine fumarate	Tablet, modified release	57.565 mg	Anticipated	Available	Unexpected increase in consumer demand	6/02/2025
  candesartan cilexetil	Tablet, uncoated	4 mg	Current	Unavailable	Manufacturing	6/02/2025
  esomeprazole	Capsule, enteric	40 mg	Current	Unavailable	Manufacturing	6/02/2025
  nebivolol hydrochloride	Tablet	5.45 mg	Current	Limited Availability	Manufacturing	6/02/2025
  dosulepin (dothiepin) hydrochloride	Tablet, film coated	75 mg	Anticipated	Available	Manufacturing	6/02/2025
  Semaglutide	Injection, solution	1.34 mg/mL	Current	Limited Availability	Unexpected increase in consumer demand	6/02/2025
  doxepin hydrochloride	Capsule, hard	11.3 mg	Current	Limited Availability	Manufacturing	6/02/2025
  Semaglutide	Injection, solution	1.34 mg/mL	Current	Limited Availability	Unexpected increase in consumer demand	6/02/2025
  atorvastatin calcium trihydrate	Tablet, film coated	43.376 mg	Current	Limited Availability	Manufacturing	6/02/2025
  lamotrigine	Tablet, chewable	100 mg	Current	Unavailable	Unexpected increase in consumer demand	6/02/2025
  levothyroxine sodium	Tablet, uncoated	50 microgram	Current	Unavailable	Manufacturing	6/02/2025
  metformin hydrochloride	Tablet, film coated	850 mg	Current	Limited Availability	Manufacturing	6/02/2025
  estradiol hemihydrate	Drug delivery system, transdermal	2.32 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	6/02/2025
  alprostadil	Injection, powder for	40 microgram/mL	Current	Unavailable	Manufacturing	6/02/2025
  nizatidine	Capsule	150 mg	Anticipated	Available	Manufacturing	6/02/2025
  betiatide	Injection, powder for	1 mg	Current	Unavailable	Manufacturing	5/02/2025
  acetylcholine chloride	Solution, powder for irrigation	10 mg/mL	Current	Limited Availability	Manufacturing	5/02/2025
  sumatriptan succinate	Tablet, film coated	140 mg	Current	Unavailable	Manufacturing	5/02/2025
  sugammadex sodium	Injection, solution	217.6 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	5/02/2025
  acetylcysteine	Injection, concentrated	2 g	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	5/02/2025
  nicotinic acid	Tablet, uncoated	250 mg	Resolved	Available	Manufacturing	5/02/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Unavailable	Manufacturing	5/02/2025
  deferasirox	Tablet, film coated	90 mg	Anticipated	Available	Manufacturing	5/02/2025
  melatonin	Oral Liquid, solution	1 mg/mL	Anticipated	Available	Unexpected increase in consumer demand	5/02/2025
  carbidopa monohydrate~levodopa	Tablet, uncoated	26.9 mg~100 mg	Current	Limited Availability	Manufacturing	5/02/2025
  imipramine hydrochloride	Tablet, sugar coated	25 mg	Current	Unavailable	Manufacturing	5/02/2025
  norethisterone~ethinylestradiol	Tablet, uncoated	1 mg~36 microgram	Current	Limited Availability	Manufacturing	5/02/2025
  citalopram hydrobromide	Tablet, film coated	24.98 mg	Current	Limited Availability	Manufacturing	5/02/2025
  nizatidine	Capsule	300 mg	Resolved	Available	Manufacturing	5/02/2025
  sodium pertechnetate(99mTc)	Injection, solution	18.5 GBq	Current	Unavailable	Manufacturing	4/02/2025
  clonidine hydrochloride	Tablet, uncoated	100 microgram	Current	Unavailable	Transport / Logistic issues / Storage capacity issues	4/02/2025
  midazolam	Injection, solution	5 mg	Current	Limited Availability	Manufacturing	4/02/2025
  adrenaline (epinephrine) acid tartrate	Injection, solution	182 microgram/mL	Current	Unavailable	Manufacturing	4/02/2025
  mesalazine	Tablet, enteric coated	800 mg	Current	Limited Availability	Manufacturing	4/02/2025
  emtricitabine~tenofovir disoproxil fumarate	Tablet, film coated	200 mg~300 mg	Current	Limited Availability	Manufacturing	4/02/2025
  Influenza virus haemagglutinin	Injection, suspension	15 microgram	Current	Unavailable	Seasonal depletion of stock	4/02/2025
  mefenamic acid	Capsule, hard	250 mg	Anticipated	Available	Transport / Logistic issues / Storage capacity issues	4/02/2025
  nebivolol hydrochloride	Tablet	5.45 mg	Resolved	Available	Manufacturing	4/02/2025
  Influenza virus haemagglutinin	Injection, suspension	15 microgram	Current	Unavailable	Seasonal depletion of stock	4/02/2025
  albendazole	Tablet, chewable	200 mg	Resolved	Available	Manufacturing	4/02/2025
  cisatracurium besilate	Injection, solution	2.68 mg/mL	Current	Unavailable	Manufacturing	4/02/2025
  estradiol~norethisterone acetate	Drug delivery system, transdermal	.62 mg~2.7 mg	Current	Unavailable	Manufacturing	4/02/2025
  hydrocortisone acetate	Eye Ointment	10 mg/g	Resolved	Available	Manufacturing	3/02/2025
  fentanyl	Drug delivery system, transdermal	4.2 mg	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	3/02/2025
  tramadol hydrochloride	Tablet, modified release	200 mg	Resolved	Available	Manufacturing	3/02/2025
  silver sulfadiazine	Cream	10 mg/g	Current	Unavailable	Manufacturing	3/02/2025
  silver sulfadiazine	Cream	10 mg/g	Current	Unavailable	Manufacturing	3/02/2025
  heparin sodium	Injection, solution	25000 IU/mL	Resolved	Available	Manufacturing	3/02/2025
  ezetimibe~rosuvastatin calcium	Tablet~Tablet, film coated	10 mg~41.583 mg	Current	Unavailable	Manufacturing	3/02/2025
  rosuvastatin calcium~ezetimibe	Tablet~Tablet, film coated	10.396 mg~10 mg	Current	Limited Availability	Manufacturing	3/02/2025
  ezetimibe~rosuvastatin calcium	Tablet~Tablet, film coated	10 mg~20.791 mg	Current	Limited Availability	Manufacturing	3/02/2025
  ezetimibe~rosuvastatin calcium	Tablet~Tablet, film coated	10 mg~5.198 mg	Current	Limited Availability	Manufacturing	3/02/2025
  midazolam	Injection, solution	5 mg	Resolved	Available	Transport / Logistic issues / Storage capacity issues	3/02/2025
  eftrenonacog alfa	Injection, powder for	250 IU	Resolved	Available	Unexpected increase in consumer demand	3/02/2025
  atorvastatin calcium trihydrate~ezetimibe	Tablet, multilayer	43.4 mg~10 mg	Resolved	Available	Manufacturing	3/02/2025
  atorvastatin calcium trihydrate~ezetimibe	Tablet, multilayer	86.8 mg~10 mg	Current	Unavailable	Manufacturing	3/02/2025
  ezetimibe	Tablet, uncoated	10 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	3/02/2025
  olmesartan medoxomil~amlodipine besilate	Tablet, film coated	40 mg~6.935 mg	Resolved	Available	Manufacturing	3/02/2025
  nebivolol hydrochloride	Tablet	1.363 mg	Current	Unavailable	Manufacturing	3/02/2025
  clobazam	Tablet, uncoated	10 mg	Current	Unavailable	Manufacturing	3/02/2025
  dasatinib propylene glycol	Tablet, film coated	58 mg	Current	Unavailable	Manufacturing	3/02/2025
  dasatinib propylene glycol	Tablet, film coated	81.2 mg	Current	Unavailable	Manufacturing	3/02/2025
  dasatinib propylene glycol	Tablet, film coated	116 mg	Current	Unavailable	Manufacturing	3/02/2025
  nitrofurantoin	Capsule, hard	100 mg	Anticipated	Available	Manufacturing	3/02/2025
  clopidogrel hydrogen sulfate	Tablet, film coated	97.875 mg	Current	Unavailable	Manufacturing	3/02/2025
  carboplatin	Injection, solution	10 mg/mL	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	3/02/2025

• 2025.02.03
  TGAオーストラリア供給不足情報（2025年1月27日～2025年2月2日）

  Active ingredients	Dosage form	Quantity of active ingredients	Shortage status	Availability	Reason	Last updated
  Coxiella burnetii	Injection	50 microgram/mL	Resolved	Available	Manufacturing	31/01/2025
  Coxiella burnetii	Injection	5 microgram/mL	Resolved	Available	Manufacturing	31/01/2025
  carvedilol	Tablet, film coated	6.25 mg	Anticipated	Available	Manufacturing	31/01/2025
  olanzapine pamoate monohydrate	Injection, powder for	931 mg	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	31/01/2025
  olanzapine pamoate monohydrate	Injection, powder for	690 mg	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	31/01/2025
  olanzapine pamoate monohydrate	Injection, powder for	483 mg	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	31/01/2025
  benzathine benzylpenicillin tetrahydrate	Injection, suspension	1200000 USP Unit	Resolved	Available	Manufacturing	31/01/2025
  fentanyl	Drug delivery system, transdermal	8.4 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	31/01/2025
  galantamine hydrobromide	Capsule, modified release	10.252 mg	Current	Unavailable	Manufacturing	31/01/2025
  galantamine hydrobromide	Capsule, modified release	20.504 mg	Current	Unavailable	Manufacturing	31/01/2025
  azithromycin dihydrate	Tablet, film coated	524.05 mg	Current	Unavailable	Manufacturing	31/01/2025
  trandolapril	Capsule, hard	.5 mg	Current	Limited Availability	Manufacturing	31/01/2025
  quetiapine fumarate	Tablet, modified release	172.695 mg	Anticipated	Available	Unexpected increase in consumer demand	31/01/2025
  quetiapine fumarate	Tablet, modified release	57.565 mg	Anticipated	Available	Unexpected increase in consumer demand	31/01/2025
  quetiapine fumarate	Tablet, film coated	28.78 mg	Current	Unavailable	Manufacturing	31/01/2025
  metoprolol succinate	Tablet, modified release	95 mg	Current	Limited Availability	Manufacturing	31/01/2025
  raloxifene hydrochloride	Tablet, film coated	60 mg	Current	Unavailable	Unexpected increase in consumer demand	31/01/2025
  docetaxel	Injection, concentrated	80 mg	Resolved	Available	Manufacturing	31/01/2025
  candesartan cilexetil	Tablet, uncoated	4 mg	Current	Limited Availability	Manufacturing	31/01/2025
  escitalopram oxalate	Tablet, film coated	12.74 mg	Resolved	Available	Transport / Logistic issues / Storage capacity issues	31/01/2025
  citalopram hydrobromide	Tablet, film coated	49.98 mg	Current	Unavailable	Manufacturing	31/01/2025
  buprenorphine	Drug delivery system, transdermal	5 mg	Resolved	Available	Transport / Logistic issues / Storage capacity issues	31/01/2025
  azithromycin dihydrate	Tablet, film coated	524 mg	Resolved	Available	Manufacturing	31/01/2025
  tenofovir disoproxil maleate~emtricitabine	Tablet, film coated	300 mg~200 mg	Current	Limited Availability	Manufacturing	31/01/2025
  irbesartan~hydrochlorothiazide	Tablet, film coated	300 mg~12.5 mg	Current	Limited Availability	Manufacturing	31/01/2025
  hydrochlorothiazide~irbesartan	Tablet, film coated	25 mg~300 mg	Current	Unavailable	Manufacturing	31/01/2025
  tadalafil	Tablet, film coated	20 mg	Current	Unavailable	Manufacturing	31/01/2025
  ivabradine hydrochloride	Tablet, film coated	5.39 mg	Current	Limited Availability	Manufacturing	31/01/2025
  cisplatin	Injection, concentrated	1 mg/mL	Current	Limited Availability	Unexpected increase in consumer demand	31/01/2025
  pregabalin	Capsule, hard	25 mg	Current	Unavailable	Manufacturing	31/01/2025
  olanzapine	Tablet, uncoated	2.5 mg	Resolved	Available	Manufacturing	31/01/2025
  levothyroxine sodium	Tablet, uncoated	.05 mg	Anticipated	Available	Unexpected increase in consumer demand	31/01/2025
  gentamicin sulfate	Injection, solution	135.6 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	31/01/2025
  tamoxifen citrate	Tablet, uncoated	15.2 mg	Current	Limited Availability	Manufacturing	31/01/2025
  levodopa~carbidopa monohydrate	Tablet, uncoated	100 mg~26.9 mg	Current	Limited Availability	Manufacturing	31/01/2025
  cabergoline	Tablet, uncoated	1 mg	Resolved	Available	Manufacturing	31/01/2025
  midazolam	Injection, solution	5 mg/mL	Anticipated	Available	Unexpected increase in consumer demand	31/01/2025
  metformin hydrochloride	Tablet, film coated	500 mg	Resolved	Available	Manufacturing	31/01/2025
  reboxetine mesilate	Tablet, uncoated	5.224 mg	Current	Limited Availability	Manufacturing	31/01/2025
  prazosin hydrochloride	Tablet, uncoated	2.19 mg	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	30/01/2025
  fludarabine phosphate	Injection, concentrated	50 mg	Resolved	Available	Manufacturing	30/01/2025
  sodium fluoride	Injection, concentrated	1 mg/mL	Current	Unavailable	Manufacturing	30/01/2025
  olmesartan medoxomil~hydrochlorothiazide~amlodipine besilate	Tablet	40 mg~25 mg~6.944 mg	Current	Limited Availability	Manufacturing	30/01/2025
  eftrenonacog alfa	Injection, powder for	250 IU	Current	Unavailable	Unexpected increase in consumer demand	30/01/2025
  cyclopentolate hydrochloride	Eye Drops, solution	10 mg/mL	Resolved	Available	Manufacturing	30/01/2025
  ropivacaine hydrochloride monohydrate	Injection, solution	2.116 mg/mL	Current	Unavailable	Commercial Changes / Commercial viability	30/01/2025
  metformin hydrochloride	Tablet, film coated	1000 mg	Anticipated	Available	Manufacturing	30/01/2025
  cisplatin	Injection, concentrated	1 mg/mL	Current	Limited Availability	Manufacturing	30/01/2025
  encorafenib	Capsule, hard	75 mg	Resolved	Available	Manufacturing	30/01/2025
  estradiol	Drug delivery system, transdermal	.39 mg	Current	Limited Availability	Manufacturing	30/01/2025
  estradiol hemihydrate	Tablet, film coated	2.06 mg	Anticipated	Available	Manufacturing	30/01/2025
  methylphenidate hydrochloride	Capsule, modified release	40 mg	Resolved	Available	Unexpected increase in consumer demand	30/01/2025
  testosterone enantate	Injection	250 mg/mL	Resolved	Available	Unexpected increase in consumer demand	29/01/2025
  clozapine	Oral Liquid, suspension	50 mg/mL	Current	Unavailable	Manufacturing	29/01/2025
  pentetic acid	Injection, powder for	5 mg	Current	Emergency Supply Only	Manufacturing	29/01/2025
  medronic acid	Injection, powder for	10 mg	Current	Unavailable	Manufacturing	29/01/2025
  rizatriptan benzoate	Wafer	14.53 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	29/01/2025
  epirubicin hydrochloride	Injection, concentrated	200 mg	Current	Unavailable	Manufacturing	29/01/2025
  Follitropin alfa	Injection, solution	150 IU	Anticipated	Available	Manufacturing	29/01/2025
  benzatropine mesilate	Injection	1 mg/mL	Resolved	Available	Manufacturing	29/01/2025
  clonazepam	Tablet, uncoated	.5 mg	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	29/01/2025
  buprenorphine	Patch, dermal	30 mg	Current	Unavailable	Unexpected increase in demand due to other sponsors unable to supply	29/01/2025
  oxaliplatin	Injection, concentrated	100 mg	Current	Limited Availability	Manufacturing	29/01/2025
  fluticasone propionate	Inhalation, pressurised	125 microgram/actuation	Resolved	Available	Unexpected increase in consumer demand	29/01/2025
  tobramycin	Injection, solution	80 mg	Current	Unavailable	Manufacturing	28/01/2025
  salbutamol sulfate	Inhalation, conventional	3 mg	Current	Unavailable	Manufacturing	28/01/2025
  sodium pyrophosphate	Injection, powder for	30 mg	Current	Unavailable	Manufacturing	28/01/2025
  trihexyphenidyl (benzhexol) hydrochloride	Tablet, uncoated	5 mg	Current	Limited Availability	Unexpected increase in consumer demand	28/01/2025
  omega3acid ethyl esters 90	Capsule, soft	1000 mg	Anticipated	Available	Manufacturing	28/01/2025
  oxytocin	Injection, solution	10 IU	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	28/01/2025
  doxorubicin hydrochloride	Injection, concentrated	2 mg/mL	Resolved	Available	Manufacturing	28/01/2025
  clonidine hydrochloride	Tablet, uncoated	100 microgram	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	28/01/2025
  montelukast sodium	Tablet, chewable	4.16 mg	Anticipated	Available	Manufacturing	28/01/2025
  quetiapine fumarate	Tablet, modified release	460.52 mg	Current	Limited Availability	Manufacturing	28/01/2025
  quetiapine fumarate	Tablet, film coated	28.78 mg	Resolved	Available	Manufacturing	28/01/2025
  midazolam	Injection, solution	5 mg	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	28/01/2025
  duloxetine hydrochloride	Capsule, enteric	33.66 mg	Current	Unavailable	Unexpected increase in consumer demand	28/01/2025
  duloxetine hydrochloride	Capsule, enteric	67.32 mg	Resolved	Available	Commercial Changes / Commercial viability	28/01/2025
  adrenaline (epinephrine) acid tartrate	Injection, solution	182 microgram/mL	Current	Unavailable	Manufacturing	28/01/2025
  tranexamic acid	Injection, solution	100 mg/mL	Resolved	Available	Manufacturing	28/01/2025
  cisatracurium besilate	Injection, solution	14.07 mg	Current	Unavailable	Transport / Logistic issues / Storage capacity issues	28/01/2025
  amiodarone hydrochloride	Injection, solution	150 mg	Anticipated	Available	Manufacturing	28/01/2025
  ezetimibe	Tablet, uncoated	10 mg	Current	Limited Availability	Unexpected increase in consumer demand	28/01/2025
  mupirocin	Ointment	20 mg/g	Current	Limited Availability	Unexpected increase in consumer demand	28/01/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Unavailable	Manufacturing	28/01/2025
  risperidone	Tablet, film coated	1 mg	Current	Unavailable	Manufacturing	28/01/2025
  risperidone	Tablet, film coated	2 mg	Current	Unavailable	Manufacturing	28/01/2025
  risperidone	Tablet, film coated	3 mg	Current	Unavailable	Transport / Logistic issues / Storage capacity issues	28/01/2025
  risperidone	Tablet, film coated	4 mg	Current	Unavailable	Manufacturing	28/01/2025
  pregabalin	Capsule, hard	75 mg	Current	Unavailable	Unexpected increase in consumer demand	28/01/2025
  dimethyl fumarate	Capsule, enteric	120 mg	Current	Limited Availability	Manufacturing	28/01/2025
  tamoxifen citrate	Tablet	30.34 mg	Current	Limited Availability	Manufacturing	28/01/2025
  levothyroxine sodium	Tablet	.05 mg	Current	Unavailable	Manufacturing	28/01/2025
  levothyroxine sodium	Tablet	.2 mg	Current	Unavailable	Manufacturing	28/01/2025
  levothyroxine sodium	Tablet	.1 mg	Current	Unavailable	Manufacturing	28/01/2025
  levothyroxine sodium	Tablet	.075 mg	Current	Unavailable	Manufacturing	28/01/2025
  olanzapine	Tablet, uncoated	5 mg	Anticipated	Available	Manufacturing	28/01/2025

• 2025.01.27
  TGAオーストラリア供給不足情報（2025年1月20日～2025年1月26日）

  Active ingredients	Dosage form	Quantity of active ingredients	Shortage status	Availability	Reason	Last updated
  methylphenidate hydrochloride	Tablet, modified release	27 mg	Current	Limited Availability	Manufacturing	24/01/2025
  amlodipine besilate	Tablet, uncoated	6.94 mg	Current	Limited Availability	Manufacturing	24/01/2025
  ropinirole hydrochloride	Tablet, film coated	.57 mg	Current	Unavailable	Manufacturing	24/01/2025
  olanzapine	Tablet, orally disintegrating	20 mg	Resolved	Available	Manufacturing	24/01/2025
  risperidone	Tablet, film coated	3 mg	Current	Unavailable	Manufacturing	24/01/2025
  risperidone	Tablet, film coated	1 mg	Current	Unavailable	Manufacturing	24/01/2025
  risperidone	Tablet, film coated	2 mg	Current	Unavailable	Manufacturing	24/01/2025
  midazolam	Injection, solution	5 mg	Current	Limited Availability	Manufacturing	24/01/2025
  donepezil hydrochloride	Tablet, film coated	10 mg	Resolved	Available	Transport / Logistic issues / Storage capacity issues	24/01/2025
  donepezil hydrochloride	Tablet, film coated	5 mg	Current	Unavailable	Transport / Logistic issues / Storage capacity issues	24/01/2025
  valsartan~hydrochlorothiazide	Tablet, film coated	320 mg~25 mg	Anticipated	Available	Manufacturing	24/01/2025
  hydrochlorothiazide~valsartan	Tablet, film coated	12.5 mg~160 mg	Anticipated	Available	Manufacturing	24/01/2025
  duloxetine hydrochloride	Capsule, enteric	33.65 mg	Current	Limited Availability	Manufacturing	24/01/2025
  afatinib dimaleate	Tablet, film coated	73.9 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	24/01/2025
  raloxifene hydrochloride	Tablet, film coated	60 mg	Current	Limited Availability	Unexpected increase in consumer demand	24/01/2025
  simvastatin	Tablet, film coated	10 mg	Current	Limited Availability	Manufacturing	24/01/2025
  citalopram hydrobromide	Tablet, film coated	49.98 mg	Current	Unavailable	Manufacturing	24/01/2025
  amiodarone hydrochloride	Injection, solution	150 mg	Anticipated	Available		24/01/2025
  ezetimibe	Tablet, uncoated	10 mg	Current	Unavailable	Manufacturing	24/01/2025
  tadalafil	Tablet, film coated	10 mg	Current	Unavailable	Manufacturing	24/01/2025
  solifenacin succinate	Tablet, film coated	5 mg	Current	Unavailable	Manufacturing	24/01/2025
  solifenacin succinate	Tablet, film coated	10 mg	Current	Unavailable	Manufacturing	24/01/2025
  pregabalin	Capsule, hard	25 mg	Current	Limited Availability	Manufacturing	24/01/2025
  pregabalin	Capsule, hard	75 mg	Resolved	Available	Manufacturing	24/01/2025
  naloxone hydrochloride dihydrate	Spray, nasal	2.2 mg/actuation	Current	Limited Availability	Unexpected increase in consumer demand	24/01/2025
  adrenaline (epinephrine)	Injection, solution	500 microgram	Anticipated	Available	Manufacturing	24/01/2025
  lamotrigine	Tablet, chewable	100 mg	Current	Limited Availability	Unexpected increase in consumer demand	24/01/2025
  dosulepin (dothiepin) hydrochloride	Capsule, hard	25 mg	Resolved	Available	Manufacturing	24/01/2025
  methylphenidate hydrochloride	Tablet, modified release	54 mg	Discontinued	Reduction in supply until supply is exhausted	Manufacturing	24/01/2025
  methylphenidate hydrochloride	Tablet, modified release	54 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	24/01/2025
  methylphenidate hydrochloride	Tablet, modified release	36 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	24/01/2025
  methylphenidate hydrochloride	Tablet, modified release	27 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	24/01/2025
  methylphenidate hydrochloride	Tablet, modified release	18 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	24/01/2025
  levothyroxine sodium	Tablet, uncoated	.1 mg	Current	Unavailable	Commercial Changes / Commercial viability	24/01/2025
  tobramycin	Injection, solution	40 mg/mL	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	24/01/2025
  famotidine	Tablet, film coated	20 mg	Current	Unavailable	Manufacturing	24/01/2025
  methylphenidate hydrochloride	Tablet, modified release	18 mg	Current	Limited Availability	Manufacturing	24/01/2025
  methylphenidate hydrochloride	Tablet, modified release	36 mg	Current	Limited Availability	Manufacturing	24/01/2025
  methylphenidate hydrochloride	Tablet, modified release	54 mg	Current	Limited Availability	Manufacturing	24/01/2025
  nizatidine	Capsule	300 mg	Current	Limited Availability	Manufacturing	24/01/2025
  midazolam	Injection, solution	5 mg/mL	Current	Limited Availability	Manufacturing	23/01/2025
  topiramate	Tablet, film coated	200 mg	Current	Limited Availability	Manufacturing	23/01/2025
  venlafaxine hydrochloride	Capsule, modified release	169.71 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	23/01/2025
  losartan potassium	Tablet, film coated	50 mg	Current	Unavailable	Manufacturing	23/01/2025
  losartan potassium	Tablet, film coated	25 mg	Current	Unavailable	Manufacturing	23/01/2025
  insulin	Injection, solution	100 IU/mL	Resolved	Available	Transport / Logistic issues / Storage capacity issues	23/01/2025
  levetiracetam	Tablet, film coated	1000 mg	Current	Unavailable	Manufacturing	23/01/2025
  quetiapine fumarate	Tablet, film coated	28.78 mg	Resolved	Available	Manufacturing	23/01/2025
  tobramycin	Injection, solution	40 mg/mL	Current	Limited Availability	Unexpected increase in consumer demand	23/01/2025
  voriconazole	Injection, powder for	200 mg	Resolved	Available	Manufacturing	23/01/2025
  ezetimibe	Tablet, uncoated	10 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	23/01/2025
  celecoxib	Capsule, hard	100 mg	Current	Limited Availability	Manufacturing	23/01/2025
  emtricitabine~tenofovir disoproxil succinate	Tablet, film coated	200 mg~300.6 mg	Current	Unavailable	Manufacturing	23/01/2025
  chloramphenicol	Eye Drops, solution	5 mg/mL	Current	Unavailable	Manufacturing	23/01/2025
  gemfibrozil	Tablet, film coated	600 mg	Current	Unavailable	Manufacturing	23/01/2025
  doxycycline hyclate	Tablet, film coated	57.5 mg	Current	Limited Availability	Manufacturing	23/01/2025
  metformin hydrochloride	Tablet, film coated	850 mg	Current	Unavailable	Manufacturing	23/01/2025
  sugammadex sodium	Injection, solution	544 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	22/01/2025
  clonidine hydrochloride	Tablet, uncoated	100 microgram	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	22/01/2025
  phenoxymethylpenicillin potassium	Tablet, film coated	280 mg	Current	Limited Availability	Manufacturing	22/01/2025
  ezetimibe~atorvastatin calcium trihydrate	Tablet, multilayer	10 mg~21.7 mg	Current	Limited Availability	Manufacturing	22/01/2025
  cinacalcet hydrochloride	Tablet	99.191 mg	Current	Limited Availability	Manufacturing	22/01/2025
  nebivolol hydrochloride	Tablet	10.9 mg	Current	Unavailable	Manufacturing	22/01/2025
  nebivolol hydrochloride	Tablet	10.9 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	22/01/2025
  levothyroxine sodium	Tablet, uncoated	.075 mg	Current	Unavailable	Commercial Changes / Commercial viability	22/01/2025
  levothyroxine sodium	Tablet, uncoated	.025 mg	Current	Unavailable	Commercial Changes / Commercial viability	22/01/2025
  levothyroxine sodium	Tablet, uncoated	.05 mg	Current	Unavailable	Commercial Changes / Commercial viability	22/01/2025
  levothyroxine sodium	Tablet, uncoated	.2 mg	Current	Unavailable	Commercial Changes / Commercial viability	22/01/2025
  isosorbide dinitrate	Tablet, uncoated	5 mg	Resolved	Available	Manufacturing	21/01/2025
  hydrocortisone acetate	Eye Ointment	10 mg/g	Current	Limited Availability	Manufacturing	21/01/2025
  acetylcysteine	Injection, concentrated	2 g	Resolved	Available	Transport / Logistic issues / Storage capacity issues	21/01/2025
  pramipexole dihydrochloride monohydrate	Tablet	.125 mg	Anticipated	Available	Manufacturing	21/01/2025
  bisoprolol fumarate	Tablet	10 mg	Current	Limited Availability	Manufacturing	21/01/2025
  eftrenonacog alfa	Injection, powder for	250 IU	Current	Unavailable	Unexpected increase in consumer demand	21/01/2025
  desvenlafaxine	Tablet, modified release	50 mg	Resolved	Available	Manufacturing	21/01/2025
  rosuvastatin calcium	Tablet, film coated	41.68 mg	Resolved	Available	Manufacturing	21/01/2025
  clonidine hydrochloride	Tablet	100 microgram	Current	Unavailable	Unexpected increase in consumer demand	21/01/2025
  anastrozole	Tablet, film coated	1 mg	Current	Unavailable	Manufacturing	21/01/2025
  irbesartan~hydrochlorothiazide	Tablet, film coated	300 mg~12.5 mg	Current	Limited Availability	Manufacturing	21/01/2025
  bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrate	Injection, solution	5.27 mg/mL~9.1 microgram/mL	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	21/01/2025
  atorvastatin calcium trihydrate~ezetimibe	Tablet, film coated	41.363 mg~10 mg	Current	Unavailable	Manufacturing	21/01/2025
  ezetimibe~atorvastatin calcium trihydrate	Tablet, film coated	10 mg~20.681 mg	Current	Unavailable	Manufacturing	21/01/2025
  ezetimibe~atorvastatin calcium trihydrate	Tablet, film coated	10 mg~82.725 mg	Current	Unavailable	Manufacturing	21/01/2025
  dutasteride~tamsulosin hydrochloride	Capsule, modified release	500 microgram~400 microgram	Current	Unavailable	Manufacturing	21/01/2025
  carboplatin	Injection, solution	10 mg/mL	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	21/01/2025
  azithromycin dihydrate	Suspension, powder for	209.65 mg	Resolved	Available	Unexpected increase in consumer demand	21/01/2025
  ketamine hydrochloride	Injection, solution	115.3 mg/mL	Current	Limited Availability	Manufacturing	21/01/2025
  pioglitazone hydrochloride	Tablet, uncoated	33.06 mg	Anticipated	Available	Manufacturing	21/01/2025
  olanzapine	Injection, powder for	10 mg	Current	Limited Availability	Unexpected increase in consumer demand	21/01/2025
  testosterone enantate	Injection	250 mg/mL	Anticipated	Available	Unexpected increase in consumer demand	20/01/2025
  topiramate	Tablet, film coated	50 mg	Resolved	Available	Manufacturing	20/01/2025
  zolpidem tartrate	Tablet, film coated	10 mg	Current	Unavailable	Manufacturing	20/01/2025
  pramipexole dihydrochloride monohydrate	Tablet	1 mg	Current	Limited Availability	Manufacturing	20/01/2025
  ondansetron hydrochloride dihydrate	Tablet, film coated	9.972 mg	Anticipated	Available	Unexpected increase in consumer demand	20/01/2025
  praziquantel	Tablet, film coated	600 mg	Discontinued	Reduction in supply until supply is exhausted	Manufacturing	20/01/2025
  ivabradine hydrochloride	Tablet, film coated	5.39 mg	Current	Limited Availability	Manufacturing	20/01/2025
  hydrocortisone	Tablet, uncoated	20 mg	Current	Limited Availability	Manufacturing	20/01/2025
  rosuvastatin calcium	Tablet, film coated	20.84 mg	Resolved	Available	Manufacturing	20/01/2025
  cabergoline	Tablet, uncoated	1 mg	Current	Unavailable	Manufacturing	20/01/2025

• 2025.01.20
  TGAオーストラリア供給不足情報（2025年1月13日～2025年1月19日）

  Active ingredients	Dosage form	Quantity of active ingredients	Shortage status	Availability	Reason	Last updated
  Coxiella burnetii	Injection	50 microgram/mL	Current	Unavailable	Manufacturing	17/01/2025
  clomipramine hydrochloride	Tablet, film coated	25 mg	Anticipated	Available	Manufacturing	17/01/2025
  monobasic potassium phosphate	Injection, concentrated	136.1 mg/mL	Anticipated	Available	Manufacturing	17/01/2025
  donepezil hydrochloride	Tablet, film coated	10 mg	Anticipated	Available	Manufacturing	17/01/2025
  pramipexole dihydrochloride monohydrate	Tablet	.125 mg	Anticipated	Available	Manufacturing	17/01/2025
  duloxetine hydrochloride	Capsule, enteric	33.65 mg	Current	Limited Availability	Manufacturing	17/01/2025
  duloxetine hydrochloride	Capsule, enteric	33.66 mg	Current	Unavailable	Unexpected increase in consumer demand	17/01/2025
  bortezomib	Injection, powder for	3.5 mg	Current	Limited Availability	Manufacturing	17/01/2025
  duloxetine hydrochloride	Capsule, enteric	33.65 mg	Current	Limited Availability	Manufacturing	17/01/2025
  rizatriptan benzoate	Tablet, orally disintegrating	14.53 mg	Resolved	Available	Manufacturing	17/01/2025
  simvastatin	Tablet, film coated	20 mg	Resolved	Available	Manufacturing	17/01/2025
  ibuprofen~codeine phosphate hemihydrate	Tablet, film coated	200 mg~12.8 mg	Resolved	Available	Transport / Logistic issues / Storage capacity issues	17/01/2025
  esomeprazole	Capsule, enteric	20 mg	Current	Limited Availability	Manufacturing	17/01/2025
  efavirenz~tenofovir disoproxil maleate~emtricitabine	Tablet, film coated	600 mg~300 mg~200 mg	Anticipated	Available	Manufacturing	17/01/2025
  cisplatin	Injection, concentrated	1 mg/mL	Current	Unavailable	Unexpected increase in consumer demand	17/01/2025
  Influenza virus haemagglutinin	Injection, suspension	15 microgram	Anticipated	Available	Seasonal depletion of stock	17/01/2025
  celecoxib	Capsule, hard	100 mg	Anticipated	Available	Manufacturing	17/01/2025
  Influenza virus haemagglutinin	Injection, suspension	15 microgram	Anticipated	Available	Seasonal depletion of stock	17/01/2025
  deferasirox	Tablet, film coated	90 mg	Anticipated	Available	Manufacturing	17/01/2025
  atorvastatin calcium trihydrate	Tablet, film coated	10.844 mg	Anticipated	Available	Manufacturing	17/01/2025
  atorvastatin calcium trihydrate	Tablet, film coated	21.688 mg	Anticipated	Available	Manufacturing	17/01/2025
  spironolactone	Tablet, uncoated	25 mg	Anticipated	Available	Manufacturing	17/01/2025
  azithromycin dihydrate	Tablet, film coated	524 mg	Current	Unavailable	Unexpected increase in consumer demand	17/01/2025
  naproxen	Tablet	500 mg	Anticipated	Available	Manufacturing	17/01/2025
  cisplatin	Injection, solution	1 mg/mL	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	17/01/2025
  cisplatin	Injection, solution	1 mg/mL	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	17/01/2025
  levodopa~carbidopa monohydrate	Tablet, uncoated	100 mg~26.9 mg	Anticipated	Available	Manufacturing	17/01/2025
  pioglitazone hydrochloride	Tablet, uncoated	16.53 mg	Anticipated	Available	Manufacturing	17/01/2025
  clonidine hydrochloride	Tablet, uncoated	150 microgram	Resolved	Available	Transport / Logistic issues / Storage capacity issues	17/01/2025
  famotidine	Tablet, film coated	40 mg	Current	Limited Availability	Manufacturing	17/01/2025
  nizatidine	Capsule	150 mg	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	17/01/2025
  nizatidine	Capsule, hard	300 mg	Resolved	Available	Manufacturing	17/01/2025
  dinoprostone	Gel	.6667 mg/g	Current	Limited Availability	Manufacturing	17/01/2025
  sildenafil citrate	Tablet, film coated	28.09 mg	Resolved	Available	Unexpected increase in consumer demand	16/01/2025
  adrenaline (epinephrine) acid tartrate~lidocaine hydrochloride monohydrate	Injection, solution	22.7 microgram/mL~21.3 mg/mL	Current	Limited Availability	Manufacturing	16/01/2025
  sumatriptan succinate	Tablet, film coated	140 mg	Current	Unavailable	Manufacturing	16/01/2025
  ramipril	Capsule, hard	1.25 mg	Current	Limited Availability	Manufacturing	16/01/2025
  topiramate	Tablet, film coated	200 mg	Current	Limited Availability	Manufacturing	16/01/2025
  losartan potassium	Tablet, film coated	50 mg	Current	Unavailable	Manufacturing	16/01/2025
  losartan potassium	Tablet, film coated	25 mg	Current	Unavailable	Manufacturing	16/01/2025
  letrozole	Tablet, film coated	2.5 mg	Current	Limited Availability	Manufacturing	16/01/2025
  midazolam	Injection, solution	5 mg	Current	Limited Availability	Manufacturing	16/01/2025
  midazolam	Injection, solution	5 mg	Current	Limited Availability	Manufacturing	16/01/2025
  pramipexole dihydrochloride monohydrate	Tablet	.25 mg	Current	Unavailable	Transport / Logistic issues / Storage capacity issues	16/01/2025
  trandolapril	Capsule, hard	.5 mg	Current	Unavailable	Manufacturing	16/01/2025
  trandolapril	Capsule, hard	1 mg	Current	Limited Availability	Manufacturing	16/01/2025
  trandolapril	Capsule, hard	2 mg	Current	Unavailable	Manufacturing	16/01/2025
  trandolapril	Capsule, hard	4 mg	Current	Unavailable	Manufacturing	16/01/2025
  risperidone	Tablet, film coated	1 mg	Current	Limited Availability	Unexpected increase in consumer demand	16/01/2025
  risperidone	Tablet, film coated	2 mg	Current	Unavailable	Unexpected increase in consumer demand	16/01/2025
  phenoxymethylpenicillin potassium	Tablet, film coated	280 mg	Current	Limited Availability	Manufacturing	16/01/2025
  metoprolol succinate	Tablet, modified release	95 mg	Anticipated	Available	Manufacturing	16/01/2025
  metoprolol succinate	Tablet, modified release	47.5 mg	Current	Unavailable	Manufacturing	16/01/2025
  metoprolol succinate	Tablet, modified release	190 mg	Current	Unavailable	Manufacturing	16/01/2025
  amlodipine besilate	Tablet	6.93 mg	Current	Unavailable	Manufacturing	16/01/2025
  tadalafil	Tablet, film coated	20 mg	Current	Limited Availability	Manufacturing	16/01/2025
  entecavir	Tablet, film coated	.5 mg	Current	Unavailable	Manufacturing	16/01/2025
  felypressin~prilocaine hydrochloride	Injection, solution	.54 microgram/mL~30 mg/mL	Current	Limited Availability	Manufacturing	16/01/2025
  tobramycin	Injection, solution	40 mg/mL	Current	Limited Availability	Unexpected increase in consumer demand	16/01/2025
  buprenorphine	Drug delivery system, transdermal	5 mg	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	16/01/2025
  tenofovir disoproxil maleate	Tablet, film coated	300 mg	Current	Limited Availability	Manufacturing	16/01/2025
  nicotinic acid	Tablet, uncoated	250 mg	Current	Unavailable	Manufacturing	16/01/2025
  cefuroxime axetil	Tablet, film coated	300.715 mg	Resolved	Available	Manufacturing	16/01/2025
  clonazepam	Tablet, uncoated	.5 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	16/01/2025
  olmesartan medoxomil~hydrochlorothiazide	Tablet	40 mg~25 mg	Current	Unavailable	Manufacturing	16/01/2025
  dosulepin (dothiepin) hydrochloride	Capsule, hard	25 mg	Resolved	Available	Manufacturing	16/01/2025
  prasugrel	Tablet, film coated	5 mg	Current	Unavailable	Manufacturing	16/01/2025
  atorvastatin calcium trihydrate	Tablet, film coated	86.751 mg	Anticipated	Available	Manufacturing	16/01/2025
  dosulepin (dothiepin) hydrochloride	Capsule, hard	25 mg	Current	Unavailable	Manufacturing	16/01/2025
  pegcetacoplan	Injection, solution	1080 mg	Resolved	Available	Manufacturing	16/01/2025
  chloramphenicol	Eye Drops, solution	5 mg/mL	Current	Unavailable	Manufacturing	16/01/2025
  furosemide	Injection, solution	10 mg/mL	Resolved	Available	Transport / Logistic issues / Storage capacity issues	16/01/2025
  metoprolol succinate	Tablet, modified release	23.75 mg	Resolved	Available	Manufacturing	16/01/2025
  methylphenidate hydrochloride	Tablet, modified release	36 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	16/01/2025
  methylphenidate hydrochloride	Tablet, modified release	27 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	16/01/2025
  daptomycin	Inhalation, powder for	350 mg	Current	Limited Availability	Manufacturing	16/01/2025
  rosuvastatin calcium~ezetimibe	Tablet	10.4 mg~10 mg	Resolved	Available	Manufacturing	16/01/2025
  ezetimibe~rosuvastatin calcium	Tablet~Tablet, film coated	10 mg~41.6 mg	Resolved	Available	Manufacturing	16/01/2025
  tamoxifen citrate	Tablet, uncoated	15.2 mg	Anticipated	Available	Manufacturing	16/01/2025
  fluticasone propionate	Inhalation, conventional	1 mg/mL	Discontinued	Unavailable	Commercial Changes / Commercial viability	16/01/2025
  fluticasone propionate	Inhalation, conventional	.25 mg/mL	Discontinued	Unavailable	Commercial Changes / Commercial viability	16/01/2025
  fluticasone propionate	Nasal Drops	400 microgram	Discontinued	Unavailable	Commercial Changes / Commercial viability	16/01/2025
  nizatidine	Capsule	300 mg	Current	Limited Availability	Manufacturing	16/01/2025
  pravastatin sodium	Tablet, uncoated	40 mg	Resolved	Available	Manufacturing	16/01/2025
  clarithromycin	Tablet, film coated	250 mg	Resolved	Available	Unexpected increase in consumer demand	16/01/2025
  prazosin hydrochloride	Tablet, uncoated	5.476 mg	Resolved	Available	Unexpected increase in consumer demand	15/01/2025
  isosorbide dinitrate	Tablet, uncoated	5 mg	Anticipated	Available	Manufacturing	15/01/2025
  fentanyl	Drug delivery system, transdermal	8.4 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	15/01/2025
  capecitabine	Tablet, film coated	500 mg	Current	Unavailable	Manufacturing	15/01/2025
  tranexamic acid	Injection, solution	100 mg/mL	Current	Unavailable	Manufacturing	15/01/2025
  fenofibrate	Tablet	145 mg	Current	Limited Availability	Manufacturing	15/01/2025
  metformin hydrochloride	Tablet, film coated	1000 mg	Current	Unavailable	Manufacturing	15/01/2025
  estradiol	Drug delivery system, transdermal	1.56 mg	Current	Limited Availability	Manufacturing	15/01/2025
  trimethoprim	Tablet, uncoated	300 mg	Resolved	Available	Manufacturing	15/01/2025
  omeprazole	Tablet, enteric coated	20 mg	Discontinued	Unavailable	Manufacturing	15/01/2025
  prucalopride succinate	Tablet	1.321 mg	Current	Unavailable	Manufacturing	15/01/2025
  oxycodone hydrochloride	Oral Liquid, solution	1 mg/mL	Current	Limited Availability	Unexpected increase in consumer demand	15/01/2025
  methylphenidate hydrochloride	Capsule, modified release	40 mg	Current	Limited Availability	Unexpected increase in consumer demand	15/01/2025
  prazosin hydrochloride	Tablet, uncoated	1.095 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	14/01/2025
  prazosin hydrochloride	Tablet, uncoated	2.19 mg	Anticipated	Available	Unexpected increase in demand due to other sponsors unable to supply	14/01/2025
  ropinirole hydrochloride	Tablet, film coated	.57 mg	Current	Unavailable	Manufacturing	14/01/2025
  fluorouracil	Injection, solution	5000 mg	Current	Unavailable	Unexpected increase in consumer demand	14/01/2025
  galantamine hydrobromide	Capsule, modified release	10.252 mg	Anticipated	Available	Manufacturing	14/01/2025
  efmoroctocog alfa	Injection, powder for	2000 IU	Resolved	Available	Unexpected increase in consumer demand	14/01/2025
  nebivolol hydrochloride	Tablet	10.9 mg	Current	Limited Availability	Manufacturing	14/01/2025
  atorvastatin calcium trihydrate	Tablet, film coated	86.76 mg	Current	Limited Availability	Manufacturing	14/01/2025
  solifenacin succinate	Tablet, film coated	5 mg	Current	Unavailable	Manufacturing	14/01/2025
  solifenacin succinate	Tablet, film coated	10 mg	Current	Unavailable	Manufacturing	14/01/2025
  aciclovir	Injection, solution	25 mg/mL	Current	Limited Availability	Manufacturing	14/01/2025
  rosuvastatin calcium	Tablet, film coated	20.84 mg	Current	Limited Availability	Manufacturing	14/01/2025
  flecainide acetate	Tablet	50 mg	Resolved	Available	Manufacturing	14/01/2025
  levothyroxine sodium	Tablet, uncoated	.2 mg	Current	Limited Availability	Manufacturing	14/01/2025
  carbachol	Injection, solution	100 microgram/mL	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	14/01/2025
  olanzapine	Injection, powder for	10 mg	Current	Limited Availability	Unexpected increase in consumer demand	14/01/2025
  balsalazide sodium	Capsule	750 mg	Anticipated	Available	Manufacturing	14/01/2025
  metformin hydrochloride	Tablet, film coated	500 mg	Anticipated	Available	Manufacturing	14/01/2025
  oxytocin	Injection, solution	10 IU	Current	Unavailable	Manufacturing	13/01/2025
  Choriogonadotropin alfa	Injection, solution	250 microgram	Current	Limited Availability	Unexpected increase in consumer demand	13/01/2025
  doxorubicin hydrochloride	Injection, concentrated	2 mg/mL	Current	Unavailable	Manufacturing	13/01/2025
  galantamine hydrobromide	Capsule, modified release	10.252 mg	Current	Unavailable	Manufacturing	13/01/2025
  galantamine hydrobromide	Capsule, modified release	20.504 mg	Anticipated	Available	Manufacturing	13/01/2025
  galantamine hydrobromide	Capsule, modified release	30.756 mg	Current	Unavailable	Manufacturing	13/01/2025
  montelukast sodium	Tablet, chewable	5.2 mg	Anticipated	Available	Unexpected increase in consumer demand	13/01/2025
  bicalutamide	Tablet, film coated	50 mg	Current	Unavailable	Manufacturing	13/01/2025
  raloxifene hydrochloride	Tablet, film coated	60 mg	Current	Limited Availability	Unexpected increase in consumer demand	13/01/2025
  candesartan cilexetil	Tablet, uncoated	4 mg	Current	Limited Availability	Manufacturing	13/01/2025
  escitalopram oxalate	Tablet, film coated	25.47 mg	Current	Unavailable	Manufacturing	13/01/2025
  cefaclor monohydrate	Oral Liquid, powder for	52.45 mg/mL	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	13/01/2025
  Tocilizumab	Injection, solution	162 mg	Discontinued	Unavailable	Commercial Changes / Commercial viability	13/01/2025
  rosuvastatin calcium	Tablet, film coated	41.68 mg	Anticipated	Available	Manufacturing	13/01/2025
  ezetimibe	Tablet, uncoated	10 mg	Current	Unavailable	Unexpected increase in consumer demand	13/01/2025
  acamprosate calcium	Tablet, enteric coated	333 mg	Current	Limited Availability	Manufacturing	13/01/2025
  lacosamide	Tablet, film coated	100 mg	Anticipated	Available	Unexpected increase in consumer demand	13/01/2025
  Tocilizumab	Injection, solution	162 mg	Discontinued	Unavailable	Commercial Changes / Commercial viability	13/01/2025
  pregabalin	Capsule, hard	75 mg	Current	Limited Availability	Manufacturing	13/01/2025
  olanzapine	Tablet, uncoated	2.5 mg	Current	Unavailable	Manufacturing	13/01/2025
  lamotrigine	Tablet, chewable	100 mg	Current	Limited Availability	Unexpected increase in consumer demand	13/01/2025

• 2025.01.13
  TGAオーストラリア供給不足情報（2025年1月6日～2025年1月12日）

  Active ingredients	Dosage form	Quantity of active ingredients	Shortage status	Availability	Reason	Last updated
  cytarabine	Injection, solution	100 mg	Resolved	Available	Unexpected increase in consumer demand	10/01/2025
  topiramate	Tablet, film coated	100 mg	Resolved	Available	Manufacturing	10/01/2025
  topiramate	Tablet, film coated	200 mg	Resolved	Available	Manufacturing	10/01/2025
  levetiracetam	Tablet, film coated	500 mg	Resolved	Available	Manufacturing	10/01/2025
  clonidine hydrochloride	Tablet, uncoated	100 microgram	Current	Unavailable	Transport / Logistic issues / Storage capacity issues	10/01/2025
  bisoprolol fumarate	Tablet	2.5 mg	Resolved	Available	Manufacturing	10/01/2025
  azithromycin dihydrate	Tablet, film coated	524.05 mg	Current	Unavailable	Manufacturing	10/01/2025
  eftrenonacog alfa	Injection, powder for	1000 IU	Resolved	Available	Unexpected increase in consumer demand	10/01/2025
  eftrenonacog alfa	Injection, powder for	250 IU	Current	Unavailable	Unexpected increase in consumer demand	10/01/2025
  clopidogrel besilate	Tablet, film coated	112.1 mg	Current	Limited Availability	Manufacturing	10/01/2025
  clonidine hydrochloride	Tablet	100 microgram	Current	Unavailable	Unexpected increase in consumer demand	10/01/2025
  clonidine hydrochloride	Tablet	100 microgram	Current	Unavailable	Manufacturing	10/01/2025
  irbesartan	Tablet, film coated	300 mg	Resolved	Available	Manufacturing	10/01/2025
  ivabradine hydrochloride	Tablet, film coated	8.085 mg	Anticipated	Available	Manufacturing	10/01/2025
  mesalazine	Tablet, enteric coated	250 mg	Current	Limited Availability	Manufacturing	10/01/2025
  risperidone	Tablet, film coated	.5 mg	Resolved	Available	Manufacturing	10/01/2025
  ravulizumab	Injection, intravenous infusion	100 mg/mL	Resolved	Available	Transport / Logistic issues / Storage capacity issues	10/01/2025
  prucalopride succinate	Tablet	2.642 mg	Current	Unavailable	Manufacturing	10/01/2025
  thiotepa	Injection, powder for	15 mg	Resolved	Available	Unexpected increase in consumer demand	10/01/2025
  thiotepa	Injection, powder for	15 mg	Current	Unavailable	Commercial Changes / Commercial viability	10/01/2025
  estradiol hemihydrate	Drug delivery system, transdermal	1.54 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	10/01/2025
  doxycycline hyclate	Tablet, film coated	57.5 mg	Current	Limited Availability	Manufacturing	10/01/2025
  estradiol hemihydrate	Drug delivery system, transdermal	.77 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	10/01/2025
  estradiol hemihydrate	Drug delivery system, transdermal	3.09 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	10/01/2025
  metformin hydrochloride	Tablet, film coated	500 mg	Current	Unavailable	Manufacturing	10/01/2025
  estradiol hemihydrate	Drug delivery system, transdermal	2.32 mg	Current	Limited Availability	Unexpected increase in demand due to other sponsors unable to supply	10/01/2025
  clonidine hydrochloride	Tablet, uncoated	150 microgram	Current	Unavailable	Transport / Logistic issues / Storage capacity issues	10/01/2025
  famotidine	Tablet, film coated	20 mg	Current	Unavailable	Manufacturing	10/01/2025
  famotidine	Tablet, film coated	40 mg	Current	Unavailable	Manufacturing	10/01/2025
  nizatidine	Capsule, hard	300 mg	Current	Limited Availability	Manufacturing	10/01/2025
  dopamine hydrochloride	Injection, concentrated	40 mg/mL	Resolved	Available	Manufacturing	9/01/2025
  paroxetine hydrochloride	Tablet, film coated	22.21 mg	Current	Limited Availability	Manufacturing	9/01/2025
  mesalazine	Tablet, enteric coated	800 mg	Current	Limited Availability	Manufacturing	9/01/2025
  Trastuzumab	Injection, powder for	60 mg	Current	Unavailable	Manufacturing	9/01/2025
  naloxone hydrochloride dihydrate	Spray, nasal	2.2 mg/actuation	Current	Limited Availability	Manufacturing	9/01/2025
  daptomycin	Injection, powder for	500 mg	Resolved	Available	Manufacturing	9/01/2025
  Adalimumab	Injection, solution	40 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	9/01/2025
  carbamazepine	Tablet, modified release	200 mg	Resolved	Available	Manufacturing	9/01/2025
  oxcarbazepine	Tablet, film coated	150 mg	Resolved	Available	Manufacturing	9/01/2025
  citalopram hydrobromide	Tablet, film coated	24.98 mg	Current	Limited Availability	Manufacturing	9/01/2025
  Meningococcal polysaccharide group C~Tetanus toxoid	Injection, suspension	20 microgram/mL~20 microgram/mL	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	9/01/2025
  diclofenac sodium	Suppository, moulded	50 mg	Resolved	Available	Transport / Logistic issues / Storage capacity issues	9/01/2025
  sevelamer hydrochloride	Tablet, film coated	800 mg	Resolved	Available	Manufacturing	8/01/2025
  hydrocortisone acetate	Eye Ointment	10 mg/g	Current	Unavailable	Manufacturing	8/01/2025
  tamsulosin hydrochloride~dutasteride	Capsule, modified release	400 microgram~500 microgram	Resolved	Available	Manufacturing	8/01/2025
  rosuvastatin calcium~ezetimibe	Tablet~Tablet, film coated	20.791 mg~10 mg	Resolved	Available	Manufacturing	8/01/2025
  quetiapine fumarate	Tablet, film coated	28.78 mg	Current	Limited Availability	Manufacturing	8/01/2025
  efmoroctocog alfa	Injection, powder for	2000 IU	Current	Unavailable	Unexpected increase in consumer demand	8/01/2025
  cisatracurium besilate	Injection, solution	14.07 mg	Current	Unavailable	Transport / Logistic issues / Storage capacity issues	8/01/2025
  citalopram hydrobromide	Tablet, film coated	12.495 mg	Current	Unavailable	Manufacturing	8/01/2025
  buprenorphine	Drug delivery system, transdermal	5 mg	Current	Limited Availability	Manufacturing	8/01/2025
  isotretinoin	Capsule, soft	10 mg	Current	Unavailable	Manufacturing	8/01/2025
  olmesartan medoxomil~hydrochlorothiazide	Tablet	20 mg~12.5 mg	Current	Unavailable	Manufacturing	8/01/2025
  hydrochlorothiazide~olmesartan medoxomil	Tablet	25 mg~40 mg	Current	Limited Availability	Manufacturing	8/01/2025
  Trastuzumab	Injection, powder for	150 mg	Current	Unavailable	Manufacturing	8/01/2025
  clobazam	Tablet, uncoated	10 mg	Current	Unavailable	Manufacturing	8/01/2025
  oxaliplatin	Injection, concentrated	100 mg	Current	Limited Availability	Manufacturing	8/01/2025
  reboxetine mesilate	Tablet, uncoated	5.224 mg	Anticipated	Available	Manufacturing	8/01/2025
  ethosuximide	Capsule, soft	250 mg	Discontinued	Unavailable	Manufacturing	8/01/2025
  acetylcysteine	Injection, concentrated	2 g	Current	Unavailable	Manufacturing	7/01/2025
  fentanyl	Drug delivery system, transdermal	2.1 mg	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	7/01/2025
  tramadol hydrochloride	Tablet, modified release	200 mg	Current	Limited Availability	Manufacturing	7/01/2025
  bisoprolol fumarate	Tablet	5 mg	Resolved	Available	Manufacturing	7/01/2025
  duloxetine hydrochloride	Capsule, enteric	33.65 mg	Current	Limited Availability	Manufacturing	7/01/2025
  bortezomib	Injection, powder for	3.5 mg	Current	Limited Availability	Manufacturing	7/01/2025
  amlodipine besilate	Tablet	6.93 mg	Current	Limited Availability	Manufacturing	7/01/2025
  doxylamine succinate~codeine phosphate hemihydrate~paracetamol	Tablet, uncoated	5.1 mg~10 mg~500 mg	Resolved	Available	Manufacturing	7/01/2025
  cefuroxime axetil	Tablet, film coated	300.715 mg	Current	Limited Availability	Manufacturing	7/01/2025
  ezetimibe	Tablet	10 mg	Resolved	Available	Unexpected increase in consumer demand	7/01/2025
  tadalafil	Tablet, film coated	5 mg	Resolved	Available	Manufacturing	7/01/2025
  tadalafil	Tablet, film coated	20 mg	Resolved	Available	Manufacturing	7/01/2025
  amlodipine besilate~olmesartan medoxomil	Tablet, film coated	6.935 mg~40 mg	Current	Unavailable	Manufacturing	7/01/2025
  dexmedetomidine hydrochloride	Injection, concentrated	118 microgram/mL	Resolved	Available	Manufacturing	7/01/2025
  dimethyl fumarate	Capsule, enteric	120 mg	Current	Limited Availability	Manufacturing	7/01/2025
  metoprolol succinate	Tablet, modified release	23.75 mg	Current	Limited Availability	Manufacturing	7/01/2025
  lanreotide acetate	Injection, solution	133.33 mg	Resolved	Available	Transport / Logistic issues / Storage capacity issues	7/01/2025
  lanreotide acetate	Injection, solution	100 mg	Resolved	Available	Transport / Logistic issues / Storage capacity issues	7/01/2025
  sitagliptin hydrochloride monohydrate	Tablet, film coated	109 mg	Current	Unavailable	Manufacturing	7/01/2025
  sitagliptin hydrochloride monohydrate	Tablet, film coated	54.5 mg	Current	Unavailable	Manufacturing	7/01/2025
  sitagliptin hydrochloride monohydrate	Tablet, film coated	27.25 mg	Current	Unavailable	Manufacturing	7/01/2025
  paracetamol	Tablet, modified release	665 mg	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	7/01/2025
  heparin sodium	Injection, solution	5000 IU/mL	Resolved	Available	Manufacturing	7/01/2025
  methylphenidate hydrochloride	Capsule, modified release	30 mg	Resolved	Available	Manufacturing	7/01/2025
  gabapentin	Tablet, film coated	800 mg	Current	Unavailable	Manufacturing	6/01/2025
  quetiapine fumarate	Tablet, film coated	28.78 mg	Resolved	Available	Manufacturing	6/01/2025
  quetiapine fumarate	Tablet, film coated	345.36 mg	Resolved	Available	Manufacturing	6/01/2025
  adefovir dipivoxil	Tablet	10 mg	Resolved	Available	Unexpected increase in consumer demand	6/01/2025
  ezetimibe	Tablet, uncoated	10 mg	Resolved	Available	Unexpected increase in demand due to other sponsors unable to supply	6/01/2025
  apomorphine hydrochloride hemihydrate	Injection, solution	10 mg	Resolved	Available	Manufacturing	6/01/2025
  lurasidone hydrochloride	Tablet, film coated	80 mg	Current	Unavailable	Manufacturing	6/01/2025
  furosemide	Injection, solution	10 mg/mL	Current	Limited Availability	Transport / Logistic issues / Storage capacity issues	6/01/2025
  rosuvastatin calcium~ezetimibe	Tablet	10.4 mg~10 mg	Current	Unavailable	Manufacturing	6/01/2025
  ezetimibe~rosuvastatin calcium	Tablet~Tablet, film coated	10 mg~41.6 mg	Current	Unavailable	Manufacturing	6/01/2025
  tamoxifen citrate	Tablet, uncoated	30.4 mg	Discontinued	Reduction in supply until supply is exhausted	Commercial Changes / Commercial viability	6/01/2025
  cabergoline	Tablet, uncoated	1 mg	Anticipated	Available	Manufacturing	6/01/2025

• 2025.01.06
  TGAオーストラリア供給不足情報（2024年12月30日～2025年1月5日）

  Active ingredients	Dosage form	Quantity of active ingredients	Shortage status	Availability	Reason	Last updated
  paclitaxel	Injection, concentrated	6 mg/mL	Current	Limited Availability	Manufacturing	3/01/2025
  galantamine hydrobromide	Capsule, modified release	10.252 mg	Anticipated	Available	Manufacturing	3/01/2025
  galantamine hydrobromide	Capsule, modified release	30.756 mg	Current	Limited Availability	Manufacturing	3/01/2025
  galantamine hydrobromide	Capsule, modified release	20.504 mg	Current	Unavailable	Manufacturing	3/01/2025
  azithromycin dihydrate	Tablet, film coated	524.05 mg	Current	Limited Availability	Manufacturing	3/01/2025
  buprenorphine	Drug delivery system, transdermal	5 mg	Current	Limited Availability	Manufacturing	3/01/2025
  linezolid	Tablet, film coated	600 mg	Anticipated	Available	Manufacturing	3/01/2025
  azithromycin dihydrate	Tablet, film coated	524 mg	Current	Limited Availability	Manufacturing	3/01/2025
  fluorouracil	Injection, solution	50 mg/mL	Current	Unavailable	Manufacturing	3/01/2025
  cisplatin	Injection, concentrated	1 mg/mL	Current	Unavailable	Unexpected increase in consumer demand	3/01/2025
  potassium chloride	Injection, concentrated	75 mg/mL	Current	Unavailable	Commercial Changes / Commercial viability	3/01/2025
  mesalazine	Tablet, enteric coated	1.6 g	Current	Limited Availability	Manufacturing	3/01/2025
  Fremanezumab	Injection, solution	225 mg	Resolved	Available	Unexpected increase in consumer demand	3/01/2025
  sitagliptin fumarate	Tablet, film coated	32.124 mg	Current	Unavailable	Manufacturing	3/01/2025
  azithromycin dihydrate	Tablet, film coated	524 mg	Current	Unavailable	Unexpected increase in consumer demand	3/01/2025
  rifabutin	Capsule, hard	150 mg	Resolved	Available	Transport / Logistic issues / Storage capacity issues	3/01/2025
  aciclovir	Injection, solution	25 mg/mL	Resolved	Available	Manufacturing	3/01/2025
  azithromycin dihydrate	Tablet, film coated	628.93 mg	Resolved	Available	Manufacturing	3/01/2025
  fluticasone propionate	Inhalation, pressurised	125 microgram/actuation	Current	Limited Availability	Unexpected increase in consumer demand	3/01/2025
  estradiol~dydrogesterone	Tablet, film coated	2 mg~10 mg	Anticipated	Available	Manufacturing	3/01/2025
  pioglitazone hydrochloride	Tablet, uncoated	33.06 mg	Anticipated	Available	Manufacturing	3/01/2025
  morphine sulfate pentahydrate	Tablet, modified release	10 mg	Current	Unavailable	Manufacturing	2/01/2025
  morphine sulfate pentahydrate	Tablet, modified release	30 mg	Current	Unavailable	Manufacturing	2/01/2025
  morphine sulfate pentahydrate	Tablet, modified release	60 mg	Current	Unavailable	Manufacturing	2/01/2025
  morphine sulfate pentahydrate	Tablet, modified release	100 mg	Current	Unavailable	Manufacturing	2/01/2025
  venlafaxine	Capsule, modified release	75 mg	Resolved	Available	Manufacturing	2/01/2025
  venlafaxine	Capsule, modified release	150 mg	Resolved	Available	Manufacturing	2/01/2025
  metronidazole	Tablet, uncoated	400 mg	Anticipated	Available	Manufacturing	2/01/2025
  candesartan cilexetil	Tablet, uncoated	4 mg	Current	Limited Availability	Manufacturing	2/01/2025
  morphine hydrochloride trihydrate	Injection, solution	10 mg/mL	Current	Limited Availability	Manufacturing	2/01/2025
  pemetrexed disodium	Injection, powder for	110.28 mg	Current	Unavailable	Manufacturing	2/01/2025
  pemetrexed disodium	Injection, powder for	551.4 mg	Current	Limited Availability	Manufacturing	2/01/2025
  pemetrexed disodium	Injection, powder for	1102.8 mg	Current	Unavailable	Manufacturing	2/01/2025
  betahistine dihydrochloride	Tablet	24 mg	Resolved	Available	Unexpected increase in consumer demand	2/01/2025
  nebivolol hydrochloride	Tablet	10.9 mg	Anticipated	Available	Manufacturing	2/01/2025
  ropinirole hydrochloride	Tablet, film coated	.285 mg	Resolved	Available	Manufacturing	2/01/2025
  risperidone	Tablet, film coated	.5 mg	Anticipated	Available	Manufacturing	2/01/2025
  levothyroxine sodium	Tablet	.05 mg	Current	Unavailable	Manufacturing	2/01/2025
  levothyroxine sodium	Tablet	.2 mg	Current	Limited Availability	Manufacturing	2/01/2025
  levothyroxine sodium	Tablet	.1 mg	Current	Unavailable	Manufacturing	2/01/2025
  fentanyl citrate	Injection, solution	157 microgram	Current	Unavailable	Manufacturing	2/01/2025
  levothyroxine sodium	Tablet	50 microgram	Resolved	Available	Manufacturing	2/01/2025
  melatonin	Capsule, hard	5 mg	Resolved	Available	Unexpected increase in consumer demand	2/01/2025
  melatonin	Oral Liquid, solution	1 mg/mL	Resolved	Available	Unexpected increase in consumer demand	2/01/2025
  riboflavine sodium phosphate~folic acid~sodium pantothenate~Biotin~pyridoxine hydrochloride~cyanocobalamin~sodium ascorbate~nicotinamide~thiamine nitrate	Injection, powder for	4.9 mg~.4 mg~16.5 mg~60 microgram~4.9 mg~5 microgram~113 mg~40 mg~3.1 mg	Resolved	Available	Manufacturing	2/01/2025
  imipramine hydrochloride	Tablet, sugar coated	25 mg	Current	Unavailable	Manufacturing	2/01/2025